syndrome	score	normalized_score
EXFOLIATION SYNDROME; XFS	6.24953811	100.0
#305390 EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, 2;;EVRX;;FEVR, X-LINKED; FEVRX	4.24613456	67.94317412363135
VITREORETINOCHOROIDOPATHY; VRCP	3.95069201	63.21574395519608
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	3.9235081599999995	62.780770209592326
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	3.7482226	59.97599396989677
#221900 PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR;;RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC; NCRNA;;RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT;;PERSISTENT FETAL VASCULATURE	3.56771022	57.08758242935173
VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY	3.4005367900000003	54.41260986245911
FOURTH CRANIAL NERVE PALSY, FAMILIAL CONGENITAL	3.25	52.00384320882237
MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1	3.1525252	50.44413114235734
RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1	3.01920108	48.31078756314681
MEGALOCORNEA	3.0169118600000004	48.274157336085125
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	2.9531824010000003	47.254410630356176
RETINAL VENOUS BEADING	2.875	46.00339976165055
NEUROFIBROMATOSIS, TYPE II	2.834248751	45.351331588247575
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.6771707000000005	42.837897023401
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	2.56480103	41.039849423368025
GROENOUW TYPE I CORNEAL DYSTROPHY	2.50611075	40.100735540598215
EXUDATIVE VITREORETINOPATHY 4	2.4834635400000002	39.73835339968829
BARDET-BIEDL SYNDROME 21; BBS21	2.4183543800000007	38.69652984642734
MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	2.41175654	38.59095660431136
#180550 RING DERMOID OF CORNEA; RDC	2.3596488	37.75717114556487
PIERSON SYNDROME	2.31522014	37.04626004752854
MACHADO-JOSEPH DISEASE; MJD	2.31290656	37.00924003166052
GAUCHER DISEASE, TYPE IIIC	2.2973101110000003	36.759678404457325
BEHCET SYNDROME	2.2638889	36.22489950701333
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	2.2547881	36.07927594508261
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	2.1832028009999997	34.93382650962024
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	2.1180163309999998	33.89076590493821
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	2.09474621	33.51841645141996
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1	2.0690473	33.107203501796064
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	2.0624011	33.00085644249316
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	2.0459658600000004	32.73787316739797
DERMOCHONDROCORNEAL DYSTROPHY	2.0357143	32.57383608466387
ANTERIOR SEGMENT DYSGENESIS 8	2.00957549	32.15558421484688
#607364 BARTTER SYNDROME, TYPE 3;;BARTTER SYNDROME, CLASSICBARTTER SYNDROME, TYPE 3, WITH HYPOCALCIURIA, INCLUDED	2.0	32.00236505158299
MICROPHTHALMIA, ISOLATED 5	1.95436787	31.272197010412345
#143200 WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1	1.9328343300000002	30.927634906445917
#133780 EXUDATIVE VITREORETINOPATHY 1; EVR1;;EXUDATIVE VITREORETINOPATHY, FAMILIAL, AUTOSOMAL DOMINANT;;FEVR, AUTOSOMAL DOMINANT;;CRISWICK-SCHEPENS SYNDROMERETINOPATHY OF PREMATURITY, INCLUDED; ROP, INCLUDED	1.91652394	30.66664937898907
BIRDSHOT CHORIORETINOPATHY	1.90617254	30.50101473819159
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	1.8999997000000002	30.40224199864909
FOVEAL HYPOPLASIA 2; FVH2	1.8766088900000002	30.027961378412975
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	1.8644771910000002	29.83383984836602
CATARACT 3, MULTIPLE TYPES; CTRCT3	1.8459912	29.538042132204872
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	1.809941	28.96119630191358
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	1.8040219409999998	28.866484358473656
MACULAR DYSTROPHY, RETINAL, 2	1.76051985	28.170399460129065
LATE-ONSET RETINAL DEGENERATION; LORD	1.75400827	28.06620648001777
RETINITIS PIGMENTOSA 83; RP83	1.74629663	27.942811120804578
PHACE ASSOCIATION	1.720309391	27.52698456622421
PERIPHERAL CONE DYSTROPHY	1.7110409100000004	27.37867791000638
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	1.6357873399999998	26.17453180071895
BLAU SYNDROME	1.61342711	25.816741679170274
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	1.60237811	25.639944613442804
VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	1.59453229	25.514402215558295
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	1.5851214100000002	25.36381700694998
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	1.5747097600000002	25.197218294905323
MYOCLONIC EPILEPSY OF LAFORA	1.55364021	24.86008057961903
Anterior segment dysgenesis 6, multiple subtypes	1.5523813	24.839936530925485
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	1.5468815710000001	24.751934363354096
#610048 CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD;;CONGENITAL STROMAL CORNEAL DYSTROPHY	1.53451368	24.554033482004005
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5277778	24.446251436652172
OCULAR MOTOR APRAXIA	1.5181818	24.292704089134677
#609508 STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR;;STICKLER SYNDROME, TYPE I, PREDOMINANTLY OCULAR;;STICKLER SYNDROME, ATYPICALRHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT, INCLUDED; DRRD,INCLUDED	1.50456621	24.074838548348335
ARTERIOSCLEROSIS, SEVERE JUVENILE	1.5	24.00177378868724
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	1.5	24.00177378868724
DUANE-RADIAL RAY SYNDROME; DRRS	1.4777882200000003	23.646359042684523
DIGEORGE SYNDROME; DGS	1.476582691	23.627069153115382
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	1.458333	23.33505251638509
RETINOBLASTOMA; RB1	1.458333	23.33505251638509
OCULOECTODERMAL SYNDROME; OES	1.444252451	23.10974708177274
JOUBERT SYNDROME 1	1.43476661	22.9579624085211
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	1.42321399	22.773106827249993
MICROCORIA, CONGENITAL	1.4219459300000001	22.75281636773634
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	1.41916561	22.708327959936227
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	1.4088616299999999	22.54345209521412
NAIL-PATELLA SYNDROME	1.4053046100000002	22.486535568946234
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	1.39588013	22.335732744255562
INCONTINENTIA PIGMENTI; IP	1.3923573410000005	22.279363954466717
CHERUBISM	1.3880263700000002	22.2100632969818
LEBER CONGENITAL AMAUROSIS 15; LCA15	1.38565307	22.17208769049334
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	1.3719849000000002	21.953380807529797
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	1.36480658	21.838519198981253
OPTIC ATROPHY 1; OPA1	1.3610616199999999	21.77859541046946
CRANIOLENTICULOSUTURAL DYSPLASIA	1.3535077500000003	21.657724557823368
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	1.35249981	21.641596325908317
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	1.3501020200000002	21.603228850459804
RETINITIS PIGMENTOSA 18	1.3494782799999998	21.59324827287116
CONE-ROD DYSTROPHY 18	1.3462561	21.541689582560206
ANTERIOR SEGMENT DYSGENESIS 3	1.34551812	21.52988102987982
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	1.3382250100000002	21.413182645589153
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	1.3359065209999998	21.376084079916108
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	1.33438133	21.351679220338415
BRANCHIOOTORENAL SYNDROME 1	1.333333	21.334904700661152
RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS	1.333333	21.334904700661152
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	1.32988076	21.27966477829831
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	1.3256893710000002	21.21259759787272
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	1.32291248	21.16816405812749
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	1.3126266100000001	21.00357797482093
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	1.30730821	20.918477285675756
SJOGREN-LARSSON SYNDROME; SLS	1.3056373909999999	20.891742205889198
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	20.89043345316923
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	1.3053446000000002	20.887057203656294
#613587 OCCULT MACULAR DYSTROPHY; OCMD;;OMD	1.2934783	20.69718237145049
CATARACT 30, MULTIPLE TYPES	1.291667	20.668199429541524
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	1.27161358	20.347320995855164
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.2709765800000001	20.33712824258624
SPINOCEREBELLAR ATAXIA 42	1.2698072699999998	20.318417899847
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	1.2674992	20.281486050494703
BLUE CONE MONOCHROMACY; BCM	1.26548715	20.249290871193683
#137580 GILLES DE LA TOURETTE SYNDROME; GTS;;TOURETTE SYNDROME; TS;;TOURETTE DISORDERCHRONIC MOTOR TICS, INCLUDED	1.2653846	20.247649949925663
PAPILLORENAL SYNDROME	1.2459278710000001	19.9363192778418
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	1.24326506	19.893711152999114
HYPEROXALURIA, PRIMARY, TYPE I; HP1	1.2406471100000003	19.851820857205723
EPISODIC ATAXIA, TYPE 2	1.23954929	19.834254439005257
ELSAHY-WATERS SYNDROME; ESWS	1.2374458700000002	19.80059723165686
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	1.23690857	19.791999796285747
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	1.231108511	19.699191993566387
#160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1;;MYOPATHY, TUBULAR AGGREGATE; TAM;;TUBULAR AGGREGATE MYOPATHY	1.2276096	19.64320528001389
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	1.22467681	19.59627717191407
COLOBOMA, OCULAR	1.22375179	19.58147575805406
DUANE RETRACTION SYNDROME 1	1.2230389000000002	19.570068675043252
CONE-ROD DYSTROPHY 2	1.22140844	19.54397938698225
GLAUCOMA 1, OPEN ANGLE, F; GLC1F	1.2095237	19.353809492970676
CONE-ROD DYSTROPHY 16	1.20861576	19.339281379308208
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	1.1949534400000001	19.12066810326244
MOWAT-WILSON SYNDROME; MOWS	1.1898333210000005	19.03874014458967
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	1.18973203	19.037119368810444
NEUROBLASTOMA, SUSCEPTIBILITY TO	1.18943742	19.03240526042652
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	1.1890325609999999	19.02592703767031
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5	1.1887820299999998	19.021918245410937
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	1.18822951	19.01307727204179
MICROPHTHALMIA, SYNDROMIC 1	1.188067471	19.010484456426497
MICROSPHEROPHAKIA WITH HERNIA	1.18762661	19.00343015909699
RETINITIS PIGMENTOSA 78; RP78	1.1859654499999999	18.976849634732446
#614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	1.17804904	18.850177713373448
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	1.17115857	18.739922045214954
#614292 MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD	1.1700165900000001	18.721649014794153
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	1.1696967100000002	18.716530556527804
#610202 CATARACT 21, MULTIPLE TYPES; CTRCT21;;CATARACT 21, MULTIPLE TYPES, WITH OR WITHOUT MICROCORNEA;;CATARACT, CONGENITAL, CERULEAN TYPE, 4; CCA4;;CATARACT, PULVERULENT, JUVENILE-ONSET	1.1597707	18.557702658764967
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	1.1555812400000003	18.49066634462047
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	1.15369188	18.46043435040354
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II	1.14346624	18.296812018320505
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.141492751	18.26523386061886
GLAUCOMA 3, PRIMARY CONGENITAL, A	1.1380953	18.21087062704543
Retinitis pigmentosa with or without skeletal anomalies	1.1333856800000002	18.135511137798314
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	1.125	18.00133034151543
CATARACT 31, MULTIPLE TYPES	1.1213235	17.942501993959358
RETINITIS PIGMENTOSA 75; RP75	1.11509251	17.842798785652978
CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE	1.1071429	17.71559562503412
#262300 ACHROMATOPSIA 3; ACHM3;;PINGELAPESE BLINDNESS;;TOTAL COLORBLINDNESS WITH MYOPIA;;ACHROMATOPSIA WITH MYOPIA;;ACHM1, FORMERLY;;ROD MONOCHROMATISM 1, FORMERLY;;ROD MONOCHROMACY 1, FORMERLY; RMCH1, FORMERLY	1.0939502300000001	17.50449730436159
STARGARDT DISEASE 3; STGD3	1.08608915	17.37871072843174
CRI-DU-CHAT SYNDROME	1.08508832	17.362696264924452
HORNER SYNDROME, CONGENITAL	1.08422237	17.34884004091624
ALBINISM, OCULAR, TYPE I	1.08059148	17.29074150729517
142500 HETEROCHROMIA IRIDIS	1.0769231	17.232043089341207
STURGE-WEBER SYNDROME	1.072344351	17.15877769085242
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	1.0703801099999999	17.12734751208678
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	1.06932105	17.110401299721016
TREMOR, HEREDITARY ESSENTIAL, 5; ETM5	1.0667311	17.06895903703834
OPTIC ATROPHY 8	1.0646323100000001	17.035375915165034
LOWE OCULOCEREBRORENAL SYNDROME	1.0636414410000001	17.01952083943689
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	1.063513621	17.01747556828644
#614970 JOUBERT SYNDROME 20; JBTS20	1.0552188	16.884748623446672
#601536 ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS;;NAVAJO BRAINSTEM SYNDROMEBOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	1.05	16.80124165208107
HYPEREKPLEXIA 2; HKPX2	1.04716789	16.755924543037953
BROWN SYNDROME	1.0454545	16.728508276910084
#165550 OPTIC NERVE HYPOPLASIA, BILATERALOPTIC NERVE APLASIA, BILATERAL, INCLUDED	1.04431939	16.710345174613234
STICKLER SYNDROME, TYPE I	1.04428771	16.709838257150817
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	1.04352544	16.697641035746884
DYSTONIA 6, TORSION	1.0433519100000002	16.694864350543185
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.04141637	16.663893421717212
RETINITIS PIGMENTOSA	1.03940008	16.631630397402283
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	1.0384615	16.61661200750722
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	1.03778941	16.605857772743466
CORNEAL DYSTROPHY, CRYSTALLINE, OF SCHNYDER	1.0357143	16.572653558872368
CORNEAL DYSTROPHY, CENTRAL TYPE	1.0357143	16.572653558872368
Oliver-McFarlane syndrome	1.0356388100000002	16.571445629603502
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	1.032457431	16.520539803540778
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.03210495	16.514899690722903
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	1.02841347	16.455831645452594
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	1.02789362	16.447513430716562
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	1.02573911	16.41303872295292
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.025641	16.411468846935314
OCULOSKELETODENTAL SYNDROME; OCSKD	1.02246212	16.360603007827727
POLYMYOCLONUS, INFANTILE	1.02195342	16.35246320627686
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	1.01963375	16.315345743207253
CONE-ROD DYSTROPHY 8; CORD8	1.01959373	16.31470537588257
CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT	1.0194961900000001	16.313144620539006
PALMOMENTAL REFLEX	1.0188679	16.303091237569877
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	1.01712691	16.2752333388043
150500 LATTICE DEGENERATION OF RETINA LEADING TO RETINAL DETACHMENT	1.0163934000000001	16.26349631140981
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	1.015621651	16.25114741479671
RETT SYNDROME; RTT	1.014957161	16.240514789020146
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	1.0148295	16.23847206205772
YOU-HOOVER-FONG SYNDROME; YHFS	1.0140845	16.226551181076008
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	1.01392478	16.223995472202983
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	1.01392478	16.223995472202983
WILSON DISEASE	1.0138944600000002	16.223510316348808
IRIS PIGMENT LAYER, CLEAVAGE OF	1.01342711	16.216032163695377
GENIOSPASM 1; GSM1	1.0128205	16.206325686363403
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	1.01270998	16.204557235670652
ATONIC-ASTATIC SYNDROME OF FOERSTER	1.010101	16.162810470484516
TEMPORAL ARTERITIS	1.00990099	16.15961007396753
#177700 GLAUCOMA 1, OPEN ANGLE, P; GLC1P	1.00980392	16.158056839179753
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	1.00964815	16.15556433497771
CORNEAL FLECK DYSTROPHY	1.00775194	16.125222732660475
IMMUNODEFICIENCY 23; IMD23	1.00713799	16.115398806648766
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	1.0064191	16.103895716542805
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	1.00408163	16.066493432424238
ALKAPTONURIA	1.00408163	16.066493432424238
116100 CATARACT, MEMBRANOUS	1.00362319	16.05915785030712
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	1.0027933	16.045878628940788
TUKEL SYNDROME	1.0027933	16.045878628940788
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	1.000915751	16.015835624690673
IRIS PIGMENT EPITHELIUM ANOMALIES	1.0	16.001182525791496
PAROXYSMAL EXTREME PAIN DISORDER	1.0	16.001182525791496
CORNEAL DYSTROPHY, BAND-SHAPED	1.0	16.001182525791496
BRADYOPSIA	1.0	16.001182525791496
CRANIAL NERVES, RECURRENT PARESIS OF	1.0	16.001182525791496
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	1.0	16.001182525791496
MYDRIASIS, CONGENITAL	1.0	16.001182525791496
MEGAEPIPHYSEAL DWARFISM	1.0	16.001182525791496
STRABISMUS, SUSCEPTIBILITY TO	1.0	16.001182525791496
DYSTROPHIA MYOTONICA 2	1.0	16.001182525791496
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	1.0	16.001182525791496
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	1.0	16.001182525791496
PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED	1.0	16.001182525791496
FUNDUS ALBIPUNCTATUS	1.0	16.001182525791496
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	1.0	16.001182525791496
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	1.0	16.001182525791496
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	1.0	16.001182525791496
COLORBLINDNESS, PARTIAL, PROTAN SERIES	1.0	16.001182525791496
NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3	1.0	16.001182525791496
Leber congenital amaurosis 17	1.0	16.001182525791496
TARDIVE DYSKINESIA	1.0	16.001182525791496
VASCULAR HYALINOSIS	1.0	16.001182525791496
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	1.0	16.001182525791496
TYROSINE TRANSAMINASE DEFICIENCY	1.0	16.001182525791496
MYOCLONUS, FAMILIAL, 2; MYOCL2	1.0	16.001182525791496
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	1.0	16.001182525791496
COLORBLINDNESS, PARTIAL, DEUTAN SERIES	1.0	16.001182525791496
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.97993821	15.680170162207396
WILLIAMS-BEUREN SYNDROME; WBS	0.9713072200000001	15.54206411583912
LEBER CONGENITAL AMAUROSIS, TYPE I	0.9702288299999998	15.524808600615126
LEBER CONGENITAL AMAUROSIS, TYPE II	0.9682248199999999	15.492742070821613
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.95732573	15.318343742366586
EXUDATIVE VITREORETINOPATHY 5; EVR5	0.95689655	15.311476354850168
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484125999999999	15.175723122360477
AICARDI SYNDROME; AIC	0.91833904	14.694510599600136
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.9153480900000001	14.646651862724621
TUBEROUS SCLEROSIS	0.903800351	14.461874383225421
#611131 RETINITIS PIGMENTOSA 37; RP37	0.90224581	14.436999888940594
JOUBERT SYNDROME 2	0.8861655199999999	14.179696233582934
MACULAR DYSTROPHY, VITELLIFORM, 4; VMD4	0.8843874	14.151244210910175
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.8731948	13.972149375372
RETINOSCHISIS OF FOVEA	0.8701151600000001	13.922871493618272
ENHANCED S-CONE SYNDROME	0.86493029	13.83990744237577
MICROPHTHALMIA, ISOLATED 6; MCOP6	0.86373753	13.820821871906308
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.8606190410000001	13.770922360212637
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.8596488	13.755397356877626
RETINITIS PIGMENTOSA 11	0.84336042	13.494764015448176
#616152 MACULAR DYSTROPHY, VITELLIFORM, 5; VMD5	0.8369565999999999	13.39229532276586
180270 RETINOSCHISIS, AUTOSOMAL DOMINANT	0.833333	13.334313437765404
WEILL-MARCHESANI SYNDROME 4; WMS4	0.82270353	13.164229348142978
ALAGILLE SYNDROME 1; ALGS1	0.8225715200000001	13.16211703203775
RETINITIS PIGMENTOSA 27; RP27	0.8114107100000001	12.983530874092072
CONE-ROD DYSTROPHY, X-LINKED, 3	0.81074451	12.97287088629339
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.804688711	12.875970941154883
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.8028121300000001	12.84594342604945
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.8006985	12.81212284662746
TRITANOPIA	0.8	12.800946020633198
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.7987169	12.780414903334353
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.7986103	12.778709177277104
SPINOCEREBELLAR ATAXIA 12	0.7965720500000001	12.74609476699391
ALPORT SYNDROME, X-LINKED; ATS	0.79500141	12.720962669671602
#613270 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.79022985	12.644612067178834
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.7881562000000001	12.611431215034226
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.78744873	12.600110858432705
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.78475019	12.556931027339555
RETINITIS PIGMENTOSA 10; RP10	0.7815686300000001	12.5060223050628
BRITTLE CORNEA SYNDROME 2; BCS2	0.7652108999999999	12.244279281625182
EXUDATIVE VITREORETINOPATHY 3; EVR3	0.76495695	12.240215781322759
#612109 OCULOAURICULAR SYNDROME; OCACS;;MICROPHTHALMIA, MICROCORNEA, ANTERIOR SEGMENT DYSGENESIS, CATARACT,OCULAR COLOBOMA, RETINAL PIGMENT EPITHELIUM ABNORMALITIES, ROD-CONEDYSTROPHY, AND ANOMALIES OF THE EXTERNAL EAR;;SCHORDERET-MUNIER-FRANCESCHETTI SYNDROME	0.7648628099999999	12.23870942999978
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.7610949199999999	12.178418734372674
#217300 CORNEA PLANA 2; CNA2	0.75961538	12.154744344778466
SYRINGOMYELIA, ISOLATED	0.7564593599999999	12.104244292703417
MARFAN SYNDROME; MFS	0.75099939	12.016878316148073
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.7473846000000001	11.959037401565666
BRITTLE CORNEA SYNDROME	0.74606781	11.93796720442753
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.7441761	11.907697607431663
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.7324637299999999	11.720285837252058
SPINOCEREBELLAR ATAXIA 14	0.73245307	11.720115264646335
DYSTONIA 25	0.7269231	11.631629205314184
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.72438094	11.590951639144418
#608895 MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3	0.7212120999999999	11.540246451909388
REVESZ SYNDROME	0.7203716399999999	11.52679809804376
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.7168248509999999	11.470045279874292
KNOBLOCH SYNDROME 1; KNO1	0.711059361	11.377790622033666
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.7081894	11.331867852230763
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.7060419410000001	11.29750596880511
SPINOCEREBELLAR ATAXIA 20	0.7019023099999999	11.231266977584683
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.70124987	11.220827166057559
Coats disease	0.7	11.200827768054046
MARCUS GUNN PHENOMENON	0.7	11.200827768054046
DYSTONIA 16; DYT16	0.6992940400000001	11.18953157323814
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.696385111	11.14298526935457
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.6921159700000001	11.074673964985232
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.69192985	11.07169582489353
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.6851296699999999	10.962884903505293
MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE	0.68476225	10.957005749021667
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.68367974	10.939684308925672
#608133 RETINITIS PIGMENTOSA 7; RP7RETINITIS PIGMENTOSA 7, DIGENIC, INCLUDED;;RETINITIS PIGMENTOSA 7 WITH BULL'S-EYE MACULOPATHY, INCLUDED	0.6817193800000001	10.908316230749413
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.681317381	10.901883771375227
CONE-ROD DYSTROPHY 6; CORD6	0.6801445999999999	10.883117888531444
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.67753557	10.84137032328618
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.67707919	10.83406770360506
CYSTINOSIS, NEPHROPATHIC; CTNS	0.67584493	10.814318084060776
STARGARDT DISEASE 1	0.67316	10.771356029061803
MACULAR DYSTROPHY, RETINAL, 3; MCDR3	0.67259715	10.762349763477161
EPISODIC ATAXIA, TYPE 4	0.6722657999999999	10.757047771647239
PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	0.666667	10.667460350921838
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.6661724209999998	10.659546502069412
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.66464651	10.635130121640302
MACULAR DYSTROPHY, CORNEAL, 1	0.66245477	10.600059689851223
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.6619281	10.591632347050366
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.6571164509999998	10.51464027315132
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.6531694509999999	10.451483605722023
KRABBE DISEASE	0.6530890409999999	10.450196950635124
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.65171408	10.42819594870828
ANGELMAN SYNDROME	0.6451781710000001	10.32361367582732
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.6450483	10.32153558625151
CHIARI MALFORMATION TYPE I	0.6429988	10.2887411626649
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.642857	10.286472194982743
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME	0.64136375	10.262578429176106
TUBEROUS SCLEROSIS 2; TSC2	0.6413003509999999	10.26156397020515
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.6400075599999999	10.24087778544645
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	10.222973102247392
OROFACIODIGITAL SYNDROME XIV; OFD14	0.6339286	10.143607236919467
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.6338695900000001	10.142663007138621
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.631890211	10.110990602471901
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.631500741	10.10475862191358
DYSTONIA 28, CHILDHOOD-ONSET	0.6303179099999999	10.085831927185415
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.6283976609999998	10.055105672441444
SPINOCEREBELLAR ATAXIA 1	0.62581157	10.013725158322142
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.62500945	10.000890289794553
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.6190433399999999	9.905425474715603
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.618624081	9.898716834931022
CORNEAL DYSTROPHY, MEESMANN	0.61702949	9.873201493286038
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.61211439	9.794554081053521
267800 RETINAL DYSTROPHY, RETICULAR PIGMENTARY, OF POSTERIOR POLE	0.609777	9.75715307702956
ACHROMATOPSIA 7; ACHM7	0.6083451	9.73424098377088
MYOPIA 17	0.608333	9.734047369462317
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.6077556399999999	9.724808926719225
RETINAL CONE DYSTROPHY 4	0.6051879299999999	9.683722530335926
CAMURATI-ENGELMANN DISEASE	0.6020461199999999	9.633449855064569
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.6019231	9.631481389590247
ALLAN-HERNDON-DUDLEY SYNDROME	0.5977058999999999	9.564001202642478
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.59760568	9.562397564129745
#116800 CATARACT, LAMELLAR;;CATARACT, ZONULAR;;PERINUCLEAR CATARACTCATARACT, MARNER TYPE, INCLUDED; CAM, INCLUDED;;CTM, INCLUDED	0.595834	9.53404858907245
CATARACT 33, MULTIPLE TYPES; CTRCT33	0.5958330000000001	9.534032587889925
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.5954046310000001	9.527178177332535
COCKAYNE SYNDROME A; CSA	0.595051951	9.521534880279336
COMBINED SAPOSIN DEFICIENCY	0.5938829800000001	9.50282996194098
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.593346221	9.494241183209619
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.593192751	9.491785481727385
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.590730631	9.452388650206982
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5874011	9.399112216950703
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.5855168909999999	9.368962644824963
DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS; DURS3	0.583333	9.33401780631753
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.580647841	9.29105208704776
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.58053867	9.289305221950237
SPINOCEREBELLAR ATAXIA 5; SCA5	0.57981936	9.277795411347608
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.57956591	9.273739911636447
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.578511141	9.2568623603449
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.574248751	9.18865907995879
#219900 CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE;;CYSTINOSIS, INTERMEDIATE	0.57037	9.126594477235695
ALACRIMA, CONGENITAL	0.57025194	9.1247053776267
ALACRIMA	0.57025194	9.1247053776267
%610158 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2;;FCD1 LOCUS;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.5690473	9.105429713108832
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.5677727800000001	9.08503588595606
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.566748171	9.06864093032949
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.5666627000000001	9.06727329325783
DYSTONIA 23; DYT23	0.5643329100000001	9.029993898221065
NANCE-HORAN SYNDROME	0.5613028599999998	8.981509515108787
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.5606936	8.971760634643127
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.5598896000000001	8.958895683892392
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.5591905199999999	8.947709577212258
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.55845016	8.935862941717465
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.55804214	8.929334139223291
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.5554580100000001	8.88798500342292
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.5548329399999999	8.87798314426152
RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,AND ANGLE CLOSURE GLAUCOMA	0.5524570299999999	8.839965774686666
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.54981686	8.797719932617548
STROMME SYNDROME; STROMS	0.54876743	8.780927811639506
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.5470447009999999	8.75336211046803
%611031 EPISODIC KINESIGENIC DYSKINESIA 2; EKD2;;DYSTONIA 19; DYT19	0.5464645	8.744078208365387
#118800 PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1;;PAROXYSMAL DYSTONIC CHOREOATHETOSIS; PDC;;CHOREOATHETOSIS, FAMILIAL PAROXYSMAL; FPD1;;MOUNT-REBACK SYNDROME;;CHOREOATHETOSIS, NONKINESIGENIC;;DYSTONIA 8; DYT8	0.54566599	8.731301104106718
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.54486284	8.718449754361126
OPTIC ATROPHY 9; OPA9	0.54383966	8.702077664424387
#612271 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11; SHEP11;;MELANESIAN BLOND HAIR;;SKIN/HAIR/EYE PIGMENTATION 11, BLUE/NONBLUE EYES	0.5434783	8.696295477106867
Pontine tegmental cap dysplasia	0.542773981	8.685025540231486
PHELAN-MCDERMID SYNDROME; PHMDS	0.5424816809999999	8.680348394579195
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.5416667000000001	8.667307734843146
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.5384426099999999	8.615718482273564
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.5371337509999999	8.59477519051404
WARBURG MICRO SYNDROME 2; WARBM2	0.53556114	8.569611554860973
STICKLER SYNDROME, TYPE II	0.53438672	8.550819446079032
Rothmund-Thomson syndrome	0.5315843100000001	8.50597757215693
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.531089741	8.49806388331633
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.53048145	8.488330507996535
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.5304414709999998	8.487690796720333
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.529584391	8.473976503201131
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.5285714	8.457767449313147
CHOREOATHETOSIS, FAMILIAL INVERTED	0.5283606409999999	8.454395056085191
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.52831981	8.453741711801483
DYSTONIA 7, TORSION	0.5269839000000001	8.432365572053452
RETICULAR DYSTROPHY OF RETINAL PIGMENT EPITHELIUM	0.5269197	8.431338296135296
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.5253719410000001	8.406572321870362
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.52504074	8.401272714216637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.5231907700000001	8.3716710065794
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.52257992	8.361896684233518
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.521348071	8.342185643540304
SVEINSSON CHORIORETINAL ATROPHY	0.52123291	8.340342931359451
141405 HEMIFACIAL SPASM, FAMILIAL	0.5188679	8.302499974674129
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.51873906	8.300438382317507
BOHRING-OPITZ SYNDROME	0.517702281	8.283848692299598
CORNEAL ENDOTHELIAL DYSTROPHY 2	0.516129	8.258674335854238
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.515873	8.254578033127636
PEHO SYNDROME; PEHO	0.515754941	8.252688949519824
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.51551897	8.24891313447803
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.5153846	8.246763055582038
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.514804651	8.23748318577739
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	8.235903053001785
GLAUCOMA 1, OPEN ANGLE, A	0.51437013	8.2305303359451
PERRY SYNDROME	0.5130255899999999	8.20901610599187
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	0.5129870000000001	8.208398620358203
#600881 CATARACT, CONGENITAL ZONULAR, WITH SUTURAL OPACITIES; CCZS	0.5126582	8.203137431543722
NANOPHTHALMOS 4; NNO4	0.51210488	8.19428365722855
FRAGILE X MENTAL RETARDATION SYNDROME	0.5100066609999999	8.160709672030466
IRIDOGONIODYSGENESIS, TYPE 2	0.50980392	8.157465576284006
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.5096481500000001	8.154973072081964
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.5085377409999999	8.13720521499468
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.50724638	8.116541911926992
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.5053911	8.086855238010541
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.50456621	8.073656022556843
ADIE PUPIL	0.504329	8.0698603820499
CHOROIDAL OSTEOMA, BILATERAL	0.50408163	8.065902169528492
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.50408163	8.065902169528492
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.5027744909999999	8.044986399802912
NEPHRONOPHTHISIS 18; NPHP18	0.50248756	8.040395164499605
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.50248756	8.040395164499605
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.50200401	8.032657792689259
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.500915751	8.015244361794924
NYSTAGMUS, HEREDITARY VERTICAL	0.5	8.000591262895748
BETHLEM MYOPATHY 2; BTHLM2	0.5	8.000591262895748
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.5	8.000591262895748
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.5	8.000591262895748
NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO	0.5	8.000591262895748
OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	0.5	8.000591262895748
NIEMANN-PICK DISEASE, TYPE B	0.5	8.000591262895748
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	8.000591262895748
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	8.000591262895748
#601885 CATARACT, ZONULAR PULVERULENT 3; CZP3;;CAE3	0.5	8.000591262895748
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	8.000591262895748
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	8.000591262895748
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.49895995	7.983949233009797
OPTIC ATROPHY 5; OPA5	0.49708841000000004	7.954002379865479
SPINOCEREBELLAR ATAXIA 2; SCA2	0.49703089000000006	7.953081991846596
RETINITIS PIGMENTOSA 58	0.49553888	7.929208067506288
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.49505789999999994	7.921511818735033
CONE-ROD DYSTROPHY 11; CORD11	0.49440404	7.911049285528719
PSEUDOXANTHOMA ELASTICUM; PXE	0.4927910499999999	7.8852395381264415
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.49072059999999995	7.8521098897659165
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.48864789000000003	7.818944078732885
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.48841031999999995	7.815142677800231
CATARACT, CONGENITAL TOTAL, WITH POSTERIOR SUTURAL OPACITIES IN HETEROZYGOTES	0.4867421	7.788449185087057
DYSTONIA 13, TORSION	0.48504197	7.761245094639483
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.47710605100000003	7.634261006210587
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.47397165	7.584106883700563
#303100 CHOROIDEREMIA; CHM;;TAPETOCHOROIDAL DYSTROPHY, PROGRESSIVE; TCDCHOROIDAL SCLEROSIS, INCLUDED	0.4726709	7.563293345530139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.4692991910000001	7.509342014397287
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.46682590100000004	7.469766449668071
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.4663689	7.462453893252601
#613428 RETINITIS PIGMENTOSA 54; RP54	0.46448192	7.432259981850082
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.46411447100000003	7.4263803633321634
MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13	0.4631313	7.4106484647071
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.46311220100000006	7.410342858122039
OPTIC ATROPHY 2	0.4621794199999999	7.3954172590844465
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.461177331	7.379382650088361
RETINITIS PIGMENTOSA 76; RP76	0.46027985000000005	7.365021892793931
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.454640131	7.2747797196807555
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.45263339999999996	7.242669650669592
%611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	0.45238354999999997	7.238671755215523
PARKINSON DISEASE, LATE-ONSET; PD	0.45235566	7.2382254822348795
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.45163480100000003	7.22669088580052
SPINOCEREBELLAR ATAXIA 15	0.45142806	7.223382785323955
SULFOCYSTEINURIA	0.45086795100000004	7.214420378980617
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.44961132	7.194312796982048
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.44841259999999994	7.17513185946473
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.44841259999999994	7.17513185946473
CENTRALOPATHIC EPILEPSY	0.44841259999999994	7.17513185946473
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.44691775999999994	7.151212651777876
WAARDENBURG SYNDROME, TYPE 1; WS1	0.4436887400000001	7.099544513378447
LEBER OPTIC ATROPHY AND DYSTONIA	0.4425495	7.081315326197762
#180104 RETINITIS PIGMENTOSA 9; RP9	0.44219907	7.0757080318052505
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.44165387	7.066984187092189
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.43969455	7.035632750145755
SPINOCEREBELLAR ATAXIA 27; SCA27	0.4386736600000001	7.019297302917001
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.43709623100000006	6.994056573566524
ANTERIOR SEGMENT DYSGENESIS 1; ASGD1	0.4361658	6.979168577307868
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.43597223	6.976071228406351
SANDHOFF DISEASE	0.43575854	6.972651935712415
VELOCARDIOFACIAL SYNDROME	0.43333299999999997	6.933840427448805
WEILL-MARCHESANI SYNDROME 1; WMS1	0.43166180000000004	6.907099251211704
WEILL-MARCHESANI SYNDROME 2; WMS2	0.43166180000000004	6.907099251211704
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.4313729	6.902476509580002
#613341 LEBER CONGENITAL AMAUROSIS 14; LCA14RETINAL DYSTROPHY, EARLY-ONSET SEVERE, LRAT-RELATED, INCLUDED;;RETINITIS PIGMENTOSA, JUVENILE, LRAT-RELATED, INCLUDED	0.43053168	6.889015994815656
RETT SYNDROME, CONGENITAL VARIANT	0.42490515100000004	6.798984877299998
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.42247950999999995	6.760171752916952
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.42144550100000006	6.743626386174643
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.42079436	6.7332073601836155
#613862 RETINITIS PIGMENTOSA 38; RP38;;ROD-CONE DYSTROPHY, CHILDHOOD-ONSET	0.42040078000000003	6.726909614765115
#613086 GLAUCOMA 3, PRIMARY CONGENITAL, D; GLC3D	0.41846594	6.695949886766912
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.41653631	6.66507352492967
COHEN SYNDROME	0.414006261	6.624589749081474
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.41168804000000003	6.587495471725351
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.407704611	6.523755897217819
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.40706676999999997	6.513549686954385
#613826 LEBER CONGENITAL AMAUROSIS 6; LCA6	0.40700583	6.512574574891264
VICI SYNDROME; VICIS	0.4055320010000001	6.48899156805046
3MC SYNDROME 1	0.40536506	6.48632031463842
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.4047616	6.476664241031408
WEILL-MARCHESANI SYNDROME 3	0.40456661000000005	6.473544170450704
#603649 CONE-ROD DYSTROPHY 7; CORD7	0.39903024000000004	6.3849557035503866
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.39814799999999995	6.3708388202788315
#217080 JALILI SYNDROME;;CONE-ROD DYSTROPHY AND AMELOGENESIS IMPERFECTA	0.39438005000000004	6.310547164580776
%153870 MACULAR DYSTROPHY, CONCENTRIC ANNULAR;;MCDCA;;MACULAR DYSTROPHY, BENIGN CONCENTRIC ANNULAR; BCAMD	0.3934783	6.296118098238143
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.39222441	6.276054375480879
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.39078148000000007	6.25296578917894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.3893698	6.230377239830929
JOUBERT SYNDROME 14	0.38673020999999996	6.188140678447675
#216900 ACHROMATOPSIA 2; ACHM2;;COLORBLINDNESS, TOTAL;;ROD MONOCHROMATISM 2;;ROD MONOCHROMACY 2; RMCH2	0.38632394000000003	6.1816398780229225
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.38553608	6.169033186358152
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.38365956	6.1390066473248535
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.38350194	6.136484540935138
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.383491851	6.136323105004635
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.38257610000000003	6.12167000610546
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	6.120111490927448
#609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	0.38101581999999995	6.096703681034117
#226670 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY;;EBS-MD;;EPIDERMOLYSIS BULLOSA SIMPLEX AND LIMB-GIRDLE MUSCULAR DYSTROPHY;;MD-EBS; MDEBS	0.380952	6.095682485565322
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.3794270599999999	6.07128164228444
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.37893524	6.063411940694607
STUVE-WIEDEMANN SYNDROME	0.3788738	6.062428828040221
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	6.004824570947372
EPILEPSY, JUVENILE ABSENCE	0.3752738	6.004824570947372
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.3743547	5.990117884087917
#615575 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D;;HMN IID;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; DHMN2D;;SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL DOMINANT, CALF-PREDOMINANT	0.37318049999999997	5.971329295566133
#615431 MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23	0.37140238999999997	5.942877432905198
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.36995241	5.919676038266451
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.36971298999999996	5.915845035146125
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.36923769000000006	5.908239673091618
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.36896251100000005	5.903836483685353
RETINITIS PIGMENTOSA 14	0.3687179400000001	5.8999230584738385
PELIZAEUS-MERZBACHER DISEASE	0.367950231	5.887638806638145
MYOCLONIC-ATONIC EPILEPSY	0.36578377	5.852972868742135
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.36562165100000005	5.850378773032237
SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE	0.3655911	5.849889920904891
DYSTONIA 27; DYT27	0.3648988	5.838812302242286
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.36312015999999997	5.8103519589546115
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.3627448	5.80434575508173
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.3627448	5.80434575508173
KUFOR-RAKEB SYNDROME	0.3627028310000001	5.803674201452308
#605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED;;AMYLOIDOSIS, CEREBROARTERIAL, APP-RELATED;;AMYLOIDOSIS, HEREDITARY, WITH CEREBRAL HEMORRHAGE, DUTCH VARIANT;HCHWAD;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, DUTCH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT;;CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT	0.3619044	5.790898361287056
RETINITIS PIGMENTOSA 51; RP51	0.36159427	5.785935914550332
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.3615599	5.78538595390692
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	5.782052907586798
EXUDATIVE VITREORETINOPATHY 7; EVR7	0.36015451	5.762898051996998
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.3596488	5.75480609398188
Diamond-Blackfan anemia 1	0.3580875	5.729823447704362
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.35704974	5.713218060526397
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.35690812	5.710951973057094
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.35669646100000013	5.707565178764869
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.3564406110000001	5.703471276215645
%153840 MACULAR DYSTROPHY, VITELLIFORM, 1; VMD1;;MACULAR DYSTROPHY, ATYPICAL VITELLIFORM	0.35593045	5.6953080969371035
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.355384031	5.686564746782543
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.355384031	5.686564746782543
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.35480744999999997	5.67733876896064
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.354476201	5.672038393250153
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.35417387	5.667200739735949
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.35389156	5.662683445897092
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.3535714	5.6575605072996344
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.35185874000000006	5.630155922035014
GROUPED PIGMENTATION OF THE MACULA	0.35	5.600413884027023
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.34934638000000007	5.589955191104517
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.3484261	5.5752296228496805
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.34812667100000005	5.570438404767166
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10; MCOPCB10	0.34787292999999997	5.566378248711888
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.34744189	5.55948109899597
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.3474175	5.559090830154167
CHROMOSOME 13q14 DELETION SYNDROME	0.3474175	5.559090830154167
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.3474175	5.559090830154167
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.34647785000000003	5.5440553189938075
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.34611005000000006	5.5381700840608215
CATARACT, CONGENITAL OR JUVENILECATARACT, JUVENILE, HUTTERITE TYPE, INCLUDED	0.3459912	5.53626834351763
PHEOCHROMOCYTOMA	0.3459912	5.53626834351763
RETINITIS PIGMENTOSA 85; RP85	0.34584753	5.533969453624151
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.34488472000000003	5.518563355076493
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.34421994100000003	5.50792610495818
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.34371809000000003	5.499895895506429
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.3429034000000001	5.486859892114493
RETINAL ARTERIES, TORTUOSITY OF	0.3425439	5.48110746699647
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.342061251	5.473384512251578
#219750 CYSTINOSIS, ADULT NONNEPHROPATHIC;;CYSTINOSIS, OCULAR NONNEPHROPATHIC;;CYSTINOSIS, BENIGN NONNEPHROPATHIC	0.34108494	5.4577623817386405
MACULAR DYSTROPHY, PATTERNED, 2; MDPT2	0.3409091	5.454948733803306
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.34074412	5.4523088587102
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.33895098	5.423616498275903
OCULOPALATOCEREBRAL SYNDROME	0.33854233	5.417077615036738
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.33744649000000004	5.399542879177675
OSTEOGENIC SARCOMA	0.33741463	5.399033081502402
DYSTONIA, JUVENILE-ONSET	0.33695619	5.391697499385279
#608810 MYOPATHY, MYOFIBRILLAR, 2, MFM2;;MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED;;MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE;;ALPHA-B CRYSTALLINOPATHY	0.33695619	5.391697499385279
LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO	0.33694311	5.391488203917842
HYPEREKPLEXIA 1; HKPX1	0.33693352000000004	5.3913347525774205
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.33649756	5.384358877043475
#610246 SPINOCEREBELLAR ATAXIA 28; SCA28	0.33381565	5.34144514561573
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.33345306100000005	5.335643292844886
UNCOMBABLE HAIR SYNDROME 2	0.333333	5.333722174869656
#602540 ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS;;HID SYNDROME	0.333333	5.333722174869656
#263300 POLYCYTHEMIA VERA;;PV;;POLYCYTHEMIA RUBRA VERA; PRV	0.333333	5.333722174869656
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.333333	5.333722174869656
%614826 NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT; NYS7	0.333333	5.333722174869656
WILDERVANCK SYNDROME	0.333333	5.333722174869656
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	0.333333	5.333722174869656
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.333333	5.333722174869656
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.333333	5.333722174869656
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.333333	5.333722174869656
INTERNAL CAROTID ARTERIES, HYPOPLASIA OF	0.333333	5.333722174869656
217520 CORNEAL DEGENERATION, BAND-SHAPED SPHEROID	0.333333	5.333722174869656
BUTYRYLCHOLINESTERASE	0.333333	5.333722174869656
GLAUCOMA 3, PRIMARY INFANTILE, B	0.333333	5.333722174869656
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, 1; CACD1	0.333333	5.333722174869656
#606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM	0.3319252500000001	5.311196510168975
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.33126192000000004	5.3005824457641415
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.3304488	5.287571564228768
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.32990590000000003	5.278884522235517
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.32962585000000005	5.2744033910691694
WHITE-SUTTON SYNDROME; WHSUS	0.32939414000000006	5.270695757066118
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.3272400200000001	5.236227289763661
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.3269231	5.231156194997586
#608471 CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A;;LATTICE CORNEAL DYSTROPHY, TYPE IIIA	0.32418039	5.187269591672272
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.32398990000000005	5.1842215264129345
#610024 RETINAL CONE DYSTROPHY 3A; RCD3A;;CONE DYSTROPHY WITH NIGHT BLINDNESS AND SUPERNORMAL ROD RESPONSES,PDE6H-RELATEDACHROMATOPSIA 6, INCLUDED; ACHM6, INCLUDED	0.3216236	5.146357928202153
DILUTION, PIGMENTARY	0.3214286	5.143237697609624
GOLDBERG-SHPRINTZEN SYNDROME	0.32000529999999994	5.120463214520663
#615034 DYSTONIA 24; DYT24	0.3186506	5.098786412552975
#154780 MARSHALL SYNDROME; MRSHS	0.31756247	5.0813750458111855
RETINAL DYSPLASIA, PRIMARY	0.31666669999999997	5.0670416665400575
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.31535154100000007	5.045997567330621
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.31481933	5.037481561977386
CATARACT 1, MULTIPLE TYPES	0.31473320000000005	5.036103380126441
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.312724731	5.003965501060045
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.31250810999999995	5.0004993089001255
STIFF-PERSON SYNDROME; SPS	0.31194096	4.991424238230623
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.31152800999999997	4.984816549906598
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.31112221	4.978323270037633
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.31050071	4.968378535097853
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.307088591	4.913780596179132
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.30695197999999996	4.9115946586331
RETINAL CONE DYSTROPHY 1; RCD1	0.3067392400000001	4.908190567062565
#611809 BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB	0.30540123	4.88678082483123
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.304959701	4.8797158387118
RETINAL CONE DYSTROPHY 3B	0.29993561	4.799324441594613
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.2996746	4.795147972943556
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.2962661	4.740607942304395
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.29529768	4.725112077122769
PRADER-WILLI SYNDROME; PWS	0.295187841	4.723354523235318
COFFIN-SIRIS SYNDROME 6; CSS6	0.2948718	4.718297493508685
CORNEAL DYSTROPHY, LATTICE TYPE I	0.2936508	4.698760049644693
RETINITIS PIGMENTOSA 25; RP25	0.29349492	4.696265785312573
DUBOWITZ SYNDROME	0.29347126	4.695887197334013
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.29333475000000003	4.693702875907417
HEMIFACIAL MICROSOMIA	0.29217868999999996	4.67520454883665
MICROCEPHALY, AUTOSOMAL DOMINANT	0.2918623	4.670141934697315
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.29000254999999997	4.640383735494974
SENIOR-LOKEN SYNDROME 4; SLSN4	0.28950988000000005	4.6325004328999935
#613194 RETINITIS PIGMENTOSA 50; RP50RETINITIS PIGMENTOSA, CONCENTRIC, INCLUDED	0.28945853000000005	4.631678772177294
Boucher-Neuhauser syndrome	0.2888577	4.622064781680322
SPINOCEREBELLAR ATAXIA 13	0.28822248	4.611900510516289
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.28469206	4.555409615703584
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.28457301	4.5535046749238886
CATARACT 17, MULTIPLE TYPES	0.28422951	4.54800826872628
PSEUDOTRISOMY 13 SYNDROME	0.28179283	4.509018507289333
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.281617551	4.506213836017396
HERMANSKY-PUDLAK SYNDROME 9	0.2809523	4.49556903334093
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.28035186000000006	4.485961283305144
CATARACT 7; CTRCT7	0.2802021	4.483564946210081
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.2799625	4.479731062876901
PRIMARY LATERAL SCLEROSIS, ADULT	0.27962250999999994	4.474290820829956
MARSILI SYNDROME; MARSIS	0.2794118	4.4709192116599485
STORMORKEN SYNDROME; STRMK	0.27895987	4.463687797241067
BARDET-BIEDL SYNDROME 1; BBS1	0.27730747	4.437247443235449
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.2767094	4.427677616002249
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.2767094	4.427677616002249
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.273754541	4.380396377805272
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.273336211	4.3737026031192565
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.27332896	4.373586578544763
RETINAL DYSTROPHY AND OBESITY; RDOB	0.27291445999999997	4.366954088387821
MELANOMA, CUTANEOUS MALIGNANT	0.2727273	4.363959307066295
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.27163273	4.346444892709039
CONE-ROD DYSTROPHY 10	0.27086592000000004	4.334175025936437
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.270815611	4.333370022444747
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.27030819	4.325250686406328
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.26991501	4.318959341460837
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.2688679	4.302204343226255
Congenital disorder of glycosylation, type IIh	0.2688679	4.302204343226255
RETINITIS PIGMENTOSA 72; RP72	0.26871607	4.299774883683364
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.268715451	4.299764978951381
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.26857121000000006	4.297456952382679
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.26848375	4.296057488958973
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.26722441	4.275906559756942
CONE-ROD DYSTROPHY 5; CORD5	0.26717409000000003	4.275101380252245
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.26706748100000005	4.273395510184353
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.266667	4.26698734060524
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.265625	4.250314108413366
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.2653846	4.246467424134166
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.26501664	4.240579629011975
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.2647059	4.235607421553911
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.26372978	4.219988347266836
#310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A;;CSNB, COMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, WITH MYOPIA;;HEMERALOPIA-MYOPIA;;MYOPIA-NIGHT BLINDNESS; NBM1NYCTALOPIA, INCLUDED	0.26289991	4.206709445924157
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.262001221	4.192329359201236
SPINOCEREBELLAR ATAXIA 31	0.2618999	4.19070810338654
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.26077846	4.172763737254816
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.2603859	4.166482313042492
CLUSTER HEADACHE, FAMILIAL	0.26036940000000003	4.166218293530816
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.25980461	4.157180985652074
RETINITIS PIGMENTOSA 77; RP77	0.25878743000000004	4.14090490281049
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.258215021	4.131745681922084
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.255475731	4.087913802641008
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.25468115100000005	4.075199583029666
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.25390092000000003	4.062714964386385
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.25335029	4.053904233252208
#608194 CONE-ROD DYSTROPHY 13; CORD13	0.25328489000000004	4.052857755915022
%300245 PTOSIS, HEREDITARY CONGENITAL 2;;PTOS2;;PTOSIS, X-LINKED; PTOSX	0.2527933	4.044991734597167
PROTEUS SYNDROME	0.2527933	4.044991734597167
311450 PALLISTER W SYNDROME;;W SYNDROME	0.25277449100000005	4.04469076835504
FRONTONASAL DYSPLASIA 2; FND2	0.25185874	4.030037669455864
#607476 NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD	0.25161680000000003	4.026166343355573
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.250810851	4.013270206300095
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.25047184	4.007845629410843
#608553 LEBER CONGENITAL AMAUROSIS 9; LCA9	0.25019874000000003	4.00347570646305
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	4.000295631447874
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.25	4.000295631447874
MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR	0.25	4.000295631447874
AMYOTROPHIC LATERAL SCLEROSIS 11	0.25	4.000295631447874
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.25	4.000295631447874
MELANOMA, UVEAL	0.25	4.000295631447874
%121400 CORNEA PLANA 1; CNA1	0.25	4.000295631447874
FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1	0.25	4.000295631447874
VAN DEN BOSCH SYNDROME	0.25	4.000295631447874
TUMOR PREDISPOSITION SYNDROME; TPDS	0.25	4.000295631447874
MACULAR DYSTROPHY WITH CENTRAL CONE INVOLVEMENT; CCMD	0.24969714999999998	3.9954496733199374
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.24941899999999997	3.9909989444003884
#611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2	0.24915761	3.9868163952999724
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.24816288000000003	3.9708995390060924
SPINOCEREBELLAR ATAXIA 26	0.24767001	3.9630130361746048
EPISODIC ATAXIA, TYPE 1; EA1	0.24689977	3.9506882853459393
RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT	0.24514719000000001	3.922644932874888
DYSTONIA 26, MYOCLONIC; DYT26	0.24512261000000002	3.9222516238084038
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.24487996999999997	3.9183690968803453
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.24408163000000002	3.9055947128227055
SPINAL MUSCULAR ATROPHY, TYPE IV	0.2430556	3.8891770195157673
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.242857	3.8859991846661455
CHROMOSOME 1P36 DELETION SYNDROME	0.242640061	3.882527904130182
#613268 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.24188714	3.870480277781681
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.24122136000000002	3.85982701047966
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.2410257	3.856696219106663
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.24096528	3.8557294276584546
JOUBERT SYNDROME 5	0.24008938999999999	3.841714151895939
#257270 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B;;NIGHT BLINDNESS, CONGENITAL STATIONARY, COMPLETE, AUTOSOMAL RECESSIVE;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.23789991	3.8066798827793695
MUCOLIPIDOSIS III ALPHA/BETA	0.2370744	3.7934707465925035
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.236469441	3.7837906872128833
#609141 CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3	0.23571430000000002	3.7717075382391747
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.234909661	3.7588323627328037
RETINITIS PIGMENTOSA 19	0.23478213	3.7567917159241073
#612572 RETINITIS PIGMENTOSA 46; RP46;;RETINITIS PIGMENTOSA, AUTOSOMAL RECESSIVE, IDH3B-RELATED	0.23445338	3.751531327168753
#606574 ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4;;OCULOCUTANEOUS ALBINISM, TYPE IV	0.23419475	3.7473929413321083
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.23358563100000002	3.7376463170331804
REESE RETINAL DYSPLASIA	0.2333337	3.733615123118275
#258100 OGUCHI DISEASE 1;;NIGHT BLINDNESS, CONGENITAL STATIONARY, OGUCHI TYPE 1; CSNBO1	0.2333337	3.733615123118275
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.23318177	3.731184063457132
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.23262577	3.7222874059727915
TEMTAMY SYNDROME; TEMTYS	0.232189501	3.7153065860734467
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.23054664	3.6890188673479423
RAMON SYNDROME	0.230296151	3.68501074713824
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.230281771	3.6847806501335185
#600886 HYPERFERRITINEMIA WITH OR WITHOUT CATARACT;;HYPERFERRITINEMIA-CATARACT SYNDROME;;HYPERFERRITINEMIA, HEREDITARY, WITH CONGENITAL CATARACTS; HHCS	0.229167	3.6669429958880597
SPINOCEREBELLAR ATAXIA 34; SCA34	0.22815407000000004	3.6507349180722106
RETINITIS PIGMENTOSA 13; RP13	0.22807007999999998	3.649390978751868
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.22767051099999996	3.6429974022512197
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.22694432	3.6313774875116334
PUPILLARY MEMBRANE, PERSISTENCE OF	0.2269442	3.63137556736973
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.22647092	3.623802527703923
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.22640479099999997	3.622744385504675
PROPIONIC ACIDEMIA	0.226270531	3.620596066738763
FOCAL DERMAL HYPOPLASIA; FDH	0.22596646	3.6157305711669627
JACOBSEN SYNDROME	0.22565114	3.61068507829293
EPISODIC ATAXIA, TYPE 6	0.22500507100000003	3.600347210299675
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	3.5911149920165863
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	3.5911149920165863
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	3.5911149920165863
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	3.5911149920165863
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	3.5911149920165863
#269400 CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES; COPOA;;SCLEROCORNEA WITH OTHER OCULAR ANOMALIES	0.22351131999999999	3.576445427900591
SPINOCEREBELLAR ATAXIA 18	0.22296848000000002	3.5677593459782906
#614180 RETINITIS PIGMENTOSA 61; RP61	0.22281562000000002	3.5653134052173985
HOLOPROSENCEPHALY 3; HPE3	0.22195852000000002	3.551598791674542
DYSTONIA 21; DYT21	0.2214286	3.5431194450304746
#300814 NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6	0.2207606	3.532430655103246
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.22049312000000001	3.5281506588012475
HOLOPROSENCEPHALY 1; HPE1	0.22020858100000001	3.5235976983265416
HOLOPROSENCEPHALY 2; HPE2	0.22020858100000001	3.5235976983265416
HUNTINGTON DISEASE-LIKE 2	0.22017345000000005	3.5230355607832284
#229300 FRIEDREICH ATAXIA 1; FRDA;;FRDA1;;FAFRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED	0.21907612	3.505476983162201
#608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD	0.21867101	3.4989947441091775
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.21753489000000004	3.4808154806179754
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.21705383	3.473117951752118
#608768 SPINOCEREBELLAR ATAXIA 8; SCA8	0.21701997	3.472576151711795
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.216824851	3.4694540169785446
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.21648356	3.4639929573931347
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1	0.21623940000000003	3.460086108667638
#613856 ACHROMATOPSIA 4; ACHM4	0.21592879000000004	3.455115981363302
#613810 RETINITIS PIGMENTOSA 43; RP43	0.21589498	3.454574981382104
CAVITARY OPTIC DISC ANOMALIES; CODA	0.21583544999999998	3.4536224309863437
SHORT SYNDROME	0.21576858999999998	3.452552591922669
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.214286	3.4288293987217564
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.214286	3.4288293987217564
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.21367608999999999	3.419070117487451
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.21296903000000003	3.4077563213707656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.21292401	3.4070359481334536
ALSTROM SYNDROME; ALMS	0.21244034	3.399296656181204
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.21214165000000001	3.3945172629725753
PETERS ANOMALY	0.21163447000000002	3.3864017832191444
RETINITIS PIGMENTOSA 84; RP84	0.21162247	3.386209769028835
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.21141856100000003	3.382946983901184
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.21120697099999997	3.379561293690551
ARTERIAL TORTUOSITY SYNDROME	0.21019244	3.3633275979814776
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.209298521	3.3490238368992045
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.20914774000000003	3.3466111625967834
GLYCOGEN STORAGE DISEASE IB	0.2078125	3.3252457436410454
GLYCOGEN STORAGE DISEASE IA	0.2078125	3.3252457436410454
#614203 PARKINSON DISEASE 17; PARK17	0.2076923	3.3233224015014446
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.20754489999999998	3.320963827197143
RETINITIS PIGMENTOSA 1	0.20742778999999997	3.319089928711547
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.20728822099999997	3.3168566596676055
HYPERLIPOPROTEINEMIA, TYPE I	0.20724638	3.316187154189544
#607541 CORNEAL DYSTROPHY, AVELLINO TYPE; CDA;;ACD;;AVELLINO CORNEAL DYSTROPHY;;COMBINED GRANULAR-LATTICE CORNEAL DYSTROPHY;;GRANULAR CORNEAL DYSTROPHY, TYPE II; CGD2	0.20689655	3.310589460506547
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.20689062000000003	3.310494573494169
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.20676925100000004	3.308552525972196
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.20651461	3.3044779688526456
SENIOR-LOKEN SYNDROME 3	0.20588320999999998	3.29437482220586
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.20583664000000002	3.2936296471356346
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.20583300100000002	3.2935714188324234
#613801 RETINITIS PIGMENTOSA 40; RP40	0.20561798	3.290130828564545
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.2049505	3.27945035925223
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.20408163	3.2655474117910455
#608380 RETINITIS PIGMENTOSA 26; RP26	0.20389778	3.262605594383679
#603786 STARGARDT DISEASE 4; STGD4	0.20386655	3.262105877453398
MUCOPOLYSACCHARIDOSIS, TYPE II	0.20370905100000003	3.259585707206769
IRIS HYPOPLASIA WITH GLAUCOMA; IHG	0.20266091999999997	3.2428143717648275
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.20245116	3.2394579637182184
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.201736841	3.228028015017577
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.20078424	3.2127852725423254
WITTEVEEN-KOLK SYNDROME	0.20070125100000002	3.2114573504056936
WARBURG MICRO SYNDROME 3; WARBM3	0.200517901	3.208523533589589
PTOSIS, HEREDITARY CONGENITAL 1	0.2	3.2002365051582995
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.2	3.2002365051582995
AMYLOIDOSIS, FINNISH TYPE	0.2	3.2002365051582995
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.2	3.2002365051582995
#610425 CATARACT, LAMELLAR 2	0.2	3.2002365051582995
APOLIPOPROTEIN C-II DEFICIENCY	0.2	3.2002365051582995
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	0.2	3.2002365051582995
RETINAL TELANGIECTASIA AND HYPOGAMMAGLOBULINEMIA	0.2	3.2002365051582995
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.2	3.2002365051582995
CAHMR SYNDROME	0.2	3.2002365051582995
PERICARDIAL EFFUSION, CHRONIC	0.2	3.2002365051582995
HYPERLIPOPROTEINEMIA, TYPE ID	0.2	3.2002365051582995
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.19991882	3.198937529160855
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.19843590000000003	3.175209055569709
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.19831847000000002	3.173330036705705
#609923 RETINITIS PIGMENTOSA 31; RP31	0.19821058000000003	3.171603669122998
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.19800946	3.1683855112934096
SEPTOOPTIC DYSPLASIA	0.197917	3.166906041957075
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.19723559000000002	3.156002676172176
AMYOTROPHIC LATERAL SCLEROSIS 1	0.19685856000000002	3.1499697503244763
ANIRIDIA	0.19673872	3.148052168610586
CORNEAL DYSTROPHY, ENDOTHELIAL, X-LINKED; XECD	0.1964286	3.143089881885688
PEROXISOME BIOGENESIS DISORDER 6B	0.19636844000000003	3.1421272507449363
WAISMAN SYNDROME; WSMN	0.196032441	3.1367508694174524
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.1960288	3.136692609111876
Fabry disease	0.195903431	3.1346865568597995
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.19549121100000003	3.1280905493990185
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.19467206	3.1149831647318336
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.19414923	3.1066172664718743
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.19364934000000003	3.0986184353390565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.1935702	3.0973521017539647
CATARACT, ANTERIOR POLAR, 2	0.1929828	3.087953007138315
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.19286432	3.086057187032659
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.19218806	3.075236227337767
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.192021001	3.072563085786191
NIEMANN-PICK DISEASE, TYPE C2	0.19200894100000002	3.0723701115249304
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.19170248	3.0674663731268934
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.19165950999999998	3.06677880231376
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.19165950999999998	3.06677880231376
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.19165950999999998	3.06677880231376
TENORIO SYNDROME; TNORS	0.19146944100000002	3.063737473552266
#613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10	0.19037207	3.0461782398827553
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.190310051	3.0451858625436885
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.19021906000000002	3.0437298989444845
RETINITIS PIGMENTOSA 41	0.18992557999999998	3.0390338718968146
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.18992543	3.0390314717194356
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.189808801	3.0371652698026352
HALLERMANN-STREIFF SYNDROME; HSS	0.18955570000000002	3.033115354504175
#613769 RETINITIS PIGMENTOSA 44; RP44	0.18813307999999998	3.010351752219333
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.18800876	3.008362485207727
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.18800356	3.0082792790585926
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.18771055	3.0035907725667106
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.18736589999999997	2.998075965009196
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.187363961	2.998044938716279
FLECK RETINA OF KANDORI	0.18709429	2.9937298838233666
PETERS-PLUS SYNDROME; PTRPLS	0.18660412100000004	2.985886600185882
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.185621121	2.9701574377630284
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.18554094	2.968874446946928
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.18537555099999997	2.9662280273701698
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.18491568999999997	2.9588697075726764
#613767 RETINITIS PIGMENTOSA 45; RP45	0.18490878	2.958759139401424
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.184789551	2.956851334410056
NIEMANN-PICK DISEASE, TYPE A	0.18473537999999998	2.9559845343514515
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.184588821	2.953639417041654
MARFANOID HYPERMOBILITY SYNDROME	0.18452369999999998	2.952597404034392
MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT	0.184019	2.9445216072136247
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.18379999000000002	2.941017188228652
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.1837164	2.9396796493813206
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.18333330000000003	2.9335495963556903
RETINITIS PIGMENTOSA 74; RP74	0.18325418	2.9322835827942493
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.183157251	2.930732604173207
NEURAMINIDASE DEFICIENCY	0.18285123099999998	2.9258359222966637
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.18252505	2.920616640579219
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.18217151999999998	2.9149597425208755
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.182070861	2.9133490794890124
CATARACT 48; CTRCT48	0.18194550000000004	2.911343155246397
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.18142295000000003	2.9029817373175444
WATSON SYNDROME	0.1813185	2.901310413802725
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	2.901006391334735
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.1812995	2.901006391334735
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.18104755099999997	2.896974909398544
ALAND ISLAND EYE DISEASE	0.18072765000000002	2.8918561151073616
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.18057091000000003	2.8893480897582693
SPINAL MUSCULAR ATROPHY, TYPE II	0.1805556	2.889103111653799
COWDEN SYNDROME 6; CWS6	0.17995425099999998	2.8794808165430963
COWDEN SYNDROME 5; CWS5	0.17995425099999998	2.8794808165430963
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.17955137	2.873034244125923
#613376 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C;;HMN IIC;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC;;DHMN2C	0.1794871	2.872005848124991
ERYTHERMALGIA, PRIMARY	0.17912430000000001	2.866200619104634
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.17895166	2.863438174953381
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.17876994000000002	2.860530440064794
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.17843599999999998	2.855187005172131
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.17828639000000002	2.852793068254448
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.1782017	2.8514379281063382
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.17774651	2.844154349832423
EPISODIC ATAXIA, TYPE 3	0.17770088	2.8434242158737715
#610359 RETINITIS PIGMENTOSA 33; RP33	0.17746932	2.8397189820480992
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.17728270000000002	2.8367328413651363
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.17701692000000002	2.8324800470734313
FLECK RETINA, FAMILIAL BENIGN; FRFB	0.17656799	2.8252966362021277
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.176529421	2.82467948659329
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.1761265	2.8182322741288157
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.17592590000000002	2.8150224369141426
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.175845171	2.8137306774500175
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.175342241	2.8056832027223213
#312600 RETINITIS PIGMENTOSA 2; RP2	0.17509387999999995	2.801709133029032
GILLESPIE SYNDROME; GLSP	0.17505995000000002	2.801166212905933
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.174882021	2.7983191385003012
#613829 LEBER CONGENITAL AMAUROSIS 7; LCA7	0.17412157	2.7861510232473807
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.17384489	2.781723816066145
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.173611	2.7779812994851873
TREMOR, HEREDITARY ESSENTIAL, 1	0.17326349000000002	2.77242072854565
#608470 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1;;CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB;;REIS-BUCKLERS CORNEAL DYSTROPHY; RBCD;;CORNEAL DYSTROPHY, GEOGRAPHIC;;GRANULAR CORNEAL DYSTROPHY, TYPE III	0.17319379999999998	2.771305606135427
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.17286593	2.7660592984206955
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.17283984000000002	2.765641827568598
%300155 RETINITIS PIGMENTOSA 24; RP24	0.17228498	2.7567634114323374
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.17228112	2.756701646867788
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.17148000000000002	2.7438827795227256
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.17142860000000001	2.7430603187409
IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST	0.17142860000000001	2.7430603187409
SPINOCEREBELLAR ATAXIA 30; SCA30	0.17128729	2.7407991916381804
DYSTONIA, DOPA-RESPONSIVE; DRD	0.17122462	2.7397963975292887
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.17026197	2.724392859170836
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.17024545000000002	2.72412851963551
#613809 RETINITIS PIGMENTOSA 39; RP39	0.17000538	2.720287115746543
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.1694808	2.7118932154171627
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.16947184	2.7117498448217323
2p15-16.1 microdeletion syndrome	0.1694603	2.7115651911753846
HYPERMANGANESEMIA WITH DYSTONIA 2	0.16936531	2.7100452388472593
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.16852574	2.696611126034081
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.16846545	2.695646414739601
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.16846317	2.695609932043442
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.16834259999999998	2.693680669466307
SPINOCEREBELLAR ATAXIA 44; SCA44	0.16814990000000002	2.6905972415935877
#610599 RETINITIS PIGMENTOSA 36; RP36	0.16788477999999998	2.6863550080823493
APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION	0.16785699999999998	2.6859104952317825
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.167582751	2.6815221869252674
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.167582751	2.6815221869252674
FRANK-TER HAAR SYNDROME; FTHS	0.16733268	2.6775207552098603
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.16724714000000002	2.676152014056604
RETINITIS PIGMENTOSA 6	0.16690447999999997	2.6706690488523153
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.166667	2.666869088026091
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.166667	2.666869088026091
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.166667	2.666869088026091
107550 AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA	0.166667	2.666869088026091
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.166667	2.666869088026091
HYPERCHOLESTEROLEMIA, FAMILIAL	0.166667	2.666869088026091
%109500 BASILAR IMPRESSION, PRIMARY	0.166667	2.666869088026091
CATARACT, ANTERIOR POLAR, 1	0.166667	2.666869088026091
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.166667	2.666869088026091
CONE-ROD DYSTROPHY, X-LINKED, 2	0.166667	2.666869088026091
#310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX;;XMEA	0.166667	2.666869088026091
HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B	0.166667	2.666869088026091
COLOBOMA OF MACULA	0.166667	2.666869088026091
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.16632861	2.661454447871188
GLAUCOMA 1, OPEN ANGLE, M	0.16611279999999998	2.658001232670297
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.16546433	2.6476249458377974
TOWNES-BROCKS SYNDROME 1; TBS1	0.165	2.640195116755597
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.164937001	2.6391870582576544
RETINITIS PIGMENTOSA 71; RP71	0.16426457	2.6284273670906537
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.16384105	2.6216505462673303
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.16370850999999997	2.6195297495353618
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.16361862	2.6180914032381186
MYELOCEREBELLAR DISORDER	0.16218285000000002	2.5951173854030634
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.16214644000000003	2.5945347823472997
#615233 RETINITIS PIGMENTOSA 66; RP66	0.16158543	2.5855579589385047
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.16155823	2.5851227267738035
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.16148542999999999	2.583957840685925
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.16131181099999997	2.58117973137698
GLYCEROL KINASE DEFICIENCY; GKD	0.16127695099999997	2.580621930154131
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.16103879999999998	2.576811232534431
MICROPHTHALMIA, ISOLATED 1	0.16060605	2.5698867207963954
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.15930549000000002	2.549076222850652
CONE-ROD DYSTROPHY 20; CORD20	0.15896806	2.543676943830974
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.1586538	2.538648412210419
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.15755961000000002	2.5211400783025235
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.15724323099999998	2.5160776401761953
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.1570513	2.5130065172128377
#607921 RETINITIS PIGMENTOSA 30; RP30	0.15698133	2.5118869144715084
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.1567459	2.508119756069461
#613763 CATARACT, POSTERIOR POLAR, 2; CTPP2CATARACT, CONGENITAL LAMELLAR, INCLUDED;;CATARACT, JUVENILE, AUTOSOMAL RECESSIVE, INCLUDED	0.1565261	2.5046026961502923
MYOPATHY, SPHEROID BODY	0.155943	2.4952724066195033
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.15573249099999997	2.491904013687181
#613582 RETINITIS PIGMENTOSA 57; RP57	0.15564198	2.4904557306555897
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.15550112000000002	2.4882018040850067
NEUROFIBROMATOSIS, TYPE I	0.155435411	2.487150382382419
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.15377945099999998	2.4606530641670092
TAY-SACHS DISEASE; TSD	0.15367374099999997	2.4589615791622075
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.1528114	2.4451631034217343
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.152802231	2.4450163885791554
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.15275798999999998	2.4443084802630315
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.15263430000000003	2.442329293996417
GM2-GANGLIOSIDOSIS, AB VARIANT	0.15234870099999998	2.437759372268233
RETINITIS PIGMENTOSA 20	0.15226723	2.4364557399266746
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.152027	2.4326117758485037
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.151991011	2.432035909290583
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.15173788000000002	2.427985513956647
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.15146449099999998	2.423610966667103
#604356 DUANE RETRACTION SYNDROME 2; DURS2	0.1513158	2.421231734836161
EPISODIC ATAXIA, TYPE 8	0.1510896	2.4176122673488267
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.1510395	2.4168106081042846
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.15103331999999997	2.4167117207962745
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.1506258	2.4101909188933646
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.15061649	2.410041947884049
CONE DYSTROPHY 4	0.15060314000000002	2.4098283320973306
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.15027693	2.4046085863455917
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.15024872	2.4041571929865393
GAUCHER DISEASE, PERINATAL LETHAL	0.15021235100000002	2.403575245979259
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.1501623	2.4027743707926605
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.1500025	2.4002173818250387
#613758 RETINITIS PIGMENTOSA 47; RP47	0.14982172000000002	2.3973246880480263
CORNELIA DE LANGE SYNDROME 1	0.14976026099999998	2.396341271371173
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.148858251	2.3819080447210843
#615725 RETINITIS PIGMENTOSA 68; RP68	0.14862298000000002	2.378143430507059
MACULAR DYSTROPHY, PATTERNED, 3; MDPT3	0.14822883	2.3718365644145183
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.14799260000000003	2.368056605066451
BRANCHIOOCULOFACIAL SYNDROME	0.147550291	2.3609791380246503
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.14750903999999998	2.3603190732442783
GLAUCOMA, PRIMARY OPEN ANGLE	0.14742320999999997	2.3589456917480893
LAMBOTTE SYNDROME	0.14720329999999998	2.355426871698843
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.14683403	2.349518115027544
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.146513361	2.344387031828181
%613144 CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 3; CACD3;;CHOROIDAL DYSTROPHY, CENTRAL AREOLAR, WITH OR WITHOUT DRUSEN	0.1464647	2.3436083982852938
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.14642962	2.343047076802289
SIFRIM-HITZ-WEISS SYNDROME	0.14631874	2.341272865683829
DEMENTIA, FAMILIAL DANISH	0.1462766	2.340598575852192
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.14626031099999998	2.340337932590029
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.1461121	2.3379663813266993
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.14608954	2.3376053946489175
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A	0.1458333	2.333505251638509
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.1455309	2.328666494042709
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.14486100999999998	2.317947461880507
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.14472796	2.3158185045454505
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.14471573999999998	2.315622970094985
#604116 CONE-ROD DYSTROPHY 3; CORD3	0.1443556	2.309860304220147
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.14434095000000002	2.309625886896144
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.14407035	2.305295966904665
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.143844291	2.3016787555840668
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.14377275099999998	2.3005340309861713
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.14377275099999998	2.3005340309861713
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.14377275099999998	2.3005340309861713
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.14345423000000002	2.2954373183268744
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.14336464999999998	2.2940039323962136
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.143250671	2.2921801336131065
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.14312444	2.290160288341693
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.14294355100000003	2.287265850435786
#613100 GLAUCOMA 1, OPEN ANGLE, O; GLC1O	0.14285699999999998	2.2858809320869953
NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL	0.14285699999999998	2.2858809320869953
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14285699999999998	2.2858809320869953
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.14285699999999998	2.2858809320869953
%179900 RETINAL APLASIA;;AMAUROSIS CONGENITA	0.14285699999999998	2.2858809320869953
BRUNNER SYNDROME; BRNRS	0.14285699999999998	2.2858809320869953
#609887 GLAUCOMA 1, OPEN ANGLE, G; GLC1G	0.14285699999999998	2.2858809320869953
NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI	0.14285699999999998	2.2858809320869953
VOCAL CORD PARALYSIS AND PTOSIS	0.14285699999999998	2.2858809320869953
GLAUCOMA WITH ELEVATED EPISCLERAL VENOUS PRESSURE	0.14285699999999998	2.2858809320869953
NYSTAGMUS, CONGENITAL MOTOR, AUTOSOMAL RECESSIVE	0.14285699999999998	2.2858809320869953
MUNGAN SYNDROME	0.14285699999999998	2.2858809320869953
#162210 NEUROFIBROMATOSIS, FAMILIAL SPINAL;;FSNF	0.14285699999999998	2.2858809320869953
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.14285699999999998	2.2858809320869953
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.14285699999999998	2.2858809320869953
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.14255515	2.2810509751415853
EDICT SYNDROME	0.14197265	2.2717302863203117
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.14162606	2.266184436468698
MENTAL RETARDATION, X-LINKED 106; MRX106	0.14128954999999999	2.2607998785369436
DYSTONIA 3, TORSION, X-LINKED	0.14118348999999997	2.2591027931182577
CREUTZFELDT-JAKOB DISEASE; CJD	0.14094677000000003	2.2553149931907535
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.14072669000000002	2.251793452940477
CHROMOSOME 17P13.1 DELETION SYNDROME	0.13952456000000002	2.2325579513907474
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.13945557000000003	2.231454029808293
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.139073651	2.225342874179225
METHYLMALONIC ACIDURIA, CBLA TYPE	0.138566001	2.2172198738700066
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.13842711	2.214997453627817
CROUZON SYNDROME	0.138305001	2.2130435652307754
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.13820837	2.2114973549621255
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.13813050999999998	2.2102515028906673
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.1375	2.200162597296331
#616118 MACULAR DEGENERATION, EARLY-ONSET; EOMD	0.13719955	2.1953550420064567
REFSUM DISEASE	0.13704428000000002	2.192870538395677
HYPERREFLEXIA	0.13703700000000002	2.1927540497868896
OCULODENTODIGITAL DYSPLASIA; ODDD	0.136444681	2.1832762453543952
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.13630622099999998	2.1810607216218734
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.135816741	2.173228462799149
Polyarteritis nodosa, childhood-onset	0.13574561000000002	2.1720902826849073
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.13564326000000002	2.1704525616533927
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.13556203	2.1691527855968227
DYSTONIA 11, MYOCLONIC	0.13535329000000001	2.1658126987563886
HARDIKAR SYNDROME	0.1353169	2.165230415724275
LEBER CONGENITAL AMAUROSIS WITH EARLY-ONSET DEAFNESS; LCAEOD	0.13524894999999998	2.1641431353716474
PRIMROSE SYNDROME; PRIMS	0.13509257	2.1616408704482644
RETINITIS PIGMENTOSA 4; RP4	0.13495076	2.159371742754282
CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS	0.13494008000000002	2.1592008501249067
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.13476974	2.156475208693463
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	2.150950960438259
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.13419336	2.147252447109248
BAKER-GORDON SYNDROME; BAGOS	0.13415261	2.1466003989213216
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.13395516000000002	2.143440965431604
CHARGE SYNDROME	0.13395357000000002	2.143415523551388
#204870 CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD;;CDGDL;;AMYLOIDOSIS, CORNEAL;;AMYLOID CORNEAL DYSTROPHY, JAPANESE TYPE;;CORNEAL DYSTROPHY, LATTICE TYPE III;;LATTICE CORNEAL DYSTROPHY, TYPE III	0.13369609000000002	2.1392955390746473
#615665 JOUBERT SYNDROME 22; JBTS22	0.13321043	2.131524404769171
NEPHRONOPHTHISIS 11; NPHP11	0.13284396999999998	2.1256606114207695
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.13279039	2.124803268061038
MAPLE SYRUP URINE DISEASE; MSUD	0.13243103099999998	2.1190530991097516
ACERULOPLASMINEMIA	0.13235199	2.1177883496417307
STICKLER SYNDROME, TYPE V; STL5	0.13230250000000002	2.1169964511185295
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.1319443	2.1112648275377905
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.1319443	2.1112648275377905
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.13182789	2.1094021298799635
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.13165177	2.106584001613521
METHYLMALONIC ACIDURIA, CBLB TYPE	0.13151527999999998	2.104400000210575
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.13099785000000003	2.096120508336256
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.13098056100000002	2.0958438638915675
#172700 PICK DISEASE OF BRAIN;;LOBAR ATROPHY OF BRAIN;;DEMENTIA WITH LOBAR ATROPHY AND NEURONAL CYTOPLASMIC INCLUSIONS	0.13055560000000002	2.089043985364224
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.13031915	2.0852605057560005
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.13001208	2.080347022637806
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.129997381	2.0801118212558594
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.12956978000000002	2.073269699606649
MARFANOID HABITUS WITH SITUS INVERSUS	0.12956621	2.073212575385031
#613660 CONE-ROD DYSTROPHY 15; CORD15RETINITIS PIGMENTOSA 65, INCLUDED; RP65, INCLUDED	0.12945182000000002	2.0713822001159063
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.12926419	2.0683798982385917
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.12914140999999998	2.0664152730480745
LISSENCEPHALY, X-LINKED, 2	0.129080311	2.065437616796932
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.12815334	2.050604984629816
#614696 AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17;;AMYOTROPHIC LATERAL SCLEROSIS, CHMP2B-RELATED	0.12799879000000003	2.0481320018704556
DESBUQUOIS DYSPLASIA 1	0.12782483	2.0453484361582683
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.1277933	2.04484391887323
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.12769105	2.043207797959968
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.12725331	2.036203440321128
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.127227041	2.0357831052573583
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.126289571	2.020782476674904
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.126270141	2.0204715736984284
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.1261218	2.01809794228137
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.12607773	2.017392770167458
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.12606376	2.017169233647573
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.125863251	2.0139608525405093
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	2.012051095404873
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.125641	2.010404573722969
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.1253919	2.0064186791557947
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.12531445	2.005179387569172
ADENYLOSUCCINASE DEFICIENCY	0.12508796100000003	2.001555295740088
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.125	2.000147815723937
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.125	2.000147815723937
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.125	2.000147815723937
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.125	2.000147815723937
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.125	2.000147815723937
VESTIBULOPATHY, FAMILIAL	0.125	2.000147815723937
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.12480213100000001	1.9969816777387412
SPINOCEREBELLAR ATAXIA 43; SCA43	0.12436788	1.9900331482257334
AICARDI-GOUTIERES SYNDROME 6	0.12420047999999999	1.9873545502709158
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.12417515	1.9869492403175377
HOLOPROSENCEPHALY 7	0.12409115100000001	1.985605156986554
GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	0.12408962	1.9855806591761067
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.12396393	1.9835694705444402
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.12393149999999999	1.9830505521951287
MCLEOD SYNDROME; MCLDS	0.12351274000000001	1.9763498970006284
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.12303451000000001	1.968697651481319
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.12271767	1.9636278368098472
WAARDENBURG-SHAH SYNDROME	0.12240541000000002	1.9586313075543438
MUCOLIPIDOSIS IV; ML4	0.12224486	1.9560623176998275
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.1221591	1.954690056286416
#615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMALDOMINANT; SMALED2	0.12189101	1.9504002992630762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.12178417100000001	1.9486907489232035
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.12143200000000001	1.943055596471913
MAST SYNDROME	0.12105589	1.9370373917121375
GITELMAN SYNDROME	0.12090723100000002	1.934658671919036
#613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC	0.12040140000000002	1.9265647777608326
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.12040140000000002	1.9265647777608326
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.12040140000000002	1.9265647777608326
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.12038934000000001	1.9263718034995714
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.120276401	1.9245646459462906
JOUBERT SYNDROME 4	0.12018581	1.923115082820097
RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS	0.12003933	1.9207712296037187
#300424 RETINITIS PIGMENTOSA 23; RP23	0.11999708	1.9200951796420043
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.11927313099999999	1.9085111395536396
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.11916635099999999	1.9068025332835354
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.11905900000000001	1.9050847903382098
GLYCOGEN STORAGE DISEASE IXA	0.11892349999999999	1.9029166301059646
GLYCOGEN STORAGE DISEASE IXC	0.11892349999999999	1.9029166301059646
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.11856014100000001	1.897102456424576
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.11840578099999999	1.8946325138898945
ROBERTS SYNDROME; RBS	0.11817538	1.8909458254347695
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.11803660999999999	1.8887253413356655
RETINITIS PIGMENTOSA 17	0.11791332	1.8867525555420608
ACROCALLOSAL SYNDROME; ACLS	0.11770577100000001	1.8834315261100156
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.1175439	1.880841398693383
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.11748374	1.8798787675526314
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.11725314	1.8761888948621839
ARIMA SYNDROME	0.1170445	1.8728504081400026
SPASTIC PARAPLEGIA 16, X-LINKED	0.11700631	1.8722393229793428
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.11698205	1.8718511342912671
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.11662153	1.8660823879670687
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.11646776100000002	1.8636219021312603
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.11642679000000002	1.8629663176819962
RETINITIS PIGMENTOSA 73; RP73	0.11632318000000001	1.861308435160499
EHLERS-DANLOS SYNDROME, TYPE VI	0.11612235	1.858094917673844
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.11595433	1.8554063989858605
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.11592399999999999	1.854921083119853
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.11588458	1.8542903165046865
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.11570875	1.8514768285811767
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.11569245	1.8512160093060064
FACIAL SPASM	0.11543999999999999	1.84717651077737
TIETZ SYNDROME	0.1149069	1.8386462803728707
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.11477482100000001	1.836532860186047
#614878 AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED;APLAID	0.11473418999999999	1.8358827161388411
RETINITIS PIGMENTOSA 59; RP59	0.114346231	1.8296749133673178
HEART AND BRAIN MALFORMATION SYNDROME	0.114155661	1.8266255680133778
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.1140414	1.824797256896798
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.113969	1.823638771281931
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.11391998999999998	1.8228545533263414
FRONTOTEMPORAL DEMENTIA; FTD	0.1138889	1.8223570765616153
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.11376589000000001	1.8203887710991173
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.11373386	1.8198762532228165
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.113491121	1.8159921421776883
MARDEN-WALKER SYNDROME	0.113263681	1.8123528332240222
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.11317421000000001	1.8109211914222572
BASAL LAMINAR DRUSEN	0.1131313	1.8102345806800753
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.11266629100000002	1.80279388679494
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.11265820000000001	1.8026644212271237
%614494 RETINITIS PIGMENTOSA 63; RP63	0.11246458000000001	1.7995662722664798
184705 STEINFELD SYNDROME	0.11236263	1.7979349517079752
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.11208263000000002	1.793454620600754
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.1120536	1.79299010627203
GLYCOGEN STORAGE DISEASE 0, LIVER	0.112026751	1.7925604905223949
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.11181577100000001	1.7891845610331036
MUSCULAR HYPERTONIA, LETHAL	0.1117215	1.7876761135552144
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.11171386999999999	1.7875540245325425
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.11151195	1.7843230657569347
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.11123699000000001	1.7799233806096433
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.11111099999999999	1.7779073916232186
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.11111099999999999	1.7779073916232186
ANISOCORIA	0.11111099999999999	1.7779073916232186
TORSION DYSTONIA WITH ONSET IN INFANCY	0.11111099999999999	1.7779073916232186
AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19	0.11111099999999999	1.7779073916232186
HYPEROPIA, HIGH	0.11111099999999999	1.7779073916232186
TIGLIC ACIDEMIA	0.11111099999999999	1.7779073916232186
Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	0.11111099999999999	1.7779073916232186
KINDLER SYNDROME; KNDLRS	0.11111099999999999	1.7779073916232186
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.11091769	1.774814203029158
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.110904101	1.7745967629598152
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.11083304000000001	1.77345970292835
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.1107372	1.7719261495950778
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.11056582100000001	1.7691838829349906
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.11015829099999999	1.7626629210202545
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.110119	1.7620342185576336
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.11004898999999999	1.7609139757690029
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.11004143000000001	1.7607930068291082
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.10985697	1.7578414287004005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.10967292000000001	1.7548964110565286
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.109051121	1.744946891763174
DYSTONIA 12; DYT12	0.10894839	1.7433030742811169
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.108736841	1.7399180401189682
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.10851130000000002	1.7363091174109189
PAPILLOMA OF CHOROID PLEXUS	0.10816213100000001	1.7307220005095707
PEROXISOME BIOGENESIS DISORDER 5B	0.10802008999999999	1.7284491765424244
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.10778578999999999	1.7247000994766317
RHABDOMYOLYSIS, ACUTE RECURRENT	0.10768735	1.7231249430687927
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.10753920000000002	1.7207543678775972
608484 CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA;;CORNEAL OPACITIES, CONGENITAL, WITH CORNEA GUTTATA AND CORECTOPIA	0.10714290000000001	1.7144130992426256
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.10708698999999999	1.7135184731276085
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.10690144	1.710549453709948
DE SANCTIS-CACCHIONE SYNDROME	0.10678908999999999	1.708751720853175
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.10677467	1.7085209838011535
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.10668159999999999	1.7070317537434778
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.10666836	1.7068198980868365
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.10647385100000001	1.7037075240749273
Yao syndrome	0.10633490000000001	1.7014841437617862
MYOCLONUS AND ATAXIA	0.10626422	1.7003531801808631
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.10603411	1.696671148069853
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.10588412100000001	1.6942711467039924
OPTIC ATROPHY 11; OPA11	0.10568597	1.6911004963853244
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.10548193	1.6878356151027618
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.10533595100000001	1.6854997784788293
#607688 PARKINSON DISEASE 11, AUTOSOMAL DOMINANT; PARK11	0.1051282	1.6821755168079136
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.1051282	1.6821755168079136
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.10488191	1.678234585563636
CHANARIN-DORFMAN SYNDROME	0.10449157	1.6719886839765188
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.10442284000000002	1.6708889227015213
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.10423219	1.667838297252979
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.10401668100000001	1.6643898984080283
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.10385127999999999	1.6617432868170796
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.1037037	1.6593818322999234
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.10369423	1.6592303011014042
HISTIDINEMIA	0.1036867	1.6591098121969854
WOLFRAM SYNDROME 2; WFS2	0.10361011	1.6578842816273347
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.10358389999999998	1.6574648906333331
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.10337694	1.6541532858977959
Pierpont syndrome	0.103282751	1.6526461505168744
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.10313647	1.6503054815358187
NAVAJO NEUROHEPATOPATHY	0.10309014	1.6495641467493987
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.10265832100000001	1.642654532112294
MASA SYNDROME	0.10248756	1.6399221541830076
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.10232868100000002	1.6373799023044926
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.102242851	1.6360065208083034
MICROPHTHALMIA, ISOLATED 3	0.10219112999999999	1.6351789236468868
MENTAL RETARDATION, X-LINKED 98; MRX98	0.102187961	1.635128215899463
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.102099731	1.633716431565212
PELVIS-SHOULDER DYSPLASIA	0.10201913	1.6324267202524507
FUMARASE DEFICIENCY; FMRD	0.10193819	1.6311315845388135
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.10185874	1.6298602905871393
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.10185874	1.6298602905871393
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.10184717100000001	1.6296751729064984
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.10183005	1.6294012166604743
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.10146994000000001	1.6236390308211117
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.101177181	1.6189545406260435
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.10108749	1.6175193785641226
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.101078601	1.6173771440526508
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.10106841100000001	1.6172140920027132
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	1.614771351478326
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.10087720000000001	1.614154489890774
TRYPTOPHANURIA WITH DWARFISM	0.10081009	1.613080650531468
CHROMOSOME 17q12 DELETION SYNDROME	0.10076128000000001	1.6122996328123842
CONE DYSTROPHY 3	0.10036279000000001	1.6059233215876816
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.10033399000000001	1.6054624875309387
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.10017076100000001	1.6028506305084362
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.1001104	1.601884783129997
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.100103731	1.6017780712437324
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.1	1.6001182525791497
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	1.6001182525791497
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	1.6001182525791497
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	1.6001182525791497
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.1	1.6001182525791497
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	1.6001182525791497
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.1	1.6001182525791497
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	1.6001182525791497
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	1.6001182525791497
#616279 CATARACT 43; CTRCT43	0.1	1.6001182525791497
TETRALOGY OF FALLOT AND GLAUCOMA	0.1	1.6001182525791497
ALAGILLE SYNDROME 2	0.1	1.6001182525791497
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	1.6001182525791497
HOMOCARNOSINOSIS	0.1	1.6001182525791497
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.1	1.6001182525791497
KAPUR-TORIELLO SYNDROME	0.09935767100000001	1.5898402290085407
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	0.09925309	1.5881668093388108
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.099089821	1.585554312269007
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.09857086999999999	1.577250482596065
RETINITIS PIGMENTOSA 56; RP56	0.09825773	1.572239872299939
CONE-ROD DYSTROPHY 17; CORD17	0.09816788000000001	1.5708021660499967
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0980487	1.5688951451165727
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.0980392	1.568743133882578
JOUBERT SYNDROME 3; JBTS3	0.09774655	1.5640603878164048
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.09766437100000001	1.5627454266376177
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.09762533000000001	1.5621207244706286
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.09748382	1.5598563971314034
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.0973804	1.5582015548345862
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.09728149	1.55661887787096
SNEDDON SYNDROME	0.097254611	1.5561887820858493
RETINITIS PIGMENTOSA 79	0.09713189000000001	1.5542251009651018
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0970666	1.5531803837579927
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.096745051	1.548035219518007
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.09671077	1.5474866829798404
SORSBY FUNDUS DYSTROPHY; SFD	0.09651651	1.5443782932623802
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.096489511	1.5439462773353663
DYSTONIA 15, MYOCLONIC; DYT15	0.09634832000000002	1.5416870543733676
#183086 SPINOCEREBELLAR ATAXIA 6; SCA6	0.09628729	1.540710502203818
YUNIS-VARON SYNDROME	0.09626414999999999	1.5403402348401711
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.09617259	1.53887516656811
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.09611821000000001	1.5380050222623576
EPILEPSY-TELANGIECTASIA	0.09590648100000002	1.5346171078873543
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.09554051100000001	1.5287611551183902
BETA-UREIDOPROPIONASE DEFICIENCY	0.095247	1.5240646320340625
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.09515182	1.5225416394812576
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.09510747000000001	1.5218319870362391
JOUBERT SYNDROME 21	0.09498245999999999	1.5198316792086894
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.09494892	1.5192949995467746
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.094655871	1.5146058690087738
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.09453229	1.5126284268710541
#615558 HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1;;HYPOBETALIPOPROTEINEMIA, FAMILIAL; FHBL;;ACANTHOCYTOSIS WITH HYPOBETALIPOPROTEINEMIA;;HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC	0.09428798000000001	1.5087191779681781
IMMUNONEUROLOGIC DISORDER, X-LINKED	0.09385960000000002	1.5018645913977797
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.09361144	1.497893737942179
ZUNICH NEUROECTODERMAL SYNDROME	0.09343389100000002	1.4950527439859076
PHENYLKETONURIA	0.093275801	1.492523117040405
BOTHNIA RETINAL DYSTROPHY	0.09303049999999999	1.4885980109656454
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.09293815	1.4871203017593888
CANAVAN DISEASE	0.09243821	1.4791206705674447
LACRIMAL DUCT DEFECT	0.09230769999999999	1.4770323562360035
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.09225031	1.4761140483708484
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.092129321	1.4741780812982355
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.09208427999999999	1.473457372036091
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.0919796	1.4717823682492912
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.09192217100000001	1.4708634363380177
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.09190099099999999	1.4705245312921211
224250 DYSMYELINATION WITH JAUNDICE	0.09182485100000001	1.4693062012546079
RODRIGUES BLINDNESS	0.09169382000000001	1.4672095503070708
15q26 overgrowth syndrome	0.09146006000000001	1.463469113879842
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.091163031	1.4587162986353885
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.09097774	1.4557514235240019
#612900 CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2	0.0909091	1.4546531023554319
NANOPHTHALMOS 1	0.0909091	1.4546531023554319
HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATALBREASTFEEDING JAUNDICE, INCLUDED	0.0909091	1.4546531023554319
#606068 RETINITIS PIGMENTOSA 28; RP28	0.09084858	1.4536847107889705
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.09057968000000001	1.4493819928077856
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.08999249000000001	1.439986258440466
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.089735671	1.4358768507453747
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.08973155099999999	1.4358109258733682
#610542 MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1	0.0896065	1.4338099619973357
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0896065	1.4338099619973357
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.0895813	1.4334067321976858
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G	0.08955468999999999	1.4329809407306744
TONNE-KALSCHEUER SYNDROME; TOKAS	0.08955216999999999	1.4329406177507091
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.08949122000000001	1.4319653456757624
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.08946827000000002	1.4315981185367956
ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT	0.08913629	1.4262860459618834
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.08899370000000001	1.4240044373455307
MICROPHTHALMIA, SYNDROMIC 3	0.08879822999999999	1.420876686197214
RETINITIS PIGMENTOSA 69	0.08874548000000002	1.4200326238189789
MYOTILINOPATHY	0.08865245000000001	1.4185440338086044
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.087946451	1.407247214946578
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.08785946100000001	1.4058552720786595
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.08771857000000001	1.4036008494714183
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.08769153	1.4031681774959206
#150250 LARSEN SYNDROME; LRS	0.08757304	1.4012721973784397
ALZHEIMER DISEASE 3; AD	0.087377701	1.398146542385034
#606952 ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B;;OCULOCUTANEOUS ALBINISM, TYPE IB;;ALBINISM, YELLOW MUTANT TYPE;;YELLOW ALBINISMALBINISM, OCULOCUTANEOUS, TYPE I, TEMPERATURE-SENSITIVE, INCLUDED;;OCA1-TS, INCLUDED	0.08735739000000001	1.3978215423667528
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.087341921	1.3975740200742612
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.08705360000000001	1.3929605431272427
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.087014271	1.3923312326196857
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.08685464	1.389776947851911
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.08665581100000001	1.3865954487314907
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.08649786000000001	1.3840680459503591
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.086299831	1.380899347775959
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.085941381	1.375163723899589
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.0858781	1.3741511530681747
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.08551310000000001	1.3683107214462609
JOUBERT SYNDROME 6	0.08532419	1.3652879380553133
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.08519204000000001	1.3631733817845302
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.08512492	1.362099382413399
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.08497740100000001	1.3597389039683767
CATARACT 22, MULTIPLE TYPES; CTRCT22	0.08496212	1.3594943898982002
ANIRIDIA AND ABSENT PATELLA	0.08485571000000001	1.3577917040656309
CRANIOSYNOSTOSIS 2	0.08473744100000002	1.3558992602094881
RETINITIS PIGMENTOSA 62; RP62	0.08468688	1.3550902244198015
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.08467504000000001	1.3549007704186962
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.08463284	1.3542255205161076
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.0845831	1.3534296216972745
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.08432892	1.3493624411228688
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0841504	1.3465059100183645
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.08410099000000001	1.3457152915897654
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.083485761	1.335870900065605
NEUROPATHY, HEREDITARY SENSORY, TYPE IF; HSN1F	0.08333330000000001	1.3334313437765406
GLYCOGEN STORAGE DISEASE V; GSD5	0.08333330000000001	1.3334313437765406
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED	0.08333330000000001	1.3334313437765406
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.08333330000000001	1.3334313437765406
#609452 MYOPATHY, MYOFIBRILLAR, 4; MFM4;;MYOPATHY, MYOFIBRILLAR, ZASP-RELATED	0.08333330000000001	1.3334313437765406
MIRROR MOVEMENTS 1; MRMV1	0.08333330000000001	1.3334313437765406
DYSTONIA, FOCAL, TASK-SPECIFIC; FTSD	0.08333330000000001	1.3334313437765406
MIRROR MOVEMENTS 3; MRMV3	0.08333330000000001	1.3334313437765406
GLYCOGEN STORAGE DISEASE XI; GSD11	0.08333330000000001	1.3334313437765406
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.08333330000000001	1.3334313437765406
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.08333330000000001	1.3334313437765406
MIRROR MOVEMENTS 4; MRMV4	0.08333330000000001	1.3334313437765406
MYOPATHY, DISTAL, 5; MPD5	0.08333330000000001	1.3334313437765406
%160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT	0.08333330000000001	1.3334313437765406
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.08333330000000001	1.3334313437765406
#614508 MIRROR MOVEMENTS 2; MRMV2	0.08333330000000001	1.3334313437765406
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.08333330000000001	1.3334313437765406
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.08333330000000001	1.3334313437765406
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.083025021	1.3284985152286721
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.08290378000000001	1.3265585158580626
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.08262103	1.3220341814988947
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.08253664	1.3206838417055433
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.08236453	1.3179298781810294
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.08227360100000002	1.3164749066551418
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.08201355	1.312313783138127
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.081622521	1.3060568567362494
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0815012	1.3041155772710378
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0814328	1.3030210963862736
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.08142295000000001	1.3028634847383946
RHEUMATOID ARTHRITIS	0.08136789999999999	1.3019826196403497
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.08120314000000001	1.2993462648074006
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.08114293000000002	1.2983828336075227
MYOPATHY, SCAPULOHUMEROPERONEAL	0.08107675	1.2973238753479657
#278750 XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV;;XERODERMA PIGMENTOSUM WITH NORMAL DNA REPAIR RATES;;PHOTOSENSITIVITY WITH DEFECTIVE DNA SYNTHESIS	0.08101194	1.2962868387084692
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.08101194	1.2962868387084692
#278720 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC;;XPCC;;XP, GROUP C;;XERODERMA PIGMENTOSUM III; XP3	0.08101194	1.2962868387084692
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.08100473000000001	1.2961714701824583
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.08100473000000001	1.2961714701824583
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.08100175999999999	1.2961239466703565
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.08098602099999999	1.295872104058583
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.08068026	1.2909795664883146
#608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8	0.08060964	1.289849562978343
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.08051610000000001	1.2883528123648806
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.08014676000000001	1.282442935610805
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.07989075100000001	1.2783464888735596
CONE-ROD DYSTROPHY 21; CORD21	0.07975699000000001	1.2762061546977272
#300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A;;CSNB, INCOMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2	0.07973609	1.2758717299829379
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.07973224999999999	1.2758102854420388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.079638351	1.2743077904040496
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.07951845	1.2723892326180248
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.079495441	1.2720210614092888
JOUBERT SYNDROME 30; JBTS30	0.079473501	1.2716699954646729
IMMUNODEFICIENCY 10; IMD10	0.0794118	1.270682706501649
KLEEBLATTSCHAEDEL SYNDROME	0.07930262	1.2689356973934833
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.07921914999999999	1.2676000786880552
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.0791525	1.2665335998727112
HUNTINGTON DISEASE; HD	0.079044221	1.2648010078300012
COLOBOMA OF OPTIC NERVEOPTIC NERVE HEAD PITS, BILATERAL CONGENITAL, INCLUDED	0.0788934	1.262387693480279
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.07886889999999999	1.2619956645083967
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.07878184	1.2606026015577014
CHYLOMICRON RETENTION DISEASE	0.07867498	1.2588927151929954
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.07867498	1.2588927151929954
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.078629	1.2581569808204596
USHER SYNDROME, TYPE IIIA	0.07859643	1.2576358223055943
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4; PPCD4	0.07832515000000001	1.2532950215099978
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.07825463099999999	1.2521666341194613
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.07815263	1.2505344975006483
OTOFACIOCERVICAL SYNDROME 2	0.078125	1.2500923848274605
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.078119791	1.2500090346676838
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.077946551	1.2472369898069156
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.07777891	1.2445545355671095
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.07767421099999999	1.2428792277578415
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.07758597	1.241467267410583
SMITH-MAGENIS SYNDROME; SMS	0.077558081	1.2410210104311215
GRACILE BONE DYSPLASIA; GCLEB	0.07755268100000001	1.2409346040454823
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.0775444	1.240802098252986
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.077392181	1.2383664142500928
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.07703089	1.2325853310141668
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.07703089	1.2325853310141668
LISSENCEPHALY 2; LIS2	0.07692310000000001	1.2308605635497119
ACHALASIA, FAMILIAL ESOPHAGEAL	0.07692310000000001	1.2308605635497119
#172800 PIEBALD TRAIT; PBT;;PIEBALDISM	0.07692310000000001	1.2308605635497119
WAARDENBURG SYNDROME, TYPE IIB	0.07692310000000001	1.2308605635497119
CANDIDIASIS, FAMILIAL, 8; CANDF8	0.07692310000000001	1.2308605635497119
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1; NISBD1	0.07692310000000001	1.2308605635497119
USHER SYNDROME, TYPE IV; USH4	0.07692310000000001	1.2308605635497119
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	1.2308605635497119
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.07692310000000001	1.2308605635497119
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.07670946000000001	1.2274420709149019
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.07670946000000001	1.2274420709149019
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.07670935100000001	1.2274403267860066
POTOCKI-LUPSKI SYNDROME	0.07660898099999999	1.2258342880958926
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D	0.07656769	1.22517358326822
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3	0.07656769	1.22517358326822
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.076486601	1.2238760633783863
GLAUCOMA 1, PRIMARY OPEN ANGLE, C; GLC1C	0.07647061999999999	1.2236203484804415
MENTAL RETARDATION, BUENOS AIRES TYPE	0.07646071	1.2234617767616112
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.07631545	1.2211374449879147
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.07619616	1.2192286639244128
OROFACIODIGITAL SYNDROME IX; OFD9	0.0757749	1.212488005773598
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.07575760000000001	1.2122111853159019
#614076 HERMANSKY-PUDLAK SYNDROME 7; HPS7	0.07556726	1.2091655202339426
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.07551023000000001	1.208252972794497
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.07547254099999999	1.207649904226282
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.0753205	1.2052170684338783
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.07523514	1.2038512074934768
CATARACT, NUCLEAR TOTAL	0.07515820000000001	1.2026200765099426
ANIRIDIA 2	0.07505179000000001	1.2009173906773731
PARKINSONISM WITH SPASTICITY, X-LINKED	0.07501261	1.2002904643460122
DERMATITIS, ATOPIC	0.07501252	1.200289024239585
PELGER-HUET ANOMALY; PHA	0.0746078	1.1938130256477468
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.074595481	1.1936159070802117
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	1.1908640077082433
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.07427031	1.1884127865571175
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.07422190000000001	1.1876381693110438
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.07422190000000001	1.1876381693110438
GAPO SYNDROME; GAPOS	0.074180361	1.186973496190105
JOUBERT SYNDROME 15	0.0740867	1.185474809433557
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.07403808099999999	1.1846968479403353
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.07401377099999999	1.1843078591931333
SPINOCEREBELLAR ATAXIA 23; SCA23	0.07399978	1.184083986648415
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.07394923	1.1832751268717363
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.07382182	1.181236416206125
#615058 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F	0.07372047	1.1796146963571361
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.073693201	1.1791783601108403
SHUKLA-VERNON SYNDROME; SHUVER	0.073664391	1.178717366042272
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.07364899	1.1784709318301925
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.073628151	1.1781374831875377
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.073628151	1.1781374831875377
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.07328734	1.1726841041697402
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.073168671	1.170785259840587
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.07311780000000001	1.1699712636843174
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.07306543	1.1691332817554416
BARAITSER-WINTER SYNDROME 1; BRWS1	0.07303955100000001	1.1687191871528568
KOOLEN-DE VRIES SYNDROME; KDVS	0.072974991	1.1676861508089917
SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE; SPG74	0.07283077	1.1653784442639394
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.072632251	1.1622019055101018
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.072433541	1.1590223105304018
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.07234435100000002	1.1575951650609266
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.07234435100000002	1.1575951650609266
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.07228467999999999	1.1566403584984297
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.07228295	1.1566126764526603
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.07225595	1.1561806445244638
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.07222589	1.1556996489777387
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.07187502999999999	1.1500854740767392
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.07187502999999999	1.1500854740767392
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.07174022999999999	1.1479285146722626
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.071646241	1.146424579527846
POSTERIOR COLUMN ATAXIA	0.07142860000000001	1.1429420661617504
GLYCOGEN STORAGE DISEASE IV	0.07142860000000001	1.1429420661617504
WAGR 11p13 deletion syndrome	0.07142860000000001	1.1429420661617504
#609140 CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2; PPCD2	0.07142860000000001	1.1429420661617504
BLEPHAROSPASM, BENIGN ESSENTIAL, SUSCEPTIBILITY TO	0.07142860000000001	1.1429420661617504
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.07142860000000001	1.1429420661617504
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.07142860000000001	1.1429420661617504
ABCD SYNDROME	0.07142860000000001	1.1429420661617504
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.07142860000000001	1.1429420661617504
ECTOPIA PUPILLAE	0.07142860000000001	1.1429420661617504
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.07142860000000001	1.1429420661617504
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.07142860000000001	1.1429420661617504
ALZHEIMER DISEASE 10	0.07142860000000001	1.1429420661617504
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.071366671	1.1419511289291107
SECKEL SYNDROME 1; SCKL1	0.071317721	1.1411678710444733
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.07103391	1.136626559430646
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.07094212	1.1351578108866034
SCLEROSTEOSIS 1; SOST1	0.07085248	1.1337234648849912
FOLATE MALABSORPTION, HEREDITARY	0.070748651	1.132062078104521
MICROPHTHALMIA, ISOLATED 8	0.07070883	1.1314248950151615
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.07064725	1.1304395421952231
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.07025200000000001	1.1241150748019042
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.07022651099999999	1.123707220660504
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.070152131	1.1225170527042359
SALLA DISEASE	0.069822181	1.117237462529851
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.06978559000000001	1.1166519632600498
AICARDI-GOUTIERES SYNDROME 7	0.069755151	1.116164903265147
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.06973193	1.1157933398057156
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.06970357	1.1153395462692843
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.06949182100000001	1.1119513118706306
Trichothiodystrophy 5, nonphotosensitive	0.0693487	1.1096612066263567
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.06909713	1.1056357891383433
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.069084351	1.1054313100268462
HAREL-YOON SYNDROME; HAYOS	0.06860229999999999	1.0977179239891057
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.0685894	1.097511508734523
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.06852543999999999	1.0964880731001734
JABERI-ELAHI SYNDROME; JABELS	0.068459041	1.0954256105816436
NEMALINE MYOPATHY 2; NEM2	0.06824249	1.0919605385045008
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.06812452	1.0900728790019332
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.06811504100000002	1.0899212037927715
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0681131	1.0898901454974887
JOUBERT SYNDROME 23; JBTS23	0.0678571	1.085793842770886
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.0678571	1.085793842770886
SPINOCEREBELLAR ATAXIA 47; SCA47	0.067845541	1.0856088851020704
RETINITIS PIGMENTOSA 80; RP80	0.06783749	1.0854800595815552
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.067836481	1.0854639143883869
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.06783040100000001	1.0853666271986302
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.06774968	1.0840749957439657
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.06763849	1.0822958242589227
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.06749325	1.0799718125088769
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.06736815	1.0779700645749002
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.06735213100000001	1.0777137416320197
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.067201451	1.0753026834490333
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.06713000999999999	1.074159542968208
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.06707888099999999	1.0733414185068468
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.06705935999999998	1.073029059422761
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.06678522	1.0686424952451408
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.06674437	1.067988846938962
CRANIOFACIOFRONTODIGITAL SYNDROME	0.06673374	1.0678187543687128
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.0666667	1.0667460350921838
#613411 OGUCHI DISEASE 2;;NIGHT BLINDNESS, CONGENITAL STATIONARY, OGUCHI TYPE 2	0.0666667	1.0667460350921838
#615041 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 10; MDDGA10	0.0666667	1.0667460350921838
#614251 PARKINSON DISEASE 18; PARK18	0.0666667	1.0667460350921838
601220 OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH	0.0666667	1.0667460350921838
KERATOSIS PILARIS ATROPHICANS; KPA	0.0666667	1.0667460350921838
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.0666667	1.0667460350921838
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.0666667	1.0667460350921838
NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2	0.0666667	1.0667460350921838
#610357 SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30	0.06665950999999999	1.0666309865898231
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.06664018000000001	1.0663216837315999
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.06658163	1.065384814494715
#610250 SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31	0.06630393999999999	1.0609414461191276
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.06630380000000001	1.0609392059535743
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.065766771	1.052346106902931
MARSHALL-SMITH SYNDROME; MRSHSS	0.065625	1.050077603255067
OSTEOGENESIS IMPERFECTA, TYPE X	0.065625	1.050077603255067
SICKLE CELL ANEMIA	0.0656084	1.0498119836251385
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.06560752	1.049797902584516
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.06560667	1.0497843015793693
RENPENNING SYNDROME 1; RENS1	0.065593361	1.0495713418411334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.06551006	1.0482384273355523
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.06524887	1.044059078471641
KURU, SUSCEPTIBILITY TO	0.0651515	1.0425010433291046
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.0649038	1.038537550417466
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.064440351	1.0311218183770705
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.06426166	1.0282625510703542
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.06423148000000001	1.0277796353817261
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	1.0266838744023596
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.063964261	1.0235038153883662
CORNEODERMATOOSSEOUS SYNDROME	0.06387444	1.0220665731727174
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.06378033100000001	1.0205607178863978
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.06378033100000001	1.0205607178863978
CITRULLINEMIA, CLASSIC	0.063780331	1.0205607178863976
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.063748	1.0200433836541563
KERATITIS, HEREDITARY	0.063748	1.0200433836541563
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.06374194	1.0199464164880498
KEARNS-SAYRE SYNDROME; KSS	0.063580751	1.0173672018779003
SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE	0.06354594	1.0168101847129947
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.06349495	1.0159942844160046
BETHLEM MYOPATHY 1	0.0634615	1.015459044860517
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	0.06330754000000001	1.0129955027988462
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.06324389999999999	1.0119771875429047
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.06324389999999999	1.0119771875429047
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.062935751	1.0070464391487646
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.0628653	1.00591913983864
SCHEIE SYNDROME	0.06275962	1.0042281348693143
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.06261251999999999	1.0018743609197702
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.06259937	1.0016639453695564
RAYNAUD-CLAES SYNDROME; MRXSRC	0.06256641099999999	1.0011365623946886
#270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5;;SITUS INVERSUS VISCERUM; SIV	0.0625	1.0000739078619685
HYDROXYKYNURENINURIA	0.0625	1.0000739078619685
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.0625	1.0000739078619685
HELIX SYNDROME; HELIX	0.0625	1.0000739078619685
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0625	1.0000739078619685
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.0625	1.0000739078619685
FASCIAL DYSTROPHY, CONGENITAL	0.0625	1.0000739078619685
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.0625	1.0000739078619685
LICHTENSTEIN SYNDROME	0.0625	1.0000739078619685
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.0625	1.0000739078619685
WARSAW BREAKAGE SYNDROME; WABS	0.0625	1.0000739078619685
181700 SCLEROCORNEA, AUTOSOMAL DOMINANT	0.0625	1.0000739078619685
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0625	1.0000739078619685
CATARACT, AGE-RELATED NUCLEAR	0.0625	1.0000739078619685
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.0625	1.0000739078619685
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0625	1.0000739078619685
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.0625	1.0000739078619685
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.062360280000000004	0.9978382226394649
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0623249	0.9972721008017024
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.062234521	0.9958259299262039
DESANTO-SHINAWI SYNDROME	0.061999331	0.992062611807963
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.061949559999999994	0.9912662169524716
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.061940201	0.991116461885213
EHLERS-DANLOS SYNDROME, TYPE I	0.061857909999999995	0.9897997085739829
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.06170581	0.9873659287118102
SPINOCEREBELLAR ATAXIA 40; SCA40	0.06163245	0.9861920819617179
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0616168	0.9859416634551893
SPINOCEREBELLAR ATAXIA 46; SCA46	0.06152291	0.9844393124278428
SPINOCEREBELLAR ATAXIA 38; SCA38	0.06152291	0.9844393124278428
LEIGH SYNDROME; LS	0.061350380999999996	0.9816786444078505
PREPAPILLARY VASCULAR LOOPS	0.0611888	0.9790931573341507
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.061043800999999995	0.9767730018690933
#253300 SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE	0.060874750000000005	0.974067985961926
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.060851830999999995	0.9737012548596171
BENT BONE DYSPLASIA SYNDROME; BBDS	0.06068224	0.9709875983138857
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.06068224	0.9709875983138857
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.06066584	0.9707251789204627
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.06058712	0.9694655658320324
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.060530180999999995	0.9685544745001964
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.060420010999999996	0.9667916242213298
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.06035237	0.965709288234103
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.060261300000000004	0.9642520605414792
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.060253161	0.9641218269169015
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.059906860000000006	0.9585806014070376
#614483 PORENCEPHALY 2; POREN2	0.059739251	0.9558986592050721
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.059492221	0.9519458870857258
NEMALINE MYOPATHY 3; NEM3	0.059447309999999996	0.95122725797731
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.05924791	0.9480366221816672
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.059247771000000005	0.9480343980172963
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0588697	0.9419848149385875
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.05883713000000001	0.9414636564237227
RUIJS-AALFS SYNDROME; RJALS	0.0588235	0.941245560305896
Bangstad syndrome	0.0588235	0.941245560305896
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.0588235	0.941245560305896
KYRLE DISEASE	0.0588235	0.941245560305896
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0588235	0.941245560305896
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.0588235	0.941245560305896
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.05873985	0.9399070613876136
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.05871605	0.9395262332434997
%300750 SPASTIC PARAPLEGIA 34, X-LINKED; SPG34	0.05871605	0.9395262332434997
GAUCHER DISEASE, TYPE I	0.0584416	0.9351347086992963
DERMOIDS OF CORNEA	0.0584416	0.9351347086992963
#613435 AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12	0.05836459	0.933902457632985
#148300 KERATOCONUS 1; KTCN1	0.058333399999999994	0.9334033807500055
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.058211921	0.9314595730979549
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0581894	0.9310992104662916
#613702 KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3	0.0581818	0.9309776014790956
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD;;SUBEPITHELIAL MUCINOUS CORNEAL DYSTROPHY	0.0579365	0.927052511405519
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.057897271	0.9264248010162146
CHROMOSOME 18Q DELETION SYNDROME	0.057732921	0.9237950066681008
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.057726970999999995	0.9236997996320723
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.05765880999999999	0.9226091430299318
Muenke syndrome	0.057629770999999996	0.9221444846905654
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.057551951000000004	0.9208992726664084
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.05750845	0.9202032052253539
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.05744802	0.9192362537653204
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.057359350999999996	0.917817444911941
SPINOCEREBELLAR ATAXIA 37; SCA37	0.05734947	0.9176593372274037
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.057345151000000004	0.9175902281200748
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	0.917338193494111
VALINEMIA	0.05724638	0.9160097753208198
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.057228191	0.9157187298118581
JOUBERT SYNDROME 28	0.05722281	0.9156326274486868
MICROHYDRANENCEPHALY; MHAC	0.056966579999999996	0.9115326444501032
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.056887611000000005	0.9102690470672241
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.056676699999999997	0.9068942216595268
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	0.9064141861837531
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.056373381	0.9020407589769862
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0562079	0.8993928672914357
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.056160961	0.8986417877848577
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.05614495	0.8983855928514372
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.056129	0.8981303739901507
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.056040400000000004	0.8967126692183658
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.056003410999999996	0.8961208014779192
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.055820129999999996	0.8931880887434095
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.055630620000000006	0.8901557046429469
ZTTK SYNDROME; ZTTKS	0.055556471	0.8889692329598421
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	0.888955295929862
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	0.888955295929862
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	0.888955295929862
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	0.888955295929862
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	0.888955295929862
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.055555600000000004	0.888955295929862
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	0.888955295929862
FIBROCHONDROGENESIS 1; FBCG1	0.055493020000000004	0.8879539419273981
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0554315	0.8869695491784112
MECKEL SYNDROME 13; MKS13	0.0552188	0.8835660976551754
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.055064051	0.8810899306604917
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0550528	0.880909901355894
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0550528	0.880909901355894
#614465 JOUBERT SYNDROME 16; JBTS16	0.0549068	0.8785737287071285
MENTAL RETARDATION, X-LINKED 102	0.054878461	0.87812027119553
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.054813	0.8770728177862092
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.05478277000000001	0.8765891020384546
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.054744351	0.8759743526069961
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.05468958	0.875097951838876
COACH SYNDROME	0.054587761	0.8734687274352825
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.05452147	0.8724079930444653
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.054480299999999995	0.8717492243598783
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.05441131	0.870645302777424
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.0543463	0.8696050659014224
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.0543463	0.8696050659014224
ROBINOW-SORAUF SYNDROME	0.0543463	0.8696050659014224
ABETALIPOPROTEINEMIA	0.054278400000000004	0.8685185856079211
MOEBIUS SYNDROME; MBS	0.05409075000000001	0.8655159637069565
SILVER-RUSSELL SYNDROME; SRS	0.0540865	0.8654479586812218
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.053969439999999994	0.8635748602547524
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.05387895	0.8621269132479937
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0538461	0.8616012744020215
RETINITIS PIGMENTOSA 35; RP35	0.05382307000000001	0.8612327671684525
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.05379184	0.8607330502381719
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.05378257100000001	0.8605847352773406
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.05377674	0.8604914323820326
JOUBERT SYNDROME 35; JBTS35	0.053723599999999996	0.859641129542612
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.053703321	0.8593166415621714
SPINOCEREBELLAR ATAXIA 41; SCA41	0.053613	0.8578713987552595
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.05349446100000001	0.8559746345798347
#602433 AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, WITH PYRAMIDAL FEATURES	0.05342451	0.8548553358609731
#601553 HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD;;HYPOTRICHOSIS WITH CONE-ROD DYSTROPHY	0.05337929	0.8541317623871567
#604232 LEBER CONGENITAL AMAUROSIS 3; LCA3RETINITIS PIGMENTOSA, JUVENILE, SPATA7-RELATED, INCLUDED	0.05333001	0.8533432241122857
EPILEPSY, PYRIDOXINE-DEPENDENT	0.053280430000000004	0.852549885482657
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.053256871	0.8521729136235319
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.05310587	0.8497567190609548
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.05305141	0.8488852946606001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.053036929999999996	0.8486535975376266
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.053030299999999995	0.8485475096974806
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.05297915	0.8477290492112864
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.05296598	0.8475183136374218
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.05293871000000001	0.8470819613899436
WERNICKE-KORSAKOFF SYNDROME	0.0527933	0.8447552294388683
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.0527778	0.8445072111097183
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.052774491	0.8444542631967404
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.05269429	0.8431709523569895
GLYCINE ENCEPHALOPATHY; GCE	0.052611541	0.8418468705041627
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.052569210000000005	0.8411695244466636
RETINITIS PIGMENTOSA 29; RP29	0.05255597	0.8409576687900221
HYPOPHOSPHATASIA, INFANTILE	0.052381931	0.8381728389844159
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.052358710999999995	0.8378012915261669
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.05230531100000001	0.8369468283792899
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.05230410099999999	0.8369274669484333
BEHR SYNDROME	0.052218190000000005	0.8355527893564603
LOEYS-DIETZ SYNDROME 5	0.05208786	0.8334673552378737
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.05196921	0.8315688149311886
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.051959291	0.8314100992017152
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.05191546	0.8307087513704273
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.051898321	0.8304345071031177
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.05189521	0.83038472742428
PELLAGRA-LIKE SYNDROME	0.051886680000000004	0.8302482373373351
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.05185874	0.8298011642975645
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.05185874	0.8298011642975645
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.051844111	0.8295670829983945
RUTHERFURD SYNDROME	0.0518433	0.8295541060393662
WIEACKER-WOLFF SYNDROME	0.051768301	0.8283540333511145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.051706301	0.8273619600345153
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.051700630000000004	0.8272712173284116
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.051675421	0.8268678435181188
HYPERLYSINEMIA, TYPE I	0.051673360999999994	0.8268348810821157
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.0516313	0.8261618553438984
#276880 UROCANASE DEFICIENCY	0.05161728	0.8259375187648867
JOUBERT SYNDROME 25	0.0515151	0.8243025179344015
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.05143471000000001	0.8230161828711532
#300867 KABUKI SYNDROME 2; KABUK2	0.051286411	0.8206432235037607
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.05127992	0.8205393598279858
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.051126	0.8180764578136159
MYASTHENIA GRAVIS; MG	0.051056790000000005	0.816969015971006
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.050868461	0.8139555292671061
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.050867949999999995	0.8139473526628354
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.05079914	0.8128463112932357
METACHROMATIC LEUKODYSTROPHY	0.050734250999999994	0.8118080105603196
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.050717751	0.8115439910486442
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.05063708	0.8102531596531061
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.0506006	0.8096694365145651
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.0506006	0.8096694365145651
CRANIOTELENCEPHALIC DYSPLASIA	0.05054283	0.8087450482000501
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.05042804099999999	0.806908288459097
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0503781	0.8061091734025765
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.05033719	0.8054545650254463
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.050126880000000006	0.8020893563284472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.050058150999999995	0.800989611054632
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.05002521	0.80046251610105
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.050006661	0.800165710166379
COLE-CARPENTER SYNDROME 1; CLCRP1	0.05	0.8000591262895749
#614815 JOUBERT SYNDROME 18; JBTS18	0.05	0.8000591262895749
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.04986511099999999	0.7979007427798531
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.049840551	0.7975077537370198
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.049814281	0.7970874026720673
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.04980106	0.7968758510378938
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.0497924	0.7967372807972205
COFFIN-SIRIS SYNDROME 1; CSS1	0.049690871	0.7951126967365594
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.049676031	0.7948752391878767
Xq28 (MECP2) duplication	0.049594861	0.7935764232022582
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.049509410000000004	0.7922091061542468
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.049453751000000004	0.7913184963360437
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.04925185	0.7880878415829039
BARDET-BIEDL SYNDROME 5; BBS5	0.049096280000000006	0.7855985376173666
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.04908059	0.7853474790635369
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.04905076	0.7848701637887925
WARBURG MICRO SYNDROME 1	0.04881827	0.7811500488633711
PREMATURE OVARIAN FAILURE 12	0.04868663	0.779043653195676
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.048591751	0.7775254769988115
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.04857244	0.7772164781630558
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.048569351000000004	0.7771670505102337
LANDAU-KLEFFNER SYNDROME	0.048558450999999996	0.7769926376207025
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	0.7766653974368676
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	0.7766653974368676
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.04852824	0.7765092258954159
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.04851905999999999	0.7763623350398289
SPONDYLOOCULAR SYNDROME; SOS	0.0483364	0.773439559039668
MEHMO SYNDROME; MEHMO	0.048327841	0.7733026049184298
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.048287551000000005	0.7726579172744658
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.048281171	0.772555829729951
NOONAN SYNDROME 4; NS4	0.04813034000000001	0.7701423553684036
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.04811245	0.769856094213017
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.04811245	0.769856094213017
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.047915041	0.7666973167717831
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.047792760000000004	0.7647406761713468
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.047787960000000004	0.764663870495223
Helsmoortel-van der Aa syndrome	0.047742441	0.7639355126678314
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.047713309999999995	0.7634693822196725
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.04766902	0.7627606898456053
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.047619	0.7619603106956653
CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36	0.047619	0.7619603106956653
TRACHEOPATHIA OSTEOPLASTICA	0.047619	0.7619603106956653
FETAL AKINESIA SYNDROME, X-LINKED	0.047619	0.7619603106956653
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.047619	0.7619603106956653
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.047619	0.7619603106956653
CILIARY DYSKINESIA, PRIMARY, 40; CILD40	0.047619	0.7619603106956653
CILIARY DYSKINESIA, PRIMARY, 17; CILD17	0.047619	0.7619603106956653
#234810 PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2;;HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY	0.047619	0.7619603106956653
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.047619	0.7619603106956653
CILIARY DYSKINESIA, PRIMARY, 35; CILD35	0.047619	0.7619603106956653
300270 ADRENOMYODYSTROPHY	0.047619	0.7619603106956653
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.047619	0.7619603106956653
CILIARY DYSKINESIA, PRIMARY, 33	0.047619	0.7619603106956653
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	0.047619	0.7619603106956653
GERMAN SYNDROME	0.047619	0.7619603106956653
PANBRONCHIOLITIS, DIFFUSE	0.047619	0.7619603106956653
#615348 NEMALINE MYOPATHY 8; NEM8	0.047619	0.7619603106956653
215030 CHOLESTEROL PNEUMONIA	0.047619	0.7619603106956653
249300 MEGALOCORNEA	0.047619	0.7619603106956653
JOUBERT SYNDROME 8	0.0475622	0.7610514435282002
CHROMOSOME 19p13.13 DELETION SYNDROME	0.047513810999999996	0.7602771623069596
TERATOMA, PINEAL	0.04745851	0.759392280912101
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.047380251	0.758140044368815
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.047379041	0.7581206829379588
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.047187351	0.7550534162595899
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.047136529999999996	0.7542402201624465
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.04710959	0.7538091483052017
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.047091750999999994	0.7535237032101241
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.04707625	0.7532756688797919
AL KAISSI SYNDROME; ALKAS	0.047005291000000005	0.7521402409689443
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.0469976	0.7520171758741384
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.0468638	0.7498762176521875
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.04681679	0.74912400206165
ROIFMAN-CHITAYAT SYNDROME	0.04673485000000001	0.7478128651654867
HUNTINGTON DISEASE-LIKE 1	0.04665399	0.7465190095464511
CONE-ROD DYSTROPHY 19; CORD19	0.0466457	0.7463863597433124
HYPOADRENOCORTICISM, FAMILIAL	0.046623631	0.7460332296461506
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.046529871	0.7445329587725324
RETINITIS PIGMENTOSA 70; RP70	0.046372680000000006	0.7420177168901209
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.046321111	0.7411925519084481
EPISODIC ATAXIA, TYPE 5	0.04628729	0.7406513759142435
LEBER CONGENITAL AMAUROSIS 16	0.04627655	0.7404795232139164
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.0462716	0.7404003173604138
Contractural arachnodactyly, congenital	0.046232909999999995	0.7397812316084907
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.04619331	0.7391475847804695
BARAITSER-WINTER SYNDROME 2; BRWS2	0.046177120999999995	0.7388885416365595
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.0459495	0.7352463364688563
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.04574985999999999	0.7320518603894071
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.045588601	0.7294715256964807
HYPERPROLINEMIA, TYPE I	0.045541261	0.7287140297157096
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.045523551	0.728430648773178
RAHMAN SYNDROME	0.04547006	0.7275747295186907
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0454545	0.7273257511185895
#614782 TREMOR, HEREDITARY ESSENTIAL, 4; ETM4	0.0454545	0.7273257511185895
VERVERI-BRADY SYNDROME; VERBRAS	0.04540914	0.7265999374792196
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.045356721	0.7257611714924002
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.045324071	0.7252387328829331
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.0453204	0.7251799925418808
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.04520131	0.7232744117148844
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.04516304	0.7226620464596224
BARDET-BIEDL SYNDROME 17; BBS17	0.0450192	0.7203604363651126
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.044972911	0.7196197576271761
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.04496556	0.7195021329344291
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.04496556	0.7195021329344291
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0449306	0.7189427315933273
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0449245	0.71884512437992
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.04489246	0.7183324464917937
IMMUNODEFICIENCY 61; IMD61	0.0447964	0.7167953728983661
PARKINSON DISEASE 21; PARK21	0.04459647	0.7135962564759847
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.04445999999999999	0.7114125750966898
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.044394051000000004	0.7103573131102966
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.044394051000000004	0.7103573131102966
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.044350050999999995	0.7096532610791615
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.044320361	0.709178185969971
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.04427585	0.7084659573345653
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.04417079	0.7067848730984057
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.044117699999999996	0.7059353703181114
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.044117699999999996	0.7059353703181114
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.0440705	0.7051801145028941
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.04404506	0.7047730444194379
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.04401233	0.7042493257153688
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.043774720999999996	0.7004473007365979
Adrenoleukodystrophy	0.043745241000000004	0.6999755858757377
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.0437074	0.6993700851277792
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.04369145	0.6991148662664928
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.04362319	0.6980226255472822
SOTOS SYNDROME 2	0.043594150000000005	0.6975579512067334
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.043552969999999996	0.6968990225103212
#234580 HEIMLER SYNDROME 1; HMLR1;;HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS;;PEROXISOME BIOGENESIS DISORDER 1C; PBD1C	0.043478300000000004	0.6957042142111204
MACULAR DYSTROPHY, X-LINKED	0.043478300000000004	0.6957042142111204
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.043478300000000004	0.6957042142111204
MACULAR DYSTROPHY, FENESTRATED SHEEN TYPE	0.043478300000000004	0.6957042142111204
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.04342381	0.69483230977529
PEROXISOME BIOGENESIS DISORDER 3B	0.043280280000000004	0.6925356600473632
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0432773	0.6924879765234362
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.043276231	0.6924708712593162
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.043262781	0.6922556553543443
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.04319716999999999	0.6912058017676445
TURNPENNY-FRY SYNDROME; TPFS	0.04319359	0.6911485175342023
HURLER SYNDROME	0.04317432	0.6908401747469304
HYPERCALCEMIA, INFANTILE, 1	0.04313158	0.6901562842057779
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0430534	0.6889053117559115
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.0427905	0.684698600869881
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.04272617099999999	0.6836692607991792
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.042686299999999996	0.6830312776506934
NEMALINE MYOPATHY 10	0.0426304	0.6821368115475017
OCULOCEREBROCUTANEOUS SYNDROME	0.042610891	0.681824644477606
SENIOR-LOKEN SYNDROME 8; SLSN8	0.042610850000000006	0.6818239884291226
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.042541601	0.6807159225403939
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.042506750999999995	0.6801582813293701
IVIC SYNDROME	0.04248756	0.6798512026355177
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0424837	0.6797894380709681
OSTEOGENESIS IMPERFECTA, TYPE V	0.04243393	0.6789930592166595
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.04236547	0.6778976182609439
#156550 KNIEST DYSPLASIA	0.04235781	0.6777750492027963
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.042342471000000007	0.6775296070640332
IMMUNODEFICIENCY 9; IMD9	0.0422323	0.6757667407839842
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.041942430999999995	0.6711284940064155
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.04192514	0.6708518175593621
JOUBERT SYNDROME 7	0.04184701	0.6696016451686219
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.0416822	0.6669644902765463
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.041668809999999994	0.6667502344425258
ECTOPIA LENTIS	0.041666699999999994	0.6667164719473964
#604571 BARE LYMPHOCYTE SYNDROME, TYPE I;;BLS, TYPE I;;HLA CLASS I DEFICIENCY	0.041666699999999994	0.6667164719473964
%614628 KERATOCONUS 8; KTCN8	0.041666699999999994	0.6667164719473964
%614623 KERATOCONUS 6; KTCN6	0.041666699999999994	0.6667164719473964
%614629 KERATOCONUS 7; KTCN7	0.041666699999999994	0.6667164719473964
%614622 KERATOCONUS 5; KTCN5	0.041666699999999994	0.6667164719473964
ECTOPIA LENTIS, ISOLATED	0.041666699999999994	0.6667164719473964
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.041666699999999994	0.6667164719473964
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.04166527	0.6666935902563845
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0415952	0.6655723873968024
MANITOBA OCULOTRICHOANAL SYNDROME	0.04154987	0.6648470537929083
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.041514151	0.6642755075542695
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.04140347999999999	0.6625046406829576
GLUTATHIONE SYNTHETASE DEFICIENCY	0.041394741	0.6623648063488647
MYOPIA 3	0.041393400000000004	0.6623433487630978
MYOPIA 5	0.041393400000000004	0.6623433487630978
#608030 AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS6AMYOTROPHIC LATERAL SCLEROSIS 6, AUTOSOMAL RECESSIVE, INCLUDED	0.04125699	0.6601606274547545
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0412548	0.660125584865023
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.041238370999999996	0.6598627014373067
BASAL CELL NEVUS SYNDROME	0.04116353999999999	0.6586653169477191
PITT-HOPKINS SYNDROME	0.041026401000000004	0.6564709307773148
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.04095188	0.6552785066543103
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.040915751	0.654700399930836
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.040915751	0.654700399930836
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.04059941	0.6496385698494445
#300695 SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM;;SCAPULOPERONEAL MYOPATHY, FHL1-RELATED	0.0405469	0.6487983477550151
SENIOR-LOKEN SYNDROME 9	0.04041255	0.6466485888826751
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.0404001	0.646449374160229
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.040379351	0.6461173656240013
WEAVER SYNDROME	0.04032914099999999	0.6453139462493812
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.040299959999999996	0.6448470157420961
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.040248921	0.6440303313871624
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.040215390000000004	0.6434937957358902
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.039929900000000004	0.6389256181366019
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA	0.03985291	0.6376936870939411
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.03984001	0.6374872718393585
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.03980284	0.6368925078848747
MICROPHTHALMIA, SYNDROMIC 12	0.03969113	0.6351050157849185
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.03969113	0.6351050157849185
MICROPHTHALMIA, SYNDROMIC 4	0.03969113	0.6351050157849185
FRYNS MICROPHTHALMIA SYNDROME	0.03969113	0.6351050157849185
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.039627140000000005	0.6340811001150932
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.039623620000000005	0.6340247759526024
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.039600920000000005	0.633661549109267
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.039588	0.6334548138310336
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.039580481	0.6333345009396223
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.039557369999999994	0.6329646976102686
CRANIOECTODERMAL DYSPLASIA 1	0.03952262	0.6324086565174974
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.03948048	0.6317343666858606
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.03946554	0.6314953090189253
GAUCHER DISEASE, TYPE II	0.039455570999999995	0.6313357932303256
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.03943589	0.6310208739570355
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.039411401	0.6306290209981614
MECKEL SYNDROME, TYPE 1; MKS1	0.03933336999999999	0.6293804327244913
METAPHYSEAL DYSPLASIA, ANETODERMA, AND OPTIC ATROPHY	0.039324410000000004	0.6292370621290604
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.039299060999999996	0.6288314481532139
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.039283151	0.6285768693392287
ROIFMAN SYNDROME; RFMN	0.039276099999999994	0.6284640450012392
CYCLIC VOMITING SYNDROME	0.039192191	0.6271214017766826
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.039175191	0.6268493816737443
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.039167501	0.6267263325801209
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.039124330000000006	0.6260355455293001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.039061281	0.6250266869722314
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.038917161	0.6227205965466143
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.03886751	0.6219261218330262
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.038803699999999997	0.6209050863760555
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.038695469999999996	0.619173278391289
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.038661509999999996	0.6186298782327131
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	0.6154294817157296
THUMB DEFORMITY	0.0384615	0.6154294817157296
Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	0.0384615	0.6154294817157296
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	0.6154294817157296
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	0.6154294817157296
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	0.6154294817157296
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	0.6154294817157296
ARTERIES, ANOMALIES OF	0.0384615	0.6154294817157296
ACRORENAL-MANDIBULAR SYNDROME	0.0384615	0.6154294817157296
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.0384615	0.6154294817157296
ATROPHODERMA VERMICULATA; AVA	0.0384615	0.6154294817157296
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	0.6154294817157296
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.03841012	0.6146073409575544
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.03839307	0.6143345207954897
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0383723	0.614002176234429
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.0383486	0.6136229482085677
#602099 AMYOTROPHIC LATERAL SCLEROSIS 5, JUVENILE; ALS5	0.0381819	0.6109555510815182
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.038173261	0.610817316865678
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.038124351	0.6100346990283415
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.038100020000000005	0.6096453742563066
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0380987	0.6096242526953725
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.03808701	0.6094371988716459
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.038083760999999994	0.6093852110296195
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.038063551	0.6090618271307734
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.03806248999999999	0.6090448498761134
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.03804562	0.6087749099269035
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.03786055	0.6058135710768552
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.037816840000000004	0.6051141593886529
CHROMOSOME 10Q26 DELETION SYNDROME	0.037665391	0.6026907962963043
SAUL-WILSON SYNDROME; SWILS	0.037648509999999996	0.6024206803340864
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.03755527	0.6009287300753816
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.037459940000000004	0.5994033373451979
OCULORENOCEREBELLAR SYNDROME	0.03745203	0.5992767679914188
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.03732955	0.59731694315566
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.03732955	0.59731694315566
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.037327551	0.5972849567917908
#300834 MACULAR DEGENERATION, X-LINKED ATROPHIC	0.03719955	0.595236789427307
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.037180201	0.5949271825466156
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4	0.03714993	0.5944428107503772
RING CHROMOSOME 14 SYNDROME	0.03712004000000001	0.5939645354046815
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.03708704	0.5934364963813302
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.037080250999999995	0.5933278643531625
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.03706488000000001	0.5930819101765588
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.037054591	0.5929172740095507
CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF	0.037037	0.5926357972077396
BARDET-BIEDL SYNDROME 11; BBS11	0.037037	0.5926357972077396
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.037037	0.5926357972077396
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.037006251000000004	0.5921437768462541
OPTIC ATROPHY WITH NEGATIVE ELECTRORETINOGRAMS	0.03694341	0.5911382465351508
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	0.5908932684306809
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	0.5908932684306809
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.036756931	0.5881543620189237
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.03670899	0.5873872493274547
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.03665818	0.5865742292433193
CAROLI DISEASE, ISOLATED	0.03665818	0.5865742292433193
PETTIGREW SYNDROME	0.036599491	0.5856351358420631
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.036494751	0.5839591719843117
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.036494751	0.5839591719843117
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.03646587	0.5834970418317842
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.036397151	0.5823974565697945
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0363839	0.5821854249001451
HYPER-IGD SYNDROME	0.03637766	0.5820855775211843
CEREBROOCULONASAL SYNDROME	0.03634154	0.5815076148083526
MEVALONIC ACIDURIA; MEVA	0.036311079999999996	0.581020218788617
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.036255611	0.5801326491950939
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.036246161000000006	0.5799814380202253
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.03619308	0.5791320792505738
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0361468	0.57839154452328
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.036116960000000004	0.5779140692367105
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0360332	0.5765738101883501
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.03602333	0.5764158785168205
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.035960259999999994	0.5754066839349188
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.035954650000000005	0.5753169173009492
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.035940751	0.5750945168650232
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.035902039999999996	0.5744750950882672
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.035879641	0.5741166846008721
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.03586821	0.5739337750834197
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.035823701	0.5732215784503794
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.035775051	0.5724431209204995
%300778 CORNEAL DYSTROPHY, LISCH EPITHELIAL; LECD;;LISCH EPITHELIAL CORNEAL DYSTROPHY;;BAND-SHAPED AND WHORLED MICROCYSTIC CORNEAL EPITHELIAL DYSTROPHY	0.035714300000000004	0.5714710330808752
HURLER-SCHEIE SYNDROME	0.035714300000000004	0.5714710330808752
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.035714300000000004	0.5714710330808752
MORQUIO SYNDROME C	0.035714300000000004	0.5714710330808752
#615523 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8; FECD8	0.035714300000000004	0.5714710330808752
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.035714300000000004	0.5714710330808752
#277950 WINCHESTER SYNDROME; WNCHRS	0.035714300000000004	0.5714710330808752
APOLIPOPROTEIN A-I; APOA1	0.035714300000000004	0.5714710330808752
MENTAL RETARDATION, X-LINKED 90	0.035661411	0.5706247465382686
ANIRIDIA 3	0.035649310000000003	0.570431116228524
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.035647661000000004	0.5704047302785391
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.035579	0.5693060730851356
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.03554444	0.5687530722170442
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.035528121	0.5684919489194059
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.035510111000000004	0.5682037676221164
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.035457911	0.5673685058942701
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.03543495099999999	0.5670011187434778
RHYNS SYNDROME; RHYNS	0.03531835	0.565135364859788
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.035208931	0.5633845314689985
ARGININOSUCCINIC ACIDURIA	0.035208931	0.5633845314689985
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.03489432	0.5583503834333767
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.03486037	0.5578071432866261
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.03474566	0.5559716476390925
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.0347328	0.5557658724318109
#612657 CONE-ROD DYSTROPHY 12; CORD12	0.03467435	0.5548306033131783
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.03465095	0.5544561756420748
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0344929	0.5519271887438735
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0344929	0.5519271887438735
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.0344828	0.551765576800363
SCHINDLER DISEASE, TYPE I	0.034331011	0.5493367733059557
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.034327811	0.549285569521873
LESCH-NYHAN SYNDROME; LNS	0.03429943	0.5488314399606086
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.03429318	0.5487314325698224
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.034206191	0.5473395057030862
#612775 CONE-ROD DYSTROPHY 9; CORD9	0.033950640000000004	0.5432503875074378
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.03392947	0.5429116424733668
224550 DYSTONIA WITH RINGBINDEN	0.03388905	0.5422648746756742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.03383547	0.5414075313159423
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.03382361	0.5412177572911865
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.03374661	0.5399856662367005
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.033737451	0.5398391114059469
PEHO-LIKE SYNDROME; PEHOL	0.03370709	0.5393532995032813
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.033690881	0.5390939363357207
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.033681451	0.5389430451845024
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.03365987	0.5385977236644134
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.033646521	0.5383841238788766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.033583141	0.5373699689303919
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.03358074	0.5373315500911474
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.0335738	0.5372205018844185
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	0.5372205018844185
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.03353207	0.5365527725376171
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.03352425	0.5364276432902655
#300029 RETINITIS PIGMENTOSA 3; RP3;;RETINITIS PIGMENTOSA 15; RP15;;CONE-ROD DEGENERATION, X-LINKED;;CHOROIDORETINAL DEGENERATION WITH RETINAL REFLEX IN HETEROZYGOUS WOMEN	0.03339578	0.5343719713711771
BARDET-BIEDL SYNDROME 4; BBS4	0.03338568	0.5342103594276666
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.03327475	0.5324353482500805
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.033211660999999996	0.5314258496457108
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.033202931000000005	0.5312861593222609
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.033173851	0.5308208449344107
PYRUVATE CARBOXYLASE DEFICIENCY	0.033173851	0.5308208449344107
2q33.1 deletion syndrome	0.033173851	0.5308208449344107
CRANIOSYNOSTOSIS 4; CRS4	0.03310874	0.5297789919389738
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.033095320000000004	0.5295642560694779
LOEYS-DIETZ SYNDROME 3; LDS3	0.03296375	0.5274589804845594
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0329524	0.5272773670628916
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.03293426	0.5269871056118738
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.032876221	0.5260584129792594
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.03279268	0.5247216581898722
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.032790559999999996	0.5246877356829175
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.032733951	0.523781924741315
N-ACETYLASPARTATE DEFICIENCY; NACED	0.032733951	0.523781924741315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.032702641	0.5232809277164325
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.032557481	0.5209581960609886
AL-RAQAD SYNDROME; ARS	0.03255177	0.5208668133075838
NEMALINE MYOPATHY 4	0.0325341	0.5205840724123532
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.03248546	0.5198057748942986
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.032400521	0.5184466504517404
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.03231345099999999	0.5170534274892196
MENTAL RETARDATION, X-LINKED 105; MRX105	0.0322581	0.5161677460352345
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0322581	0.5161677460352345
BREATH-HOLDING SPELLS	0.0322581	0.5161677460352345
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.0322498	0.5160349362202706
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.032249661	0.5160327120558994
CHROMOSOME Xp11.3 DELETION SYNDROME	0.03221811	0.5155278587460282
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.032175021	0.5148383837921744
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.032165751	0.5146900528301603
3MC SYNDROME 2	0.0321396	0.5142716059059282
Aarskog-Scott syndrome	0.03213958	0.5142712858822779
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.03210792	0.5137646884435112
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.032010491	0.5122057092312059
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.03199959	0.5120312803404923
CONE-ROD DYSTROPHY 1; CORD1	0.03185943	0.5097885545976774
FRONTOOCULAR SYNDROME	0.03180559	0.5089270509304887
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.03162652	0.5060617191755952
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.031625381	0.5060434938286984
SENGERS SYNDROME	0.031519900000000003	0.5043556730946954
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.03147935	0.5037068251432746
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.031373551	0.5020139160332283
SPINAL MUSCULAR ATROPHY, PROXIMAL, ADULT, AUTOSOMAL DOMINANTSPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE, INCLUDED	0.031355999999999995	0.501733079278718
FRONTONASAL DYSPLASIA 1; FND1	0.03134066	0.5014876211387724
MENTAL RETARDATION, X-LINKED 77	0.031313110000000005	0.501046788560187
LATHOSTEROLOSIS	0.031273740999999994	0.5004168380053289
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.031267611	0.5003187507564459
231970 GLUTEAL MUSCLES, ABSENCE OF	0.03125	0.5000369539309842
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.031202471000000002	0.4992764337267159
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.031148671	0.4984155701068283
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.031141941	0.49830788214842975
TYSHCHENKO SYNDROME	0.03107552	0.4972450676038841
XYLOSIDASE DEFICIENCY	0.031027370999999995	0.4964746266664497
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.0310096	0.49619026965178387
Myhre syndrome	0.031008221000000002	0.49616820402108086
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.030982271000000002	0.49575297333453666
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.030932550999999996	0.49495739453935417
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.030484450999999996	0.487787264649547
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.03048145	0.4877392451007872
#608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE A;;RI-CMTA	0.03048145	0.4877392451007872
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.03048145	0.4877392451007872
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.03048145	0.4877392451007872
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.03048145	0.4877392451007872
#614455 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE;;CHARCOT-MARIE-TOOTH NEUROPATHY WITH FOCAL SEGMENTAL GLOMERULONEPHRITIS	0.03048145	0.4877392451007872
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.03048145	0.4877392451007872
#118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS;;CHARCOT-MARIE-TOOTH NEUROPATHY AND DEAFNESS, AUTOSOMAL DOMINANT;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1E; CMT1E	0.03048145	0.4877392451007872
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.03048145	0.4877392451007872
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.03048145	0.4877392451007872
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.03048145	0.4877392451007872
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.03048145	0.4877392451007872
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.03048145	0.4877392451007872
#118210 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1;;CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A1;;CHARCOT-MARIE-TOOTH DISEASE, NEURONAL, TYPE 2A1;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2A1;;HEREDITARY MOTOR AND SENSORY NEUROPATHY IIA1;;HMSN IIA1;;HMSN2A1	0.03048145	0.4877392451007872
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.030444480000000003	0.4871476813828087
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.030402951	0.48648316827369514
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.030331101	0.4853334833092169
PSEUDODIASTROPHIC DYSPLASIA	0.0303309	0.48533026707152926
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	0.48533026707152926
#613710 THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATIONAND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4;;BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY;;STRIATAL NECROSIS, BILATERAL, AND PROGRESSIVE POLYNEUROPATHY	0.0303074	0.4849542392821732
MACULAR DEGENERATION, AGE-RELATED, 4	0.030302999999999997	0.48488383407905966
#613757 MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6	0.030302999999999997	0.48488383407905966
MACULAR DEGENERATION, AGE-RELATED, 2	0.030302999999999997	0.48488383407905966
#611953 MACULAR DEGENERATION, AGE-RELATED, 11; ARMD11	0.030302999999999997	0.48488383407905966
SCHAAF-YANG SYNDROME; SHFYNG	0.030288861	0.4846575933593275
CATARACT 44; CTRCT44	0.030202100000000003	0.48326931476220736
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.03019156	0.48310066229838544
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.030062151000000002	0.48102996526890535
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.0299129	0.4786417727757484
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.029882231	0.47815103250886487
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.02983599	0.47741112182768974
#613954 AMYOTROPHIC LATERAL SCLEROSIS 14, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS14	0.02983599	0.47741112182768974
#614808 AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18	0.02983599	0.47741112182768974
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.029821141	0.47717352026836435
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.02975473	0.476110865735644
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.029725891	0.4756494076327827
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.02966307	0.4746441973453299
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.02965204	0.4744677043020704
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.02962251	0.47399518938208385
#270685 SPASTIC PARAPLEGIA 17; SPG17;;SPASTIC PARAPLEGIA WITH AMYOTROPHY OF HANDS AND FEET;;SILVER SYNDROME;;SILVER SPASTIC PARAPLEGIA SYNDROME	0.02962251	0.47399518938208385
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.02962251	0.47399518938208385
#603563 SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8	0.02962251	0.47399518938208385
#615625 SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72SPASTIC PARAPLEGIA 72, AUTOSOMAL DOMINANT	0.02962251	0.47399518938208385
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.02962251	0.47399518938208385
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.02962251	0.47399518938208385
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.029622509999999998	0.4739951893820838
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.029507821	0.47216002975938337
THAUVIN-ROBINET-FAIVRE SYNDROME	0.02950267	0.472077607668193
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.029487151	0.4718292853165752
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.029487151	0.4718292853165752
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.029481920000000002	0.4717455831307828
PERRAULT SYNDROME 5; PRLTS5	0.029470961	0.47157022617148264
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.029469099999999998	0.4715404479708021
DOHLE BODIES AND LEUKEMIA	0.0294118	0.4706235802120743
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.0294118	0.4706235802120743
MAJEED SYNDROME	0.0294118	0.4706235802120743
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0294118	0.4706235802120743
FAMILIAL MEDITERRANEAN FEVER; FMF	0.0294118	0.4706235802120743
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.0294118	0.4706235802120743
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.0294118	0.4706235802120743
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0294118	0.4706235802120743
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.029396199999999997	0.4703739617646719
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.02939166	0.47030131639600486
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.02938764	0.47023699164225113
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.02925416	0.46810115379870854
GLASS SYNDROME	0.029237461	0.46783395005171036
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.029136099999999998	0.4662120541897135
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.029132531	0.466154945969279
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.029132531	0.466154945969279
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.029132531	0.466154945969279
INFANTILE LIVER FAILURE SYNDROME 2	0.029132531	0.466154945969279
MARINESCO-SJOGREN SYNDROME; MSS	0.029049670000000003	0.46482907198400947
GABRIELE-DE VRIES SYNDROME; GADEVS	0.02895763	0.4633563231443356
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.02892687	0.4628641267698423
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.028889151000000002	0.46226057816615196
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.028827631	0.4612761854171652
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.028809969999999997	0.46099358853257716
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.02880336	0.46088782071608175
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.028795131	0.460756146985077
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.02878899	0.4606578837231861
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.028664241	0.4586617522042762
LETTERER-SIWE DISEASE	0.0285948	0.45755061408850267
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.0285714	0.45717618641739916
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.0285714	0.45717618641739916
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.0285714	0.45717618641739916
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.0285714	0.45717618641739916
AMYLOIDOSIS VI	0.0285714	0.45717618641739916
DERMOGRAPHISM, FAMILIAL	0.0285714	0.45717618641739916
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.0285714	0.45717618641739916
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.0285714	0.45717618641739916
WOLFF-PARKINSON-WHITE SYNDROME	0.0285714	0.45717618641739916
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.0285714	0.45717618641739916
#615745 ATRIAL STANDSTILL 2; ATRST2;;ATRIAL DILATION AND STANDSTILL;;CARDIOMYOPATHY, ATRIAL DILATED, WITH ATRIAL STANDSTILL	0.0285714	0.45717618641739916
CARDIOMYOPATHY, DILATED, 1E	0.0285714	0.45717618641739916
STROKE, ISCHEMIC	0.0285714	0.45717618641739916
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.028533831	0.4565750379910877
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.028506069999999998	0.45613082916298914
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.02848328	0.45576616221322636
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.0284735	0.45560967064812413
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.028457101000000002	0.4553472672558837
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.02845145	0.45525684457343046
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.028449990000000005	0.4552334828469428
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.028408701	0.4545728100216354
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.028373811	0.45401452876331044
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02835192	0.45366424687663837
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.02829991	0.45283202537347206
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.0282832	0.4525646456134661
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.028282219999999997	0.4525489644545907
ATELOSTEOGENESIS, TYPE I; AO1	0.028282219999999997	0.4525489644545907
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.028281901	0.452543860077365
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.028220699999999998	0.451564571705604
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.02821678	0.45150184707010294
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.028205100000000004	0.45131495325820176
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.027877080000000002	0.4460662453660916
CIRRHOSIS, FAMILIAL	0.0278638	0.4458537496621491
DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17	0.027808990000000002	0.44497672484791045
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.02758609	0.4414100612629115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.02758474	0.4413884596665017
COSTELLO SYNDROME; CSTLO	0.027547799999999997	0.44079737598399893
MYOPATHY, CENTRONUCLEAR, 5	0.02754135	0.44069416835670755
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.027507851	0.4401581447432761
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.027507300999999998	0.4401493440928869
MENTAL RETARDATION, X-LINKED 104; MRX104	0.027407871	0.4385583465143475
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.027369281	0.4379408608806772
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.027364100000000002	0.43785795875401107
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.02736164	0.4378185958449976
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.02730475	0.4369082885711053
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.02726002	0.43619255567672666
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.027250500000000004	0.4360402244190812
CHROMOSOME 3q13.31 DELETION SYNDROME	0.027090410000000002	0.4334785951085272
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0270736	0.4332096152302686
#115900 CATARACT 42; CTRCT42	0.027028330000000003	0.4324852416973261
AMYOTROPHY, MONOMELIC	0.027027	0.43246396012456667
ATAXIA WITH FASCICULATIONS	0.027027	0.43246396012456667
SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	0.027027	0.43246396012456667
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.026996339999999997	0.4319733638683259
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.02690707	0.4305449383042486
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.026858740000000002	0.42977160115277707
HAMAMY SYNDROME; HMMS	0.026858740000000002	0.42977160115277707
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.026836651	0.4294181510319649
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.026808929999999998	0.42897458225116736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.0267677	0.428314853495629
ADAMS-OLIVER SYNDROME 2; AOS2	0.026738691000000002	0.42785067519173836
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.026711291	0.42741224279053164
#610092 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3;;MICROPHTHALMIA, COLOBOMATOUS, ISOLATED 3MICROPHTHALMIA, CATARACTS, AND IRIS ABNORMALITIES, INCLUDED	0.02668862	0.42704947998148934
MENTAL RETARDATION, X-LINKED 72	0.026673361	0.42680531793732834
TANGIER DISEASE; TGD	0.026630839999999996	0.42612493165514914
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.026628521	0.42608782491287184
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.026561331	0.42501270545896397
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.026491180000000003	0.42389020650359716
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.026383121000000002	0.4221611347210426
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	0.4210839191122238
MENTAL RETARDATION, X-LINKED 41	0.0263158	0.4210839191122238
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	0.4210839191122238
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.0263158	0.4210839191122238
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.02630383	0.42089238495739006
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.026234530000000002	0.4197835030083528
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.02615245	0.4184701259466358
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.02615245	0.4184701259466358
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.02615245	0.4184701259466358
INFANTILE SIALIC ACID STORAGE DISEASE	0.026121261	0.4179710650648389
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.026072121	0.4171847669555214
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.026029989999999996	0.4165106211345273
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.026029989999999996	0.4165106211345273
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.025949900999999997	0.41522910242721917
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.025932919999999998	0.4149573863467488
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.025915751	0.4146826620439635
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.025890161	0.41427319178312844
RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	0.02576445	0.4122616671266287
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.025763041	0.4122391214604499
Smith-Magenis Syndrome	0.02575761	0.4121522190381523
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.025727349999999996	0.4116680232549218
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.025726	0.411646421658512
IMMUNODEFICIENCY 46; IMD46	0.025641000000000004	0.41028632114381974
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.025641000000000004	0.41028632114381974
#612692 AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79B DEFECT	0.025641000000000004	0.41028632114381974
#601495 AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO IGHM DEFECT	0.025641000000000004	0.41028632114381974
#613493 IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3;;ANTIBODY DEFICIENCY DUE TO CD19 DEFECT	0.025641000000000004	0.41028632114381974
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.025641000000000004	0.41028632114381974
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.025641000000000004	0.41028632114381974
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.025641000000000004	0.41028632114381974
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.025641000000000004	0.41028632114381974
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.025641000000000004	0.41028632114381974
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.025641000000000004	0.41028632114381974
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.025641000000000004	0.41028632114381974
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5	0.025641000000000004	0.41028632114381974
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.02558479	0.40938689467404493
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.025520599999999997	0.40835977876771434
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.025509340999999998	0.4081796214536565
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.025490561	0.4078791192458221
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.025417920000000004	0.4067167773459662
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.02538489	0.4061882582871393
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.02536818	0.4059208785271333
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.02535823	0.40576166676100167
COLE-CARPENTER SYNDROME 2; CLCRP2	0.02535776	0.40575414620521455
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.02535776	0.40575414620521455
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.02535776	0.40575414620521455
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.025320101	0.4051515576724758
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.02523979	0.40386648670264697
FANCONI ANEMIA	0.02523979	0.40386648670264697
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.02523979	0.40386648670264697
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.02523979	0.40386648670264697
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.025232541	0.40375049413051745
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.025165890000000003	0.40268399931399096
#615185 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF	0.0251623	0.4026265550687233
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.02511736	0.40190746192601423
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.025109270999999996	0.4017780283605631
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.025101250999999998	0.40164969887670626
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.02504074	0.40068145132088806
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.02504074	0.40068145132088806
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.02504074	0.40068145132088806
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.02503275	0.40055360187250705
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.02503275	0.40055360187250705
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.025015500000000003	0.40027758147393716
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.025015500000000003	0.40027758147393716
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.025015500000000003	0.40027758147393716
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.025015500000000003	0.40027758147393716
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.025015500000000003	0.40027758147393716
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.025015500000000003	0.40027758147393716
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.025015500000000003	0.40027758147393716
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.025012390000000002	0.40022781779628197
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.025	0.40002956314478744
MENTAL RETARDATION, X-LINKED 92	0.025	0.40002956314478744
MYOPIA 25, AUTOSOMAL DOMINANT	0.025	0.40002956314478744
#614167 MYOPIA 21, AUTOSOMAL DOMINANT; MYP21	0.025	0.40002956314478744
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.025	0.40002956314478744
DEAFNESS AND MYOPIA; DFNMYP	0.025	0.40002956314478744
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.025	0.40002956314478744
SINUS NODE DISEASE AND MYOPIA	0.025	0.40002956314478744
MYOPIA 26, X-LINKED, FEMALE-LIMITED; MYP26	0.025	0.40002956314478744
TORTICOLLIS	0.025	0.40002956314478744
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.025	0.40002956314478744
%613969 MYOPIA 19, AUTOSOMAL DOMINANT; MYP19	0.025	0.40002956314478744
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.025	0.40002956314478744
Ullrich congenital muscular dystrophy 1	0.025	0.40002956314478744
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.025	0.40002956314478744
XFE PROGEROID SYNDROME; XFEPS	0.02489472	0.398344958648472
JOUBERT SYNDROME 32; JBTS32	0.02485354	0.39768602995206
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.02484302	0.39751769751188865
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.02479965	0.396823726225745
ACROCRANIOFACIAL DYSOSTOSIS	0.02475182	0.39605838966553647
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.024737199999999997	0.3958244523770093
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.024737199999999997	0.3958244523770093
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.024737199999999997	0.3958244523770093
SPINOCEREBELLAR ATAXIA 48; SCA48	0.024720400000000003	0.3955556325105762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.024712561	0.39543019924075645
JOUBERT SYNDROME 24	0.024684940000000002	0.3949882305782116
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.02465704	0.394541797585742
COFFIN-SIRIS SYNDROME 2; CSS2	0.024632491	0.3941489845559163
COFFIN-SIRIS SYNDROME 3; CSS3	0.024632491	0.3941489845559163
COFFIN-SIRIS SYNDROME 4; CSS4	0.024632491	0.3941489845559163
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.024621161	0.3939676911578991
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.024605270999999998	0.3937134323675642
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.024605270999999998	0.3937134323675642
FONTAINE PROGEROID SYNDROME; FPS	0.02455647	0.392932558659123
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.02454261	0.39271078226931555
OGDEN SYNDROME; OGDNS	0.024540720000000002	0.39268054003434194
WIEDEMANN-STEINER SYNDROME; WDSTS	0.024492851	0.3919145794280148
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.024484591	0.3917824096603517
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.024484591	0.3917824096603517
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.02447551	0.391637102921835
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.02447551	0.391637102921835
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.02446543	0.39147581100197504
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.02444116	0.3910874623020741
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.02432128	0.3891692405408822
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.024174371	0.38681852281720064
HYPOPHOSPHATASIA, CHILDHOOD	0.024174371	0.38681852281720064
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.02414851	0.38640471623590117
PALLISTER-KILLIAN SYNDROME	0.024118771000000004	0.38592885706876673
FRYNS SYNDROME; FRNS	0.024111821	0.38581764885021236
611961 STEVENSON-CAREY SYNDROME	0.023981181	0.383727254365043
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.023942490999999996	0.3831081686131201
WOODHOUSE-SAKATI SYNDROME	0.02388849	0.38224408875554483
MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES	0.02388842	0.3822429686727681
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.023837251000000004	0.3814242041641059
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.02374194	0.37989911545639016
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.023734101	0.3797736821865705
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.02372047	0.37955557006756135
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.023712561000000004	0.379429016714965
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.02368952	0.37906033346838813
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.02367887	0.3788899208744885
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.023643050999999998	0.3783167745175971
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.023643050999999998	0.3783167745175971
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.023622880000000002	0.3779940146648694
FILIPPI SYNDROME; FLPIS	0.023523221	0.37639935281553155
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.023499020000000002	0.37601210819722486
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.023499020000000002	0.37601210819722486
DESBUQUOIS DYSPLASIA 2; DBQD2	0.023499020000000002	0.37601210819722486
KOSAKI OVERGROWTH SYNDROME; KOGS	0.02348782	0.375832894952936
LAMB-SHAFFER SYNDROME	0.023484380000000003	0.37577785088504734
CRANIOFRONTONASAL SYNDROME; CFNS	0.02347055	0.37555655453071557
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.023447170000000003	0.37518244688326263
#158580 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A;;HMN VIIA;;NEUROPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA;;DHMN7A;;DHMNVP;;SPINAL MUSCULAR ATROPHY, DISTAL, WITH VOCAL CORD PARALYSIS;;HARPER-YOUNG MYOPATHY	0.02328447	0.37257905448631634
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.02325665	0.3721339015884488
BARTSOCAS-PAPAS SYNDROME; BPS	0.02319607	0.3711645499510363
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.023161880000000003	0.3706174695204796
#614497 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7	0.02306543	0.36907415546586697
MICROPHTHALMIA, ISOLATED 4	0.02306543	0.36907415546586697
CURRY-JONES SYNDROME	0.02306543	0.36907415546586697
COFFIN-SIRIS SYNDROME 7; CSS7	0.023052589999999998	0.36886870028223573
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.02304249	0.36870708833872523
TARP SYNDROME; TARPS	0.023012750000000002	0.36823121317040824
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	0.3672196184111277
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	0.3672196184111277
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	0.3672196184111277
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	0.3672196184111277
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	0.3672196184111277
Bardet-Biedl syndrome 2	0.02285938	0.3657771118064276
BARDET-BIEDL SYNDROME 16; BBS16	0.02285938	0.3657771118064276
TERMINAL OSSEOUS DYSPLASIA; TOD	0.022833839999999998	0.3653684416047188
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.022827161000000002	0.36526156970662915
XQ25 DUPLICATION SYNDROME	0.022827161000000002	0.36526156970662915
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.022827161000000002	0.36526156970662915
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.022827161000000002	0.36526156970662915
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.02277042	0.36435364660893316
MYOCLONIC EPILEPSY, JUVENILE, 2	0.02277042	0.36435364660893316
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.02276995	0.3643461260531461
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.022752230000000002	0.3640625850987891
COHEN-GIBSON SYNDROME; COGIS	0.02274243	0.3639057735100363
MYELINATED OPTIC NERVE FIBERS	0.0227273	0.363663675618421
OCULAR CICATRICIAL PEMPHIGOID	0.0227273	0.363663675618421
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0227273	0.363663675618421
IMINOGLYCINURIA	0.0227273	0.363663675618421
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0227273	0.363663675618421
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0227273	0.363663675618421
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0227273	0.363663675618421
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.0227273	0.363663675618421
UNIQUE GREEN PHENOMENON	0.0227273	0.363663675618421
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0227273	0.363663675618421
AGNATHIA-OTOCEPHALY COMPLEX	0.0227273	0.363663675618421
STICKLER SYNDROME, TYPE III	0.0227273	0.363663675618421
MELKERSSON-ROSENTHAL SYNDROME	0.0227273	0.363663675618421
#184095 SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE;;SED, MAROTEAUX TYPE;;PSEUDO-MORQUIO SYNDROME, TYPE 2	0.0227273	0.363663675618421
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0227273	0.363663675618421
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0227273	0.363663675618421
BLEPHAROCHALASIS AND DOUBLE LIP	0.0227273	0.363663675618421
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.0227273	0.363663675618421
CARNEY COMPLEX, TYPE 1; CNC1	0.0227273	0.363663675618421
PUPIL, EGG-SHAPED	0.0227273	0.363663675618421
SEA-BLUE HISTIOCYTE DISEASE	0.0227273	0.363663675618421
611426 TENTED EYEBROWS	0.0227273	0.363663675618421
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0227273	0.363663675618421
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0227273	0.363663675618421
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0227273	0.363663675618421
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.022721741	0.3635747250447602
JOUBERT SYNDROME 31; JBTS31	0.022673369999999998	0.3628007318448051
CINCA SYNDROME; CINCA	0.02257992	0.3613054213377699
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.022579050999999996	0.36129151631015494
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.022531111	0.36052441961986853
ELEJALDE DISEASE	0.022527561	0.36046761542190203
CREE MENTAL RETARDATION SYNDROME	0.02250914	0.3601728576385944
FACIOCARDIOMELIC SYNDROME	0.0224011	0.3584440898785079
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0224011	0.3584440898785079
KNIEST-LIKE DYSPLASIA, LETHAL	0.02226694	0.35629737123084765
RESTRICTIVE DERMOPATHY, LETHAL	0.02226694	0.35629737123084765
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.022242711000000002	0.35590967857943034
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.022240720999999998	0.35587783622620395
HYPERLEUCINE-ISOLEUCINEMIA	0.022238781	0.3558467939321039
EPILEPSY, HOT WATER, 1	0.0222222	0.35558147832464376
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	0.35558147832464376
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.0222222	0.35558147832464376
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.0222222	0.35558147832464376
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.02219594	0.35516128727151647
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.022192351	0.3551038590274314
MELNICK-NEEDLES SYNDROME	0.022121309999999998	0.35396711901961664
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.022082841	0.35335156952903196
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.022067321	0.3531032311762317
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.021995250999999997	0.35195002595159786
GLUTARIC ACIDEMIA I; GA1	0.021995250999999997	0.35195002595159786
HOLOPROSENCEPHALY 11	0.021958520000000002	0.35136228651624307
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.021952279999999998	0.35126243913728206
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.021886151	0.35020429693803407
PSEUDO-TORCH SYNDROME 2	0.021886151	0.35020429693803407
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.021850221	0.34962937444988235
KABUKI SYNDROME 1	0.021821610999999998	0.34917158061781944
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.021804989999999996	0.3489056249630582
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.02171836	0.34751944252084893
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.021669321000000002	0.3467347605309667
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.021650211	0.3464289779328988
CHROMOSOME 2q37 DELETION SYNDROME	0.021634931	0.3461844798639047
TRISOMY 18-LIKE SYNDROME	0.02162553	0.34603405274697974
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.021620399999999998	0.34595196668062245
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.021403661	0.34248388638116495
THROMBOCYTOPENIA 6	0.02138377	0.3421656068595444
KENNERKNECHT SYNDROME	0.02138377	0.3421656068595444
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.02138377	0.3421656068595444
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.021323950999999997	0.34120843212203406
KAGAMI-OGATA SYNDROME	0.021323950999999997	0.34120843212203406
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.021320031	0.341145707486533
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.021320031	0.341145707486533
OHDO SYNDROME	0.021252951	0.3400723481627029
VAN BOGAERT-HOZAY SYNDROME	0.02123291	0.3397516684637035
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0212241	0.33961069804565125
PEROXISOME BIOGENESIS DISORDER 11B	0.02116709	0.33869847062985586
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.021166410000000004	0.3386875898257384
#609340 SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28	0.021166410000000004	0.3386875898257384
OPTICOCOCHLEODENTATE DEGENERATION	0.02115401	0.33848917516241855
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.02113528	0.3381894730137105
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.021133980999999996	0.3381686874776094
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.021098020000000002	0.3375932689527995
Temtamy preaxial brachydactyly syndrome	0.02109385	0.33752654402166693
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.02108954	0.3374575789249808
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.021079499999999998	0.3372969270524218
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.021028161	0.3364754423427302
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.020982631	0.33574690850233097
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.020952391	0.335263032742751
WERNER SYNDROME; WRN	0.020864590000000002	0.333858112915804
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.020840869999999997	0.3334785648662921
MYOPATHY, DISTAL, INFANTILE-ONSET	0.0208333	0.33335743591457195
WELANDER DISTAL MYOPATHY; WDM	0.0208333	0.33335743591457195
TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.0208333	0.33335743591457195
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.0208333	0.33335743591457195
MYOPATHY, DISTAL 3	0.0208333	0.33335743591457195
ADAMS-OLIVER SYNDROME 1; AOS1	0.020829980999999997	0.33330432798976883
MUCOLIPIDOSIS III GAMMA	0.02069521	0.33114783261958536
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.02067945	0.3308956539829789
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.020646651000000002	0.33037083119731553
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.020644950999999998	0.33034362918702165
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.020639450000000004	0.33025560668194737
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.020608541	0.32976102613125763
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.020473711000000002	0.3276035866913051
DEAFNESS, X-LINKED 5; DFNX5	0.02047065	0.3275546070715937
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.020456771	0.32733252665931817
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.020431790000000002	0.3269328011186414
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	0.32655533322285796
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	0.32655533322285796
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	0.32655533322285796
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.020408199999999998	0.32655533322285796
TEMPLE SYNDROME	0.020408199999999998	0.32655533322285796
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	0.32655533322285796
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.020408199999999998	0.32655533322285796
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	0.32655533322285796
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.020408199999999998	0.32655533322285796
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	0.32655533322285796
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.02040428	0.3264926085873569
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.02040428	0.3264926085873569
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.02032388	0.32520611351228323
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.020319401	0.3251344442157503
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.020281111	0.3245217589368377
ICHTHYOSIS, X-LINKED	0.020210629999999997	0.32339397959123733
JOUBERT SYNDROME 27	0.02018581	0.32299683024094716
ALAZAMI SYNDROME; ALAZS	0.020119770000000002	0.32194011214694396
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.020065740999999998	0.32107558425625793
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.02004054	0.3206723384554255
LEGIUS SYNDROME	0.02003664	0.3206099338435749
GLYCOGEN STORAGE DISEASE II	0.02002505	0.32042448013810093
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.02002505	0.32042448013810093
CODAS SYNDROME	0.019990441000000005	0.3198706952120659
PEROXISOME BIOGENESIS DISORDER 14B	0.019981360000000004	0.3197253884735492
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.019942800000000004	0.3191083828753547
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.019937921	0.3190303131058113
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.01990458	0.31849681767921895
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.019853740999999998	0.31768333356079015
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.019808511	0.3169596000751486
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.019739421000000004	0.31585407837444174
RITSCHER-SCHINZEL SYNDROME 1	0.019715840000000002	0.315476754489301
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.019713599999999998	0.3154409118404432
LARON SYNDROME	0.01970663	0.3153293835982385
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.019677151	0.31485768473856063
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0196078	0.3137479867292145
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0196078	0.3137479867292145
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.01959141	0.31348572734761676
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.019577361	0.31326092673431194
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.01954914	0.31280935736225157
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.019491821	0.3118921855810557
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.019480499999999998	0.3117110361936812
KLEEFSTRA SYNDROME	0.019441191	0.3110820457097749
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.019402640000000002	0.3104651841222231
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.019402640000000002	0.3104651841222231
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.019402640000000002	0.3104651841222231
CAMPOMELIC DYSPLASIA	0.019402640000000002	0.3104651841222231
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.019402640000000002	0.3104651841222231
FLOATING-HARBOR SYNDROME	0.01940221	0.310458303613737
HADZISELIMOVIC SYNDROME	0.019365359999999998	0.30986866003766156
EMANUEL SYNDROME	0.019350421	0.3096296183719088
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.019295560000000003	0.3087517774973614
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.01929283	0.3087080942690659
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.01929283	0.3087080942690659
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.019201151	0.3072411218562839
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.019185171	0.30698542295952175
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.01918477	0.30697900648532894
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.019050551	0.30483134376789967
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.019048331	0.30479582114269244
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.019041381	0.3046846129241382
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.018922299999999996	0.3027791761077843
CEREBELLOPARENCHYMAL DISORDER II	0.018876241	0.30204217764182895
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.30190871177838136
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.30190871177838136
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.30190871177838136
CERVICAL RIB	0.0188679	0.30190871177838136
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.30190871177838136
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.30190871177838136
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.30190871177838136
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.30190871177838136
JUMPING FRENCHMAN OF MAINE	0.0188679	0.30190871177838136
DIASTEMATOMYELIA	0.0188679	0.30190871177838136
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.30190871177838136
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.30190871177838136
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.30190871177838136
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.30190871177838136
269800 SENILE PLAQUE FORMATION	0.0188679	0.30190871177838136
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.0188679	0.30190871177838136
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.30190871177838136
NEPHRONOPHTHISIS 13	0.0188679	0.30190871177838136
ALCOHOL DEPENDENCE	0.0188679	0.30190871177838136
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.30190871177838136
MYOPATHY, CONGENITAL	0.0188679	0.30190871177838136
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	0.30190871177838136
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.30190871177838136
RUVALCABA SYNDROME	0.0188679	0.30190871177838136
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.30190871177838136
LEBER CONGENITAL AMAUROSIS 13; LCA13	0.0188679	0.30190871177838136
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.30190871177838136
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0188679	0.30190871177838136
THUMBS, CONGENITAL CLASPED	0.0188679	0.30190871177838136
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	0.30190871177838136
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.30190871177838136
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.30190871177838136
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.30190871177838136
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.30190871177838136
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.30190871177838136
TRANSSEXUALITY	0.0188679	0.30190871177838136
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.30190871177838136
CARDIAC ARRHYTHMIA	0.0188679	0.30190871177838136
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.30190871177838136
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.30190871177838136
MOTION SICKNESS	0.0188679	0.30190871177838136
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01878753	0.3006226967387835
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.018610361	0.2977877832318715
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.018576231	0.2972416628722662
OROFACIODIGITAL SYNDROME VI	0.01856865	0.2971203579075382
#256520 NEU-LAXOVA SYNDROME; NLS	0.018564280000000002	0.29705043273990056
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.018422341	0.2947792408933722
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.0184183	0.29471458011478546
CHROMOSOME 5Q12 DELETION SYNDROME	0.018414951	0.29466099215450664
245800 LAURENCE-MOON SYNDROME	0.018397410000000003	0.29438031541182175
IMMUNODEFICIENCY 47	0.018343631	0.29351978781676713
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.01832909	0.29328711462165963
PALLIDAL DEGENERATION, PROGRESSIVE, WITH RETINITIS PIGMENTOSA	0.018327959999999997	0.29326903328540543
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.0182469	0.29197197742986486
AYME-GRIPP SYNDROME; AYGRP	0.018225991	0.29163740870443305
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.018217900000000002	0.2915079431366169
Cat-Eye Syndrome (Type I)	0.018181799999999998	0.2909303004474358
JOUBERT SYNDROME 17; JBTS17	0.018181799999999998	0.2909303004474358
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.018181799999999998	0.2909303004474358
BIEMOND SYNDROME II	0.018181799999999998	0.2909303004474358
JOUBERT SYNDROME 33; JBTS33	0.018181799999999998	0.2909303004474358
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0181779	0.2908678958355852
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.018164811	0.29065845635750515
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.01816288	0.29062755807404783
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.018159091	0.2905669295934576
RETINAL DEGENERATION AND EPILEPSY	0.018157151	0.2905358872993576
RETINITIS PIGMENTOSA 12; RP12	0.018148289999999997	0.2903941008209965
#614895 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F	0.01813965	0.2902558506039737
WEBB-DATTANI SYNDROME; WEDAS	0.018116011	0.28987759865024654
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.01811256	0.28982237856935
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.017977350000000003	0.28765885868003777
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.01793157	0.286926324544007
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.017925991	0.28683705394669556
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.01787216	0.28597569429014974
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.017870459999999998	0.2859484922798558
OTODENTAL DYSPLASIA	0.0178571	0.2857347164813113
CHARGE-LIKE SYNDROME, X-LINKED	0.0178571	0.2857347164813113
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.0178571	0.2857347164813113
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.0178571	0.2857347164813113
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.0178571	0.2857347164813113
TREACHER COLLINS SYNDROME 2; TCS2	0.0178571	0.2857347164813113
TREACHER COLLINS SYNDROME 3; TCS3	0.0178571	0.2857347164813113
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0178571	0.2857347164813113
#612018 CATARACT, JUVENILE, WITH MICROCORNEA AND GLUCOSURIA;;CJMG	0.017707689999999998	0.28334397980013276
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.017707689999999998	0.28334397980013276
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.017677940000000003	0.28286794461999054
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.017655581	0.2825101741798963
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.017625661	0.2820314187987246
AUTISM	0.017582451	0.2813400077017852
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.017582451	0.2813400077017852
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.017582451	0.2813400077017852
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.017582451	0.2813400077017852
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.017582451	0.2813400077017852
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.017582451	0.2813400077017852
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.017582451	0.2813400077017852
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.017582451	0.2813400077017852
MYELOPATHY, HTLV-1-ASSOCIATED	0.0175439	0.28072314611423344
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.0175439	0.28072314611423344
OSTEOPETROSIS, AUTOSOMAL DOMINANT 2	0.0175439	0.28072314611423344
AUROCEPHALOSYNDACTYLY	0.0175439	0.28072314611423344
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0175439	0.28072314611423344
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.0175439	0.28072314611423344
SCHOLTE SYNDROME; SHLTS	0.0175439	0.28072314611423344
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0175439	0.28072314611423344
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.0175439	0.28072314611423344
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0175439	0.28072314611423344
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.0175439	0.28072314611423344
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0175439	0.28072314611423344
BEEMER LETHAL MALFORMATION SYNDROME	0.0175439	0.28072314611423344
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.0175439	0.28072314611423344
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.0175439	0.28072314611423344
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0175439	0.28072314611423344
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.0175439	0.28072314611423344
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.0175439	0.28072314611423344
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.0175439	0.28072314611423344
Adult-onset autosomal dominant leukodystrophy (ADLD)	0.0175439	0.28072314611423344
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.017489400000000002	0.2798510816665778
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.01748374	0.2797605149734818
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01748374	0.2797605149734818
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.01748374	0.2797605149734818
PACHYGYRIA, FRONTOTEMPORAL	0.017480390999999998	0.2797069270132029
HYPERTELORISM, TEEBI TYPE; TBHS	0.01747254	0.27958130172919293
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.017433271	0.2789529512925876
CHROMOSOME 15q25 DELETION SYNDROME	0.01724334	0.27591383069428155
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.01724334	0.27591383069428155
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.017242421	0.2758991256075403
#614844 NEPHRONOPHTHISIS 14; NPHP14JOUBERT SYNDROME 19, INCLUDED; JBTS19, INCLUDED	0.0172414	0.2758827884001815
#613615 SENIOR-LOKEN SYNDROME 7; SLSN7	0.0172414	0.2758827884001815
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.0172414	0.2758827884001815
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0172414	0.2758827884001815
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.0172414	0.2758827884001815
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.0172414	0.2758827884001815
GABA-TRANSAMINASE DEFICIENCY	0.017238211	0.27583176062910675
BARTH SYNDROME; BTHS	0.017200260000000002	0.2752244997510705
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.0171495	0.2744122797260613
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0171495	0.2744122797260613
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.017127530999999998	0.2740607497471521
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.017127530999999998	0.2740607497471521
Glycosylphosphatidylinositol biosynthesis defect 18	0.017004261	0.2720882839771978
CHOPS SYNDROME; CHOPS	0.016966059999999998	0.27147702280353003
HOLOPROSENCEPHALY 4	0.0168778	0.2700647584338037
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.016858991	0.2697637921916761
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.016830421	0.26930663840691427
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.016808661	0.26895845267515295
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.016672251	0.26677573136680977
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.0166667	0.2666869088026091
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.0166667	0.2666869088026091
BARATELA-SCOTT SYNDROME	0.0166667	0.2666869088026091
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.0166667	0.2666869088026091
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.0166667	0.2666869088026091
#170100 PROLIDASE DEFICIENCY	0.01660769	0.2657426790217622
XIA-GIBBS SYNDROME	0.01656464	0.26505382811402683
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.016540751	0.2646715758646682
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.01643194	0.2629304711928543
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.016430860999999998	0.262913205916909
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.016393400000000002	0.2623137856183103
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.016393400000000002	0.2623137856183103
%180050 RETINAL DETACHMENT	0.016393400000000002	0.2623137856183103
#609016 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;LCHAD DEFICIENCY	0.016393400000000002	0.2623137856183103
SECKEL SYNDROME 10; SCKL10	0.016393400000000002	0.2623137856183103
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.01639018	0.26226226181057727
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.016300351	0.26082489158546796
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.016300351	0.26082489158546796
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.016300351	0.26082489158546796
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.016300351	0.26082489158546796
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.016300351	0.26082489158546796
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.016300351	0.26082489158546796
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.016300351	0.26082489158546796
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.016300351	0.26082489158546796
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.01628139	0.2605214931635964
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.01627384	0.2604006842355267
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.016135891	0.25819333710727627
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.016128999999999998	0.258083072958491
FISH-EYE DISEASE	0.016128999999999998	0.258083072958491
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.016128999999999998	0.258083072958491
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.016128999999999998	0.258083072958491
MORQUIO SYNDROME A	0.016128999999999998	0.258083072958491
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.016128999999999998	0.258083072958491
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.016128999999999998	0.258083072958491
#614594 PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTICPLAQUES;;OLMSTED SYNDROME; OLMS	0.016128999999999998	0.258083072958491
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.016128999999999998	0.258083072958491
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.016128999999999998	0.258083072958491
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.016077661	0.2572615882487994
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.016067250999999998	0.2570950159387059
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.016067250999999998	0.2570950159387059
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.016067250999999998	0.2570950159387059
MENTAL RETARDATION, X-LINKED 12; MRX12	0.016035960000000002	0.2565943229362914
MENTAL RETARDATION, X-LINKED 63	0.015985060000000002	0.2557798627457286
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.015965840000000002	0.2554723200175829
HOLOPROSENCEPHALY 5; HPE5	0.01594324	0.2551106932925
HARTSFIELD SYNDROME; HRTFDS	0.01594324	0.2551106932925
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.01594324	0.2551106932925
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.01589847	0.2543943203508203
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.015872999999999998	0.25398677023188837
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.015872999999999998	0.25398677023188837
CHOREA, BENIGN FAMILIAL	0.015872999999999998	0.25398677023188837
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.015872999999999998	0.25398677023188837
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.015860601	0.2537883715697511
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.015783119999999998	0.25254858394647023
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.015767241	0.25229450116914326
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.015767241	0.25229450116914326
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.015761491	0.25220249436961995
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.01576052	0.2521869572213874
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.015754941	0.252097686624076
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.015686520000000002	0.2510028697144789
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.01564076	0.25027065560209855
HYDROXYLYSINURIA	0.015625	0.2500184769654921
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.015625	0.2500184769654921
CARNOSINEMIA	0.015625	0.2500184769654921
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.015625	0.2500184769654921
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.015625	0.2500184769654921
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.015625	0.2500184769654921
PAINE SYNDROME	0.015625	0.2500184769654921
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.015625	0.2500184769654921
OSTEOGENESIS IMPERFECTA, TYPE I	0.015625	0.2500184769654921
GRANT SYNDROME	0.015625	0.2500184769654921
OSTEOGENESIS IMPERFECTA, TYPE IV	0.015625	0.2500184769654921
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.015625	0.2500184769654921
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	0.2500184769654921
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.015625	0.2500184769654921
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.015625	0.2500184769654921
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	0.2500184769654921
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	0.2500184769654921
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.015625	0.2500184769654921
Osteogenesis imperfecta, type IX	0.015625	0.2500184769654921
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.015625	0.2500184769654921
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.015624641	0.25001273254096534
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.015624411000000001	0.25000905226898446
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.015621650999999999	0.2499648890052132
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.015621650999999999	0.2499648890052132
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	0.2499648890052132
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.015621650999999999	0.2499648890052132
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.015621650999999999	0.2499648890052132
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.015594991	0.24953829747907563
CROME SYNDROME	0.015577961000000001	0.2492657973406614
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.015577961000000001	0.2492657973406614
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.015564441	0.2490494613529127
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.015564441	0.2490494613529127
USHER SYNDROME, TYPE IID; USH2D	0.01551897	0.24832187158228244
CZECH DYSPLASIA, METATARSAL TYPE	0.0153846	0.24617179268629186
#602111 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE;;SEMD, MISSOURI TYPEMETAPHYSEAL ANADYSPLASIA 1, INCLUDED; MANDP1, INCLUDED	0.0153846	0.24617179268629186
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.0153846	0.24617179268629186
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0153846	0.24617179268629186
PSEUDOACHONDROPLASIA	0.0153846	0.24617179268629186
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.0153846	0.24617179268629186
#608728 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED;;SEMD, MATN3-RELATED	0.0153846	0.24617179268629186
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.0153846	0.24617179268629186
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0153846	0.24617179268629186
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.0153846	0.24617179268629186
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.0153846	0.24617179268629186
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0153846	0.24617179268629186
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0153846	0.24617179268629186
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.0153846	0.24617179268629186
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.0153846	0.24617179268629186
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.0153846	0.24617179268629186
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.0153846	0.24617179268629186
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0153846	0.24617179268629186
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.0153846	0.24617179268629186
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.0153846	0.24617179268629186
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.0153846	0.24617179268629186
FACIOCARDIORENAL SYNDROME	0.0153846	0.24617179268629186
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.0153846	0.24617179268629186
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.0153846	0.24617179268629186
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.0153846	0.24617179268629186
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0153846	0.24617179268629186
#156500 METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS;;SPONDYLOMETAPHYSEAL DYSPLASIA, JAPANESE TYPE	0.0153846	0.24617179268629186
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0153846	0.24617179268629186
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.015363051	0.24582698320404356
CRANIOECTODERMAL DYSPLASIA 4	0.01523336	0.24375177384109112
NEMALINE MYOPATHY 7; NEM7	0.01522014	0.24354023820810014
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.01522014	0.24354023820810014
CHROMOSOME 1p35 DELETION SYNDROME	0.015198861000000001	0.2431997490451339
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.015153111	0.2424676949445789
#608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D;;DUCHENNE-LIKE AUTOSOMAL RECESSIVE MUSCULAR DYSTROPHY, TYPE 2; DMDA2;;ADHALINOPATHY, PRIMARY	0.015151499999999998	0.24244191703952983
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.015115241	0.24186173016232715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.015115241	0.24186173016232715
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.01511264	0.24182011108657758
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.01511177	0.24180619005778015
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.01509737	0.24157577302940875
HYPERTRYPTOPHANEMIA; HYPTRP	0.01508535	0.24138343881544874
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.0150734	0.24119222468426552
LIVER FAILURE, INFANTILE, TRANSIENT	0.01505888	0.24095988751399103
CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED; CRYPTOP	0.015012250000000001	0.24021375237281337
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.015000251	0.2400217541836864
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.015000251	0.2400217541836864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.015000251	0.2400217541836864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.015000251	0.2400217541836864
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.015000251	0.2400217541836864
SECKEL SYNDROME 7; SCKL7	0.015000251	0.2400217541836864
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.015000251	0.2400217541836864
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.015000251	0.2400217541836864
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.015000251	0.2400217541836864
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.014998319999999999	0.23999085590022906
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.014998319999999999	0.23999085590022906
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.014998319999999999	0.23999085590022906
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.014998319999999999	0.23999085590022906
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.014998319999999999	0.23999085590022906
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.014998319999999999	0.23999085590022906
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.014998319999999999	0.23999085590022906
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.01496649	0.23948153826043317
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.01495152	0.23924200055802206
MEIER-GORLIN SYNDROME 7	0.01492779	0.238862292496685
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.01485149	0.23764140226996713
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.014804651	0.2368919228816416
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.014804651	0.2368919228816416
FLYNN-AIRD SYNDROME	0.014723131	0.23558750648213908
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.0147059	0.23531179010603714
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.0147059	0.23531179010603714
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.0147059	0.23531179010603714
HALOTHANE HEPATITIS	0.0147059	0.23531179010603714
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.0147059	0.23531179010603714
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.0147059	0.23531179010603714
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.0147059	0.23531179010603714
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.23531179010603714
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.23531179010603714
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.0147059	0.23531179010603714
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.23531179010603714
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.0147059	0.23531179010603714
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.0147059	0.23531179010603714
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.0147059	0.23531179010603714
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0147059	0.23531179010603714
PANCREATITIS, HEREDITARY	0.0147059	0.23531179010603714
FEVER, FAMILIAL LIFELONG PERSISTENT	0.0147059	0.23531179010603714
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.0147059	0.23531179010603714
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.0147059	0.23531179010603714
CYCLIC NEUTROPENIA	0.0147059	0.23531179010603714
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.0147059	0.23531179010603714
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0147059	0.23531179010603714
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0147059	0.23531179010603714
PSORIASIS 14, PUSTULAR	0.0147059	0.23531179010603714
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.0147059	0.23531179010603714
CAFFEY DISEASE	0.0147059	0.23531179010603714
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.0147059	0.23531179010603714
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.23531179010603714
NEUROPATHY, PAINFUL	0.0147059	0.23531179010603714
ACHALASIA-MICROCEPHALY SYNDROME	0.0147059	0.23531179010603714
RAGWEED SENSITIVITY	0.0147059	0.23531179010603714
IMMUNODEFICIENCY 32B; IMD32B	0.0147059	0.23531179010603714
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.0147059	0.23531179010603714
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.0147059	0.23531179010603714
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0147059	0.23531179010603714
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.014679240000000001	0.23488519857989956
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.014662210000000002	0.23461269844148536
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.014625571	0.23402643111492286
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.01443	0.23089706384717126
DYSOSTEOSCLEROSIS	0.014426851	0.23084667612339754
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.014387860999999998	0.23022279001671692
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.014352961	0.22966434874656683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.014352961	0.22966434874656683
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.014335661	0.22938752828887063
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.014181311	0.2269177457660147
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.014104491	0.2256885349243834
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.0140845	0.2253686552845103
WEYERS ACROFACIAL DYSOSTOSIS	0.0140845	0.2253686552845103
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.0140845	0.2253686552845103
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0140845	0.2253686552845103
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.0140845	0.2253686552845103
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.0140845	0.2253686552845103
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.0140845	0.2253686552845103
LIG4 SYNDROME	0.0140845	0.2253686552845103
SUDANOPHILIC CEREBRAL SCLEROSIS	0.0140845	0.2253686552845103
601095 HARROD SYNDROME	0.0140845	0.2253686552845103
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0140845	0.2253686552845103
CULLER-JONES SYNDROME; CJS	0.0140845	0.2253686552845103
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.014073651	0.225195058455288
VISCERAL STEATOSIS, CONGENITAL	0.014073651	0.225195058455288
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.014073651	0.225195058455288
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.013982620000000001	0.2237384548087827
Mental retardation, autosomal dominant 21	0.01396168	0.2234033900466926
SPINOCEREBELLAR ATAXIA 45; SCA45	0.013903910000000002	0.22247900173217766
AICARDI-GOUTIERES SYNDROME 5	0.013888900000000001	0.2222388239824655
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.013888900000000001	0.2222388239824655
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.013814390000000001	0.22104657587246876
LUSCAN-LUMISH SYNDROME; LLS	0.013736251000000001	0.219796259471086
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.013678751	0.21887619147585294
MEND SYNDROME; MEND	0.013629851	0.21809373365034176
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.013512971	0.21622351543672721
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.0135111	0.2161935772242215
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.013495881	0.21595005522736144
SHASHI-PENA SYNDROME; SHAPNS	0.013441811	0.21508487128819187
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.01343721	0.21501124984739073
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.01341991	0.21473442938969456
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.013383591	0.21415328244154033
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.01317254	0.21077621686828948
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.013171221	0.210755111308538
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.0131579	0.2105419595561119
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.0131579	0.2105419595561119
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.0131579	0.2105419595561119
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0131579	0.2105419595561119
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0131579	0.2105419595561119
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0131579	0.2105419595561119
MYXEDEMA	0.0131579	0.2105419595561119
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0131579	0.2105419595561119
HEMOCHROMATOSIS, TYPE 2A	0.0131579	0.2105419595561119
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.013061901	0.20900586203481847
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.013057250999999999	0.20893145653607348
MENTAL RETARDATION, X-LINKED 1	0.013018690999999999	0.20831445093787898
#615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 4	0.01290999	0.20657510639614293
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.012894300000000001	0.20632404784231329
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.012875491000000001	0.2060230816001857
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.012820500000000002	0.20514316057190987
PANIC DISORDER 1	0.012820500000000002	0.20514316057190987
POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	0.012820500000000002	0.20514316057190987
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.012820500000000002	0.20514316057190987
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.012820500000000002	0.20514316057190987
#609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K; LGMD2K	0.012820500000000002	0.20514316057190987
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.012820500000000002	0.20514316057190987
OBSESSIVE-COMPULSIVE DISORDER 1	0.012820500000000002	0.20514316057190987
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.012820500000000002	0.20514316057190987
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.012820500000000002	0.20514316057190987
ADIPOSIS DOLOROSA	0.012820500000000002	0.20514316057190987
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.012820500000000002	0.20514316057190987
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.012820500000000002	0.20514316057190987
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.012820500000000002	0.20514316057190987
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.012820500000000002	0.20514316057190987
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q	0.012820500000000002	0.20514316057190987
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.012820500000000002	0.20514316057190987
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.012820500000000002	0.20514316057190987
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.012815651	0.2050655708378423
COFFIN-SIRIS SYNDROME 8; CSS8	0.012799961	0.20481451228401265
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.012763	0.20422309257667687
GLUTATHIONURIA	0.012704159999999999	0.20328158299685928
CATARACT 45	0.012658200000000001	0.2025461686479739
%614422 CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	0.012658200000000001	0.2025461686479739
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.012658200000000001	0.2025461686479739
#614691 CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 5; CATC5	0.012658200000000001	0.2025461686479739
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.012658200000000001	0.2025461686479739
FECHTNER SYNDROME	0.012658200000000001	0.2025461686479739
CATARACT 13 WITH ADULT I PHENOTYPE	0.012658200000000001	0.2025461686479739
CATARACT, CRYSTALLINE ACULEIFORM	0.012658200000000001	0.2025461686479739
#615188 CATARACT, MULTIPLE TYPES	0.012658200000000001	0.2025461686479739
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.01252606	0.20043177238901583
FRIAS SYNDROME	0.01252606	0.20043177238901583
RETINITIS PIGMENTOSA 60; RP60	0.01251453	0.2002472787544934
MENTAL RETARDATION, X-LINKED 101; MRX101	0.012494221	0.19992231073857714
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.012307809999999999	0.1969395143027618
CEREBELLOPARENCHYMAL DISORDER V	0.012146150000000001	0.1943527631356424
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.012144831	0.19433165757589085
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.012144831	0.19433165757589085
Cerebral creatine deficiency syndrome 2	0.012144831	0.19433165757589085
HYPEREKPLEXIA 4; HKPX4	0.012144831	0.19433165757589085
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.012144831	0.19433165757589085
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.012010671	0.19218493892823066
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.011865480000000001	0.18986171123612847
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.011865401	0.18986044714270892
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.011865401	0.18986044714270892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.011823811	0.18919495796146127
#613827 RETINITIS PIGMENTOSA 48; RP48	0.01179082	0.18866706294875288
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.011716831	0.1874831514548521
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.011542291	0.18469030505680045
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.011521551000000001	0.18435844053121556
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.01149199	0.1838854295745706
#615420 MYOPIA 22, AUTOSOMAL DOMINANT; MYP22	0.01146276	0.18341771500934173
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.01145412	0.18327946479231888
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.01143152	0.182917838067236
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.011397020999999999	0.18236581327127868
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.011379581	0.1820867526480289
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.011265671	0.180264057946516
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.011016751	0.17628104359219599
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.011016751	0.17628104359219599
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.011016751	0.17628104359219599
USHER SYNDROME, TYPE IE; USH1E	0.01093713	0.17500701343830993
GALACTOSEMIA	0.01086957	0.17392597354686745
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.01086957	0.17392597354686745
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.010719671	0.17152741228743384
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.010702581	0.17125395207806807
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.010701180000000001	0.17123153442134945
POPOV-CHANG SYNDROME; POPCHAS	0.010667320000000001	0.17068973438102614
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.01066388	0.1706346903131374
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.010649691	0.17040764953427895
ICHTHYOSIS AND MALE HYPOGONADISM	0.010615361	0.16985832893816855
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.0106058	0.16970534163203943
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.010586991	0.16940437538991185
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.010563901	0.16903490808539132
VITAMIN A METABOLIC DEFECT	0.010526299999999999	0.168433247621239
NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL PATHWAY AND AUTONOMIC DISTURBANCE	0.0105005	0.16802041711207358
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.01034992	0.1656109590473399
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.01034992	0.1656109590473399
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.010143841	0.16231345135360734
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.010101	0.1616279446930199
NYSTAGMUS, MYOCLONIC	0.010068530000000001	0.16110838629640745
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.010020870999999999	0.16034578593841073
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.010006661	0.16011840913471925
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.010006661	0.16011840913471925
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.010006661	0.16011840913471925
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.010006661	0.16011840913471925
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.010006661	0.16011840913471925
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.010006661	0.16011840913471925
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.009973531	0.1595882899576398
OROFACIODIGITAL SYNDROME III	0.00992326	0.1587838945108857
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00990099	0.15842754817603633
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00990099	0.15842754817603633
NEMALINE MYOPATHY 6	0.00990099	0.15842754817603633
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00990099	0.15842754817603633
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00990099	0.15842754817603633
MUSK, INABILITY TO SMELL	0.00990099	0.15842754817603633
HYDROCEPHALUS, NORMAL-PRESSURE	0.00990099	0.15842754817603633
FREESIA FLOWERS, INABILITY TO SMELL	0.00990099	0.15842754817603633
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00990099	0.15842754817603633
THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6	0.00990099	0.15842754817603633
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00990099	0.15842754817603633
MYOPATHY, DISTAL, 1; MPD1	0.00990099	0.15842754817603633
NONAKA MYOPATHY	0.00990099	0.15842754817603633
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.00990099	0.15842754817603633
TEEBI-SHALTOUT SYNDROME; TBSH	0.00986037	0.1577775801418387
RICHARDS-RUNDLE SYNDROME; RRNS	0.00981072	0.15698312142943316
ACKERMAN SYNDROME	0.00980392	0.15687431338825775
ASCITES, CHYLOUS	0.00980392	0.15687431338825775
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00980392	0.15687431338825775
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.00980392	0.15687431338825775
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00980392	0.15687431338825775
LOWRY-MACLEAN SYNDROME	0.00980392	0.15687431338825775
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.00978683	0.15660085317889197
SPASTIC PARAPARESIS AND DEAFNESS	0.00975816	0.15614209927587752
#615179 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00975595	0.15610673666249553
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00975595	0.15610673666249553
CHITAYAT SYNDROME	0.00973276	0.15573566923972243
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00973276	0.15573566923972243
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00973276	0.15573566923972243
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00973276	0.15573566923972243
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00973276	0.15573566923972243
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.00973276	0.15573566923972243
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.00973276	0.15573566923972243
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00973276	0.15573566923972243
RAINE SYNDROME	0.00973276	0.15573566923972243
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.00973276	0.15573566923972243
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.00973276	0.15573566923972243
TRICHOHEPATOENTERIC SYNDROME 1	0.00973276	0.15573566923972243
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00973276	0.15573566923972243
MEESTER-LOEYS SYNDROME; MRLS	0.00973276	0.15573566923972243
257960 OCULOTRICHODYSPLASIA; OTD	0.009699610000000001	0.15520523003899245
HOOFT DISEASE	0.009699610000000001	0.15520523003899245
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00967124	0.15475127649073572
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.00964815	0.1543818091862152
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.00964815	0.1543818091862152
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D	0.00964815	0.1543818091862152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2	0.00964815	0.1543818091862152
#300717 MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE	0.00964815	0.1543818091862152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.00964815	0.1543818091862152
CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS	0.00964815	0.1543818091862152
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00964815	0.1543818091862152
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB	0.00964815	0.1543818091862152
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00964815	0.1543818091862152
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00964815	0.1543818091862152
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB	0.00964815	0.1543818091862152
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.00964815	0.1543818091862152
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00961538	0.15385745043484503
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.00961538	0.15385745043484503
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.00961538	0.15385745043484503
#184460 STAPES ANKYLOSIS WITH BROAD THUMB AND TOES;;ANKYLOSIS OF STAPES, HYPEROPIA, BROAD THUMBS, BROAD FIRST TOES, ANDSYNDACTYLY;;TEUNISSEN-CREMERS SYNDROME;;STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM	0.00961538	0.15385745043484503
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00961538	0.15385745043484503
BRACHYDACTYLY, TYPE B2	0.00961538	0.15385745043484503
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.00961538	0.15385745043484503
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00961538	0.15385745043484503
#605726 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2;;NEURONOPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE;;NEUROPATHY, DISTAL HEREDITARY MOTOR, JERASH TYPE; HMNJ;;SPINAL MUSCULAR ATROPHY, JERASH TYPE	0.00951035	0.15217684623416117
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.009476360999999999	0.151632982041292
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.009338861	0.1494328194439957
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00924117	0.14786964792186857
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00924117	0.14786964792186857
BARDET-BIEDL SYNDROME 18; BBS18	0.00924117	0.14786964792186857
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.00921825	0.14750290081837747
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.00915801	0.14653898958302375
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00915801	0.14653898958302375
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00915801	0.14653898958302375
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00914361	0.14630857255465238
ZIMMERMANN-LABAND SYNDROME 1	0.009105151	0.14569318307589296
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00910512	0.14569268703923463
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.00909091	0.14546531023554315
SCHIZOPHRENIA 15; SCZD15	0.00909091	0.14546531023554315
Potocki-Lupski syndrome (17p11.2 duplication syndrome)	0.00909091	0.14546531023554315
8p23.1 deletion syndrome	0.00909091	0.14546531023554315
NIJMEGEN BREAKAGE SYNDROME	0.00909091	0.14546531023554315
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00909091	0.14546531023554315
ALAZAMI-YUAN SYNDROME	0.00909091	0.14546531023554315
#615401 IMMUNODEFICIENCY 8; IMD8	0.00909091	0.14546531023554315
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.00909091	0.14546531023554315
MENTAL RETARDATION, X-LINKED 107; MRX107	0.00909091	0.14546531023554315
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.00909091	0.14546531023554315
SOTOS SYNDROME 3	0.00909091	0.14546531023554315
#614199 NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES;NPHS5	0.00905778	0.14493519105846367
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.009030811	0.14450365516692562
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.009017431	0.14428955934473053
THYROCEREBRORETINAL SYNDROME	0.008980271	0.1436949554020721
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.008980271	0.1436949554020721
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.008980271	0.1436949554020721
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.008980271	0.1436949554020721
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.008980271	0.1436949554020721
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.008980271	0.1436949554020721
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.008980271	0.1436949554020721
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.008947331	0.14316787644967252
#614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2	0.00892926	0.14287871908024896
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.008831519999999999	0.14131476350017808
PEROXISOME BIOGENESIS DISORDER 10B	0.008791760000000001	0.14067855648295266
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.008789771	0.14064673013090884
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.008789771	0.14064673013090884
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.008789771	0.14064673013090884
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00873367	0.13974904779002942
PREECLAMPSIA/ECLAMPSIA 1	0.008728251	0.13966233738192213
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.008728251	0.13966233738192213
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.008728251	0.13966233738192213
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.008728251	0.13966233738192213
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.008728251	0.13966233738192213
INFANTILE LIVER FAILURE SYNDROME 1	0.008728251	0.13966233738192213
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.008728251	0.13966233738192213
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.008722461	0.13956969053509782
ASPARTYLGLUCOSAMINURIA; AGU	0.008620571	0.1379393300475449
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.008607491	0.13773003458010757
SPASTIC PARAPLEGIA 77, AUTOSOMAL RECESSIVE	0.00834591	0.13354442925382848
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00834591	0.13354442925382848
CORNELIA DE LANGE SYNDROME 3	0.008275261	0.13241396170956388
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.008215021	0.13145005047421016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.008215021	0.13145005047421016
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.008215021	0.13145005047421016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.008215021	0.13145005047421016
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.008215021	0.13145005047421016
1p36 microdeletion syndrome	0.008215021	0.13145005047421016
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.008215021	0.13145005047421016
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.0081894	0.13104008417671686
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.008162131	0.13060374793042107
LISSENCEPHALY 5; LIS5	0.008149051000000001	0.13039445246298373
LISSENCEPHALY 8; LIS8	0.008149051000000001	0.13039445246298373
CEREBELLAR HYPOPLASIA	0.00813898	0.13023330455376647
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.00811506	0.12985055626774955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.008093641	0.1295078269392296
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00808985	0.12944716645627433
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.00806452	0.129041856502896
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.00806452	0.129041856502896
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00806452	0.129041856502896
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.008055351	0.12889514166031707
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.007982821	0.12773457589172138
#604432 SPINOCEREBELLAR ATAXIA 11; SCA11	0.00797756	0.1276503936704532
CHROMOSOME 16p13.3 DELETION SYNDROME	0.007969521	0.12752176016412836
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.007969521	0.12752176016412836
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00795219	0.12724444366977386
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00793911	0.12703514820233652
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00787402	0.12599363123173274
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00787402	0.12599363123173274
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00787402	0.12599363123173274
TETRALOGY OF FALLOT	0.00787402	0.12599363123173274
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.00787402	0.12599363123173274
BECKWITH-WIEDEMANN SYNDROME	0.00787402	0.12599363123173274
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00787402	0.12599363123173274
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00787402	0.12599363123173274
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00787402	0.12599363123173274
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.00787402	0.12599363123173274
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.00787402	0.12599363123173274
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00787402	0.12599363123173274
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.00787402	0.12599363123173274
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.00787402	0.12599363123173274
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00787402	0.12599363123173274
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00787402	0.12599363123173274
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00787402	0.12599363123173274
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00787402	0.12599363123173274
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00787402	0.12599363123173274
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.007870261	0.12593348278661828
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.0078125	0.12500923848274606
SCLEROSING CHOLANGITIS, NEONATAL	0.0078125	0.12500923848274606
TYROSINEMIA, TYPE I; TYRSN1	0.0078125	0.12500923848274606
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.0078125	0.12500923848274606
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.0078125	0.12500923848274606
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.0078125	0.12500923848274606
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0078125	0.12500923848274606
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	0.0078125	0.12500923848274606
GLYCOGEN STORAGE DISEASE VI	0.0078125	0.12500923848274606
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.0078125	0.12500923848274606
REYNOLDS SYNDROME	0.0078125	0.12500923848274606
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0078125	0.12500923848274606
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.0078125	0.12500923848274606
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.0078125	0.12500923848274606
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.0078125	0.12500923848274606
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.0078125	0.12500923848274606
Lipodystrophy, congenital generalized, type 2	0.0078125	0.12500923848274606
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.0078125	0.12500923848274606
HEMOCHROMATOSIS, TYPE 1	0.0078125	0.12500923848274606
HEMOCHROMATOSIS, TYPE 2B	0.0078125	0.12500923848274606
#600803 GALLBLADDER DISEASE 1; GBD1;;CHOLELITHIASIS, LOW PHOSPHOLIPID-ASSOCIATED; LPAC	0.0078125	0.12500923848274606
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.0078125	0.12500923848274606
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.0078125	0.12500923848274606
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0078125	0.12500923848274606
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.0078125	0.12500923848274606
Lipodystrophy, congenital generalized, type 1	0.0078125	0.12500923848274606
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.0078125	0.12500923848274606
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.0078125	0.12500923848274606
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0078125	0.12500923848274606
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.0078125	0.12500923848274606
#300752 PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP;;PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED DOMINANT; XLDPP;;ERYTHROHEPATIC PROTOPORPHYRIA, X-LINKED;	0.0078125	0.12500923848274606
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.0078125	0.12500923848274606
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.0078125	0.12500923848274606
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0078125	0.12500923848274606
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0078125	0.12500923848274606
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0078125	0.12500923848274606
#603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2;;CITRIN DEFICIENCY	0.0078125	0.12500923848274606
#615506 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	0.0078125	0.12500923848274606
#615395 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16	0.0078125	0.12500923848274606
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.0078125	0.12500923848274606
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.0078125	0.12500923848274606
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.0078125	0.12500923848274606
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00775949	0.12416101579705385
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00775194	0.12404020686898412
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00775194	0.12404020686898412
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00770482	0.12328623114836884
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.007703501	0.12326512558861731
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00769589	0.12314334058841352
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.0073595100000000005	0.11776086281038778
HUNTER-MACDONALD SYNDROME	0.0073595100000000005	0.11776086281038778
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.007334851000000001	0.11736628965048428
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00729927	0.11679695157503409
GERODERMA OSTEODYSPLASTICUM; GO	0.00729927	0.11679695157503409
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00729927	0.11679695157503409
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00729927	0.11679695157503409
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00729927	0.11679695157503409
FORSYTHE-WAKELING SYNDROME; FWS	0.00729927	0.11679695157503409
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.00729927	0.11679695157503409
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00729927	0.11679695157503409
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00729927	0.11679695157503409
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00729927	0.11679695157503409
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00729927	0.11679695157503409
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.00729927	0.11679695157503409
2q37 monosomy	0.00729927	0.11679695157503409
PORPHYRIA, ACUTE HEPATIC	0.00724638	0.11595064903124497
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00724638	0.11595064903124497
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00724638	0.11595064903124497
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.00724638	0.11595064903124497
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00724638	0.11595064903124497
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00724638	0.11595064903124497
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.00724638	0.11595064903124497
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00724638	0.11595064903124497
PORPHYRIA VARIEGATA	0.00724638	0.11595064903124497
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00724638	0.11595064903124497
VISCERAL MYOPATHY; VSCM	0.00724638	0.11595064903124497
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00724638	0.11595064903124497
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.00724638	0.11595064903124497
GALACTOSE EPIMERASE DEFICIENCY	0.00724638	0.11595064903124497
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00724638	0.11595064903124497
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00724638	0.11595064903124497
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00724638	0.11595064903124497
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00724638	0.11595064903124497
ANGIOEDEMA, HEREDITARY, TYPE III	0.00724638	0.11595064903124497
ALPHA-METHYLACETOACETIC ACIDURIA	0.00724638	0.11595064903124497
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00724638	0.11595064903124497
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00724638	0.11595064903124497
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00724638	0.11595064903124497
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00724638	0.11595064903124497
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00724638	0.11595064903124497
CONGENITAL SHORT BOWEL SYNDROME	0.00724638	0.11595064903124497
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00724638	0.11595064903124497
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00724638	0.11595064903124497
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.00724638	0.11595064903124497
ACID PHOSPHATASE DEFICIENCY	0.00724638	0.11595064903124497
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00724638	0.11595064903124497
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00724638	0.11595064903124497
CHAR SYNDROME	0.007139600000000001	0.11424204276114097
CRANIOSYNOSTOSIS 6; CRS6	0.007139600000000001	0.11424204276114097
MCDONOUGH SYNDROME	0.0071396	0.11424204276114097
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0071396	0.11424204276114097
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0071396	0.11424204276114097
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.0071396	0.11424204276114097
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0071379899999999994	0.11421628085727444
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0071223	0.11396522230344476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.007088591	0.11342583844168286
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.007088591	0.11342583844168286
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.00706707	0.1130814769925453
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.00706707	0.1130814769925453
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00706707	0.1130814769925453
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00706707	0.1130814769925453
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00706707	0.1130814769925453
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.007013421000000001	0.11222302955121913
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0069545100000000006	0.11128038388744223
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.0069545100000000006	0.11128038388744223
KERATOCONUS 9; KTCN9	0.00689655	0.11035295534824734
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00689062	0.1102580683358694
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.0068749300000000005	0.11000700978203973
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.006856121000000001	0.10970604353991212
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.006856121	0.1097060435399121
CHROMOSOME 18P DELETION SYNDROME	0.00680924	0.1089558921019205
JOUBERT SYNDROME 26	0.00665605	0.10650467095079448
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00657022	0.10513128945460579
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.006542951	0.10469495320830999
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.006542951	0.10469495320830999
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.006542951	0.10469495320830999
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.006542951	0.10469495320830999
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.006533731	0.1045474223054222
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.006529871	0.10448565774087264
CHROMOSOME 9P DELETION SYNDROME	0.0064249500000000005	0.10280679766908407
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0064249500000000005	0.10280679766908407
GASTROCUTANEOUS SYNDROME	0.0064249500000000005	0.10280679766908407
NOONAN SYNDROME 6; NS6	0.0064249500000000005	0.10280679766908407
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00641649	0.10267142766491588
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0063976810000000005	0.10237046142278826
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.006234901	0.09976578893123993
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.006234901	0.09976578893123993
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.006196611	0.09915310365232737
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.006196611	0.09915310365232737
N SYNDROME	0.00617284	0.09877273954250677
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00617284	0.09877273954250677
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00617284	0.09877273954250677
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00613497	0.09816677476025505
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.00613497	0.09816677476025505
#176500 CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1;;DEMENTIA, FAMILIAL BRITISH; FBD;;PRESENILE DEMENTIA WITH SPASTIC ATAXIA;;CEREBRAL AMYLOID ANGIOPATHY, BRITISH TYPE	0.00613497	0.09816677476025505
#610297 PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13	0.00613497	0.09816677476025505
PALLISTER-HALL SYNDROME	0.006124081	0.09799253788373169
#606070 AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21;;MYOPATHY, DISTAL, 2, FORMERLY; MPD2, FORMERLY;;VOCAL CORD AND PHARYNGEAL DYSFUNCTION WITH DISTAL MYOPATHY, FORMERLY;VCPDM, FORMERLY	0.005973549999999999	0.09558386387694177
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.005973549999999999	0.09558386387694177
LARSEN-LIKE SYNDROME	0.00594037	0.09505294464073603
%608572 BURN-MCKEOWN SYNDROME	0.00594037	0.09505294464073603
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00594037	0.09505294464073603
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00594037	0.09505294464073603
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.005939051	0.0950318390809845
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.005866251	0.09386695299310689
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.005866251	0.09386695299310689
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.005866251	0.09386695299310689
LISSENCEPHALY, X-LINKED, 1; LISX1	0.005728751000000001	0.09166679039581056
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.005627200000000001	0.0900418543091339
BARDET-BIEDL SYNDROME 3; BBS3	0.00561798	0.0898943234062461
USHER SYNDROME, TYPE IG	0.00561798	0.0898943234062461
#612943 RETINITIS PIGMENTOSA 42; RP42	0.00561798	0.0898943234062461
BARDET-BIEDL SYNDROME 9; BBS9	0.00561798	0.0898943234062461
BARDET-BIEDL SYNDROME 7; BBS7	0.00561798	0.0898943234062461
BARDET-BIEDL SYNDROME 13; BBS13	0.00561798	0.0898943234062461
USHER SYNDROME, TYPE ID	0.00561798	0.0898943234062461
BARDET-BIEDL SYNDROME 12; BBS12	0.00561798	0.0898943234062461
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00561798	0.0898943234062461
BARDET-BIEDL SYNDROME 20	0.00561798	0.0898943234062461
BARDET-BIEDL SYNDROME 10; BBS10	0.00561798	0.0898943234062461
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00561798	0.0898943234062461
#615565 RETINITIS PIGMENTOSA 67; RP67	0.00561798	0.0898943234062461
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.00561798	0.0898943234062461
SENIOR-LOKEN SYNDROME 1	0.00561798	0.0898943234062461
#613575 RETINITIS PIGMENTOSA 55; RP55	0.00561798	0.0898943234062461
USHER SYNDROME, TYPE IIC	0.00561798	0.0898943234062461
USHER SYNDROME, TYPE IF	0.00561798	0.0898943234062461
BARDET-BIEDL SYNDROME 19; BBS19	0.00561798	0.0898943234062461
SENIOR-LOKEN SYNDROME 5; SLSN5	0.00561798	0.0898943234062461
USHER SYNDROME, TYPE IC	0.00561798	0.0898943234062461
BARDET-BIEDL SYNDROME 14; BBS14	0.00561798	0.0898943234062461
JOUBERT SYNDROME 10	0.00561798	0.0898943234062461
%614990 USHER SYNDROME, TYPE IK; USH1K	0.00561798	0.0898943234062461
USHER SYNDROME, TYPE IIA	0.00561798	0.0898943234062461
RETINITIS PIGMENTOSA, Y-LINKED	0.00561798	0.0898943234062461
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.00561798	0.0898943234062461
#300455 RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITHOR WITHOUT DEAFNESS	0.00561798	0.0898943234062461
#613756 RETINITIS PIGMENTOSA 49; RP49	0.00561798	0.0898943234062461
RETINITIS PIGMENTOSA, LATE-ADULT ONSET	0.00561798	0.0898943234062461
#614869 USHER SYNDROME, TYPE IJ; USH1J	0.00561798	0.0898943234062461
BARDET-BIEDL SYNDROME 6; BBS6	0.00561798	0.0898943234062461
BARDET-BIEDL SYNDROME 8; BBS8	0.00561798	0.0898943234062461
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00561412	0.08983255884169655
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.005567791000000001	0.08909124005645917
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.00546885	0.08750806705617481
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0054073210000000005	0.0865235302965454
#602398 DESMOSTEROLOSIS	0.0054073210000000005	0.0865235302965454
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.005407321	0.08652353029654539
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00531915	0.08511269003206383
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00531915	0.08511269003206383
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00531915	0.08511269003206383
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y; CMT2Y	0.00531915	0.08511269003206383
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.00531915	0.08511269003206383
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00531915	0.08511269003206383
#607706 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE;;CMT2 WITH VOCAL CORD PARESIS, AUTOSOMAL RECESSIVE;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A, AXONAL FORM;;CHARCOT-MARIE-TOOTH NEUROPATHY, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMALRECESSIVE	0.00531915	0.08511269003206383
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.00531915	0.08511269003206383
RADICULONEUROPATHY, FATAL NEONATAL	0.00531915	0.08511269003206383
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C	0.00531915	0.08511269003206383
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00531915	0.08511269003206383
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.00531915	0.08511269003206383
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00531915	0.08511269003206383
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.00531915	0.08511269003206383
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.00528086	0.08450000475315127
SCARF SYNDROME	0.00528086	0.08450000475315127
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00528086	0.08450000475315127
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.005262051	0.08419903851102367
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005262051	0.08419903851102367
RECOMBINANT CHROMOSOME 8 SYNDROME	0.005262051	0.08419903851102367
NOONAN SYNDROME 7; NS7	0.005262051	0.08419903851102367
SMITH-KINGSMORE SYNDROME; SKS	0.005262051	0.08419903851102367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005244751	0.08392221805332747
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00520833	0.0833394389845556
MECKEL SYNDROME, TYPE 5	0.00520833	0.0833394389845556
MICROPHTHALMIA, ISOLATED 7; MCOP7	0.00520833	0.0833394389845556
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00520833	0.0833394389845556
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.00520833	0.0833394389845556
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.00520833	0.0833394389845556
SECKEL SYNDROME 2; SCKL2	0.00520833	0.0833394389845556
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00520833	0.0833394389845556
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00520833	0.0833394389845556
227320 FACIOTHORACOGENITAL SYNDROME	0.00520833	0.0833394389845556
HYDROLETHALUS SYNDROME 1	0.00520833	0.0833394389845556
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.00520833	0.0833394389845556
#610093 MICROPHTHALMIA, ISOLATED 2; MCOP2;;ANOPHTHALMIA, CLINICAL, ISOLATED	0.00520833	0.0833394389845556
#609549 NANOPHTHALMOS 2; NNO2;;NANOPHTHALMIA 2;;NANOPHTHALMOS, AUTOSOMAL RECESSIVE	0.00520833	0.0833394389845556
MECKEL SYNDROME, TYPE 4; MKS4	0.00520833	0.0833394389845556
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.00520833	0.0833394389845556
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I	0.00518135	0.08290772708000978
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.00518135	0.08290772708000978
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0049505	0.0792138540939308
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.0049505	0.0792138540939308
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0049505	0.0792138540939308
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.0046520400000000005	0.07443814115728307
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.0046520400000000005	0.07443814115728307
MESOMELIA-SYNOSTOSES SYNDROME	0.0046520400000000005	0.07443814115728307
NOONAN SYNDROME 10; NS10	0.0046520400000000005	0.07443814115728307
NOONAN SYNDROME 5; NS5	0.0046520400000000005	0.07443814115728307
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.0046520400000000005	0.07443814115728307
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0046520400000000005	0.07443814115728307
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.0046520400000000005	0.07443814115728307
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0046520400000000005	0.07443814115728307
NOONAN SYNDROME 2; NS2	0.0046520400000000005	0.07443814115728307
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0046520400000000005	0.07443814115728307
NOONAN SYNDROME 8; NS8	0.0046520400000000005	0.07443814115728307
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0046520400000000005	0.07443814115728307
NOONAN SYNDROME 11; NS11	0.0046520400000000005	0.07443814115728307
3MC SYNDROME 3	0.0046520400000000005	0.07443814115728307
LATERAL MENINGOCELE SYNDROME	0.0046520400000000005	0.07443814115728307
NOONAN SYNDROME 9; NS9	0.0046520400000000005	0.07443814115728307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.0046520400000000005	0.07443814115728307
#613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3;;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2O; LGMD2O;;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY, LIMB-GIRDLE, POMGNT1-RELATED	0.00456621	0.07306475966109438
MYOPIA 15; MYP15	0.00456621	0.07306475966109438
#608908 MYOPIA 6; MYP6	0.00456621	0.07306475966109438
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00456621	0.07306475966109438
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00456621	0.07306475966109438
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00456621	0.07306475966109438
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00456621	0.07306475966109438
%609258 MYOPIA 9; MYP9	0.00456621	0.07306475966109438
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00456621	0.07306475966109438
%609256 MYOPIA 7; MYP7	0.00456621	0.07306475966109438
MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	0.00456621	0.07306475966109438
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00456621	0.07306475966109438
MYOPIA, INFANTILE SEVERE	0.00456621	0.07306475966109438
%609257 MYOPIA 8; MYP8	0.00456621	0.07306475966109438
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.00456621	0.07306475966109438
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.00456621	0.07306475966109438
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.00456621	0.07306475966109438
%310460 MYOPIA 1, X-LINKED; MYP1	0.00456621	0.07306475966109438
%609259 MYOPIA 10; MYP10	0.00456621	0.07306475966109438
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.004538941	0.07262842341479858
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.004538941	0.07262842341479858
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.004538941	0.07262842341479858
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.004538941	0.07262842341479858
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004538941	0.07262842341479858
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.004538941	0.07262842341479858
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.004525861	0.07241912794736122
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.004525861	0.07241912794736122
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.004525861	0.07241912794736122
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00449157	0.07187043139736932
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00449157	0.07187043139736932
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00449157	0.07187043139736932
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00449157	0.07187043139736932
OROFACIODIGITAL SYNDROME VIII; OFD8	0.0043463	0.06954593961184757
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0043463	0.06954593961184757
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0043463	0.06954593961184757
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0043463	0.06954593961184757
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.0043463	0.06954593961184757
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.0043289999999999995	0.06926911915415138
MUSCULAR DYSTROPHY, BECKER TYPE; BMD	0.0043289999999999995	0.06926911915415138
NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP	0.0043289999999999995	0.06926911915415138
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0043289999999999995	0.06926911915415138
#611722 KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY;;SAPOSIN A DEFICIENCY	0.0043289999999999995	0.06926911915415138
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V; CMT2V	0.0043289999999999995	0.06926911915415138
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.0043289999999999995	0.06926911915415138
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.0043289999999999995	0.06926911915415138
INCLUSION BODY MYOSITIS	0.0043289999999999995	0.06926911915415138
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H	0.0043289999999999995	0.06926911915415138
MYOPATHY, DISTAL, 4; MPD4	0.0043289999999999995	0.06926911915415138
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.0043289999999999995	0.06926911915415138
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C	0.0043289999999999995	0.06926911915415138
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.06531090663274634
GLOMUVENOUS MALFORMATIONS	0.00408163	0.06531090663274634
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00408163	0.06531090663274634
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.06531090663274634
PENDRED SYNDROME	0.00408163	0.06531090663274634
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.06531090663274634
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.06531090663274634
PROGESTERONE RESISTANCE	0.00408163	0.06531090663274634
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00408163	0.06531090663274634
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.06531090663274634
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.06531090663274634
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00408163	0.06531090663274634
OVARIAN CANCER	0.00408163	0.06531090663274634
CALVARIAL HYPEROSTOSIS	0.00408163	0.06531090663274634
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.06531090663274634
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.06531090663274634
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.06531090663274634
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.06531090663274634
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.06531090663274634
ACETYLATION, SLOW	0.00408163	0.06531090663274634
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.06531090663274634
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.06531090663274634
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00408163	0.06531090663274634
PITUITARY DWARFISM IV	0.00408163	0.06531090663274634
CARBOXYLESTERASE 1	0.00408163	0.06531090663274634
SCHIZOPHRENIA 4	0.00408163	0.06531090663274634
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00408163	0.06531090663274634
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00408163	0.06531090663274634
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.06531090663274634
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.06531090663274634
CEPHALIN LIPIDOSIS	0.00408163	0.06531090663274634
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.06531090663274634
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.06531090663274634
HYPERPROGLUCAGONEMIA	0.00408163	0.06531090663274634
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.06531090663274634
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.06531090663274634
HEINZ BODY ANEMIAS	0.00408163	0.06531090663274634
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.06531090663274634
GLUTATHIONE REDUCTASE	0.00408163	0.06531090663274634
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.06531090663274634
MACROCYTOSIS, FAMILIAL	0.00408163	0.06531090663274634
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.06531090663274634
T-SUBSTANCE ANOMALY	0.00408163	0.06531090663274634
PARAOXONASE 1	0.00408163	0.06531090663274634
BEETURIA	0.00408163	0.06531090663274634
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.06531090663274634
SPINAL ARACHNOIDITIS	0.00408163	0.06531090663274634
FINGERPRINT BODY MYOPATHY	0.00408163	0.06531090663274634
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.06531090663274634
ONCOCYTOMA	0.00408163	0.06531090663274634
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.06531090663274634
MYELOPEROXIDASE DEFICIENCY	0.00408163	0.06531090663274634
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.06531090663274634
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00408163	0.06531090663274634
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.06531090663274634
APOLIPOPROTEIN(A)	0.00408163	0.06531090663274634
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.06531090663274634
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.06531090663274634
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.06531090663274634
PREMATURE OVARIAN FAILURE 1	0.00408163	0.06531090663274634
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.06531090663274634
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.06531090663274634
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.06531090663274634
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00408163	0.06531090663274634
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.06531090663274634
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.06531090663274634
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.06531090663274634
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.06531090663274634
LYMPHOKINE DEFICIENCY	0.00408163	0.06531090663274634
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.06531090663274634
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.00408163	0.06531090663274634
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.06531090663274634
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00408163	0.06531090663274634
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.06531090663274634
CARDIAC LIPIDOSIS, FAMILIAL	0.00408163	0.06531090663274634
COUMARIN RESISTANCE	0.00408163	0.06531090663274634
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.06531090663274634
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.06531090663274634
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.06531090663274634
XANTHINURIA, TYPE I	0.00408163	0.06531090663274634
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.06531090663274634
NEPHROSIALIDOSIS	0.00408163	0.06531090663274634
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.06531090663274634
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.06531090663274634
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00408163	0.06531090663274634
AREDYLD	0.00408163	0.06531090663274634
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.00408163	0.06531090663274634
LIPASE DEFICIENCY, COMBINED	0.00408163	0.06531090663274634
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.06531090663274634
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.06531090663274634
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.06531090663274634
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.06531090663274634
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.06531090663274634
DELETED IN AZOOSPERMIA	0.00408163	0.06531090663274634
HYPOASCORBEMIA	0.00408163	0.06531090663274634
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.06531090663274634
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.06531090663274634
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00408163	0.06531090663274634
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.06531090663274634
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.06531090663274634
CITRULLINE TRANSPORT DEFECT	0.00408163	0.06531090663274634
ETHANOLAMINOSIS	0.00408163	0.06531090663274634
DERMATOLEUKODYSTROPHY	0.00408163	0.06531090663274634
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.06531090663274634
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.06531090663274634
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.06531090663274634
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.06531090663274634
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.06531090663274634
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.06531090663274634
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.06531090663274634
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.06531090663274634
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00408163	0.06531090663274634
PACMAN DYSPLASIA	0.00408163	0.06531090663274634
PYGMY	0.00408163	0.06531090663274634
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00408163	0.06531090663274634
GONADOBLASTOMA	0.00408163	0.06531090663274634
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.06531090663274634
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.06531090663274634
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.06531090663274634
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.06531090663274634
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.06531090663274634
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.06531090663274634
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00408163	0.06531090663274634
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.06531090663274634
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.06531090663274634
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.06531090663274634
FLOOD FACTOR DEFICIENCY	0.00408163	0.06531090663274634
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.06531090663274634
ZINC, ELEVATED PLASMA	0.00408163	0.06531090663274634
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.06531090663274634
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.06531090663274634
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.06531090663274634
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.06531090663274634
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.06531090663274634
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.06531090663274634
BLOOD GROUP, DUFFY SYSTEM; FY	0.00408163	0.06531090663274634
XM SYSTEM	0.00408163	0.06531090663274634
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.06531090663274634
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.06531090663274634
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.06531090663274634
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.004080311	0.06528980107299481
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.004080311	0.06528980107299481
HARTNUP DISORDER	0.004080311	0.06528980107299481
GLUTAMINE DEFICIENCY, CONGENITAL	0.004080311	0.06528980107299481
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.004080311	0.06528980107299481
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.004080311	0.06528980107299481
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00386275	0.061808567801501096
SUPRABULBAR PARESIS, CONGENITAL	0.003724741	0.05960026060229914
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.003724741	0.05960026060229914
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.003724741	0.05960026060229914
COFFIN-SIRIS SYNDROME 5	0.0037090510000000005	0.05934920204846948
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.0037090510000000005	0.05934920204846948
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.0037090510000000005	0.05934920204846948
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.0037090510000000005	0.05934920204846948
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0037090510000000005	0.05934920204846948
MECKEL SYNDROME, TYPE 10; MKS10	0.0037090510000000005	0.05934920204846948
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00362319	0.057975324515622484
MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM	0.00362319	0.057975324515622484
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.00362319	0.057975324515622484
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.00362319	0.057975324515622484
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00362319	0.057975324515622484
HYPOGONADISM-CATARACT SYNDROME	0.00362319	0.057975324515622484
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00362319	0.057975324515622484
GALACTOKINASE DEFICIENCY	0.00362319	0.057975324515622484
%609376 CATARACT 35; CTRCT35;;CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	0.00362319	0.057975324515622484
HYPERTROPHIC NEUROPATHY AND CATARACT	0.00362319	0.057975324515622484
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00362319	0.057975324515622484
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00362319	0.057975324515622484
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00362319	0.057975324515622484
CATARACT AND CONGENITAL ICHTHYOSIS	0.00362319	0.057975324515622484
NATHALIE SYNDROME	0.00362319	0.057975324515622484
TRICHOMEGALY; TCMGLY	0.00362319	0.057975324515622484
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00362319	0.057975324515622484
MARTSOLF SYNDROME	0.00362319	0.057975324515622484
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00362319	0.057975324515622484
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00362319	0.057975324515622484
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.00362319	0.057975324515622484
MYOTONIC DYSTROPHY 1	0.00362319	0.057975324515622484
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.00362319	0.057975324515622484
#610019 CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 2; CATC2	0.00362319	0.057975324515622484
#613887 CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 4; CATC4	0.00362319	0.057975324515622484
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00362319	0.057975324515622484
CATARACT, CRYSTALLINE CORALLIFORM	0.00362319	0.057975324515622484
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.00361011	0.05776602904818514
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.00361011	0.05776602904818514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.00361011	0.05776602904818514
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.00361011	0.05776602904818514
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00361011	0.05776602904818514
OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME	0.00361011	0.05776602904818514
CHROMOSOME 16p13.2 DELETION SYNDROME	0.003403311	0.05445700050303398
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.003403311	0.05445700050303398
C SYNDROME	0.003403311	0.05445700050303398
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.003403311	0.05445700050303398
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A	0.00316456	0.05063670217381873
NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D	0.00316456	0.05063670217381873
AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16	0.00316456	0.05063670217381873
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00316456	0.05063670217381873
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.00316456	0.05063670217381873
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.002919761	0.046719628692687504
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.002919761	0.046719628692687504
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.002919761	0.046719628692687504
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002919761	0.046719628692687504
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00280899	0.04494716170312305
EPISODIC ATAXIA, TYPE 7; EA7	0.00280899	0.04494716170312305
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.00280899	0.04494716170312305
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.00280899	0.04494716170312305
608028 THAI SYMPHALANGISM SYNDROME	0.0027933000000000003	0.044696103149293384
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.0027933000000000003	0.044696103149293384
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.0027933000000000003	0.044696103149293384
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.0027933000000000003	0.044696103149293384
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.0027933000000000003	0.044696103149293384
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0027933000000000003	0.044696103149293384
MEIER-GORLIN SYNDROME 8; MGORS8	0.0027933000000000003	0.044696103149293384
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.0027933000000000003	0.044696103149293384
AASE-SMITH SYNDROME I	0.0027933000000000003	0.044696103149293384
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027933000000000003	0.044696103149293384
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.0027933000000000003	0.044696103149293384
CDAGS SYNDROME	0.0027933000000000003	0.044696103149293384
WIDOW&#39;S PEAK SYNDROME	0.0027933000000000003	0.044696103149293384
DEAFNESS, X-LINKED 7; DFNX7	0.0027933000000000003	0.044696103149293384
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0027933000000000003	0.044696103149293384
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.0027933000000000003	0.044696103149293384
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0027933000000000003	0.044696103149293384
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0027933000000000003	0.044696103149293384
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.0027933000000000003	0.044696103149293384
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0027933000000000003	0.044696103149293384
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0027933000000000003	0.044696103149293384
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0027933000000000003	0.044696103149293384
SALIH MYOPATHY; SALMY	0.0027933000000000003	0.044696103149293384
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.0027933000000000003	0.044696103149293384
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.0027933000000000003	0.044696103149293384
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0027933000000000003	0.044696103149293384
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0027933000000000003	0.044696103149293384
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5	0.0027933000000000003	0.044696103149293384
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0027933000000000003	0.044696103149293384
AU-KLINE SYNDROME; AUKS	0.0027933000000000003	0.044696103149293384
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.0027933000000000003	0.044696103149293384
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.0027933000000000003	0.044696103149293384
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.0027933000000000003	0.044696103149293384
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.0027933000000000003	0.044696103149293384
PURPURA SIMPLEX	0.0027933000000000003	0.044696103149293384
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0027933000000000003	0.044696103149293384
HYPOTONIA-CYSTINURIA SYNDROME	0.0027933000000000003	0.044696103149293384
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.0027933000000000003	0.044696103149293384
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0027933000000000003	0.044696103149293384
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.0027933000000000003	0.044696103149293384
COFFIN-LOWRY SYNDROME; CLS	0.002774491	0.044395136907165775
IMMUNODEFICIENCY 49; IMD49	0.002774491	0.044395136907165775
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.002774491	0.044395136907165775
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.002774491	0.044395136907165775
AUTISM, SUSCEPTIBILITY TO, 18	0.002774491	0.044395136907165775
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.002774491	0.044395136907165775
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.002774491	0.044395136907165775
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.002774491	0.044395136907165775
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.002774491	0.044395136907165775
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.002774491	0.044395136907165775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002774491	0.044395136907165775
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.002774491	0.044395136907165775
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002774491	0.044395136907165775
#613707 LEOPARD SYNDROME 3; LPRD3	0.002774491	0.044395136907165775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.002774491	0.044395136907165775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.002774491	0.044395136907165775
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.002774491	0.044395136907165775
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.002774491	0.044395136907165775
ATKIN-FLAITZ SYNDROME	0.002774491	0.044395136907165775
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002774491	0.044395136907165775
OROFACIODIGITAL SYNDROME I; OFD1	0.002774491	0.044395136907165775
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002774491	0.044395136907165775
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002774491	0.044395136907165775
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.002774491	0.044395136907165775
KBG SYNDROME	0.002774491	0.044395136907165775
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00248756	0.03980390160385789
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.00248756	0.03980390160385789
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.00248756	0.03980390160385789
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00248756	0.03980390160385789
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.00248756	0.03980390160385789
JOHANSON-BLIZZARD SYNDROME; JBS	0.00248756	0.03980390160385789
SECKEL SYNDROME 5; SCKL5	0.00248756	0.03980390160385789
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00248756	0.03980390160385789
ABDUCENS PALSY	0.00248756	0.03980390160385789
MEIER-GORLIN SYNDROME 1; MGORS1	0.00248756	0.03980390160385789
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00248756	0.03980390160385789
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00248756	0.03980390160385789
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.00248756	0.03980390160385789
MEIER-GORLIN SYNDROME 6; MGORS6	0.00248756	0.03980390160385789
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00200401	0.03206652979351142
NYSTAGMUS, VOLUNTARY	0.00200401	0.03206652979351142
DANDY-WALKER SYNDROME	0.00200401	0.03206652979351142
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00200401	0.03206652979351142
CHIARI MALFORMATION TYPE II	0.00200401	0.03206652979351142
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00200401	0.03206652979351142
LENTIGINES	0.00200401	0.03206652979351142
Pelizaeus-Merzbacher disease	0.00200401	0.03206652979351142
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00200401	0.03206652979351142
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00200401	0.03206652979351142
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.00200401	0.03206652979351142
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.00185874	0.02974203800798968
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00185874	0.02974203800798968
OROFACIAL CLEFT 15	0.00185874	0.02974203800798968
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00185874	0.02974203800798968
OPSISMODYSPLASIA; OPSMD	0.00185874	0.02974203800798968
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00185874	0.02974203800798968
#609597 PARIETAL FORAMINA 2; PFM2	0.00185874	0.02974203800798968
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.00185874	0.02974203800798968
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00185874	0.02974203800798968
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00185874	0.02974203800798968
OROFACIODIGITAL SYNDROME XV; OFD15	0.00185874	0.02974203800798968
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00185874	0.02974203800798968
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00185874	0.02974203800798968
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.00185874	0.02974203800798968
WHITE FORELOCK WITH MALFORMATIONS	0.00185874	0.02974203800798968
HYPERTELORISM	0.00185874	0.02974203800798968
#212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII	0.00185874	0.02974203800798968
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.00185874	0.02974203800798968
NOONAN SYNDROME 3; NS3	0.00185874	0.02974203800798968
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.00185874	0.02974203800798968
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.00185874	0.02974203800798968
BARBER-SAY SYNDROME; BBRSAY	0.00185874	0.02974203800798968
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.00185874	0.02974203800798968
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00185874	0.02974203800798968
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00185874	0.02974203800798968
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00185874	0.02974203800798968
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.00185874	0.02974203800798968
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00185874	0.02974203800798968
KEIPERT SYNDROME; KPTS	0.00185874	0.02974203800798968
NEU-LAXOVA SYNDROME 2; NLS2	0.00185874	0.02974203800798968
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00185874	0.02974203800798968
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00185874	0.02974203800798968
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.00185874	0.02974203800798968
#611554 LEOPARD SYNDROME 2	0.00185874	0.02974203800798968
DIAMOND-BLACKFAN ANEMIA 5	0.00185874	0.02974203800798968
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00185874	0.02974203800798968
CLEIDOCRANIAL DYSPLASIA; CCD	0.00185874	0.02974203800798968
600736 VELOFACIOSKELETAL SYNDROME	0.00185874	0.02974203800798968
DIAMOND-BLACKFAN ANEMIA 8	0.00185874	0.02974203800798968
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00185874	0.02974203800798968
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00185874	0.02974203800798968
SCHIZOPHRENIA 1; SCZD1	0.00185874	0.02974203800798968
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00185874	0.02974203800798968
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.00185874	0.02974203800798968
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.00185874	0.02974203800798968
OROFACIODIGITAL SYNDROME IV; OFD4	0.00185874	0.02974203800798968
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00185874	0.02974203800798968
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00185874	0.02974203800798968
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.00185874	0.02974203800798968
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00185874	0.02974203800798968
NASODIGITOACOUSTIC SYNDROME	0.00185874	0.02974203800798968
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00185874	0.02974203800798968
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00185874	0.02974203800798968
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00185874	0.02974203800798968
CHROMOSOME 16Q22 DELETION SYNDROME	0.00185874	0.02974203800798968
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00185874	0.02974203800798968
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.00185874	0.02974203800798968
SCLEROSTEOSIS 2; SOST2	0.00185874	0.02974203800798968
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00185874	0.02974203800798968
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.00185874	0.02974203800798968
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.00185874	0.02974203800798968
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00185874	0.02974203800798968
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00185874	0.02974203800798968
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00185874	0.02974203800798968
DIAPHANOSPONDYLODYSOSTOSIS	0.00185874	0.02974203800798968
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00185874	0.02974203800798968
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00185874	0.02974203800798968
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00185874	0.02974203800798968
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00185874	0.02974203800798968
OROFACIODIGITAL SYNDROME V; OFD5	0.00185874	0.02974203800798968
NF1-microdeletion syndrome	0.00185874	0.02974203800798968
ABLEPHARON-MACROSTOMIA SYNDROME	0.00185874	0.02974203800798968
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00185874	0.02974203800798968
#278250 WRINKLY SKIN SYNDROME; WSS	0.00185874	0.02974203800798968
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00185874	0.02974203800798968
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00185874	0.02974203800798968
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.00185874	0.02974203800798968
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00185874	0.02974203800798968
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00185874	0.02974203800798968
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00185874	0.02974203800798968
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00185874	0.02974203800798968
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00185874	0.02974203800798968
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00185874	0.02974203800798968
WIDOW'S PEAK	0.00185874	0.02974203800798968
SWEENEY-COX SYNDROME; SWCOS	0.00185874	0.02974203800798968
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00185874	0.02974203800798968
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00185874	0.02974203800798968
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00185874	0.02974203800798968
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00185874	0.02974203800798968
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00185874	0.02974203800798968
#614976 CARPENTER SYNDROME 2; CRPT2	0.00185874	0.02974203800798968
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00185874	0.02974203800798968
STEEL SYNDROME; STLS	0.00185874	0.02974203800798968
CHROMOSOME 4q21 DELETION SYNDROME	0.00185874	0.02974203800798968
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00185874	0.02974203800798968
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00185874	0.02974203800798968
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00185874	0.02974203800798968
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00185874	0.02974203800798968
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.00185874	0.02974203800798968
TRICHOHEPATOENTERIC SYNDROME 2	0.00185874	0.02974203800798968
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00185874	0.02974203800798968
FRONTOMETAPHYSEAL DYSPLASIA	0.00185874	0.02974203800798968
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00185874	0.02974203800798968
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.014653098899176088
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.014653098899176088
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.014653098899176088
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.014653098899176088
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.014653098899176088
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000915751	0.014653098899176088
FOUNTAIN SYNDROME	0.000915751	0.014653098899176088
LISSENCEPHALY 4	0.000915751	0.014653098899176088
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.014653098899176088
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.014653098899176088
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000915751	0.014653098899176088
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000915751	0.014653098899176088
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000915751	0.014653098899176088
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000915751	0.014653098899176088
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000915751	0.014653098899176088
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000915751	0.014653098899176088
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.014653098899176088
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.014653098899176088
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000915751	0.014653098899176088
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.014653098899176088
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.014653098899176088
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.014653098899176088
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.014653098899176088
CLARK-BARAITSER SYNDROME	0.000915751	0.014653098899176088
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.014653098899176088
CATEL-MANZKE SYNDROME; CATMANS	0.000915751	0.014653098899176088
LISSENCEPHALY 1; LIS1	0.000915751	0.014653098899176088
ALEXANDER DISEASE	0.000915751	0.014653098899176088
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.014653098899176088
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.014653098899176088
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000915751	0.014653098899176088
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.014653098899176088
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.014653098899176088
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000915751	0.014653098899176088
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.014653098899176088
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000915751	0.014653098899176088
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000915751	0.014653098899176088
HYPERPROLINEMIA, TYPE II	0.000915751	0.014653098899176088
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000915751	0.014653098899176088
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.014653098899176088
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.014653098899176088
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.014653098899176088
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.014653098899176088
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.014653098899176088
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000915751	0.014653098899176088
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.014653098899176088
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.014653098899176088
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000915751	0.014653098899176088
HYPER-BETA-ALANINEMIA	0.000915751	0.014653098899176088
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.014653098899176088
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000915751	0.014653098899176088
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.014653098899176088
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000915751	0.014653098899176088
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000915751	0.014653098899176088
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000915751	0.014653098899176088
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.014653098899176088
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000915751	0.014653098899176088
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.014653098899176088
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.014653098899176088
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.014653098899176088
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000915751	0.014653098899176088
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.014653098899176088
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000915751	0.014653098899176088
KLEEFSTRA SYNDROME 2; KLEFS2	0.000915751	0.014653098899176088
DIAMINOPENTANURIA	0.000915751	0.014653098899176088
POTOCKI-SHAFFER SYNDROME	0.000915751	0.014653098899176088
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.014653098899176088
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.014653098899176088
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000915751	0.014653098899176088
Angelman syndrome (Type 2)	0.000915751	0.014653098899176088
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000915751	0.014653098899176088
MENTAL RETARDATION, X-LINKED 9	0.000915751	0.014653098899176088
KETOADIPICACIDURIA	0.000915751	0.014653098899176088
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.014653098899176088
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000915751	0.014653098899176088
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000915751	0.014653098899176088
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.014653098899176088
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.014653098899176088
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.000915751	0.014653098899176088
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000915751	0.014653098899176088
DARIER-WHITE DISEASE; DAR	0.000915751	0.014653098899176088
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.014653098899176088
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.014653098899176088
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.014653098899176088
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.014653098899176088
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.014653098899176088
MENKES DISEASE	0.000915751	0.014653098899176088
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.014653098899176088
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000915751	0.014653098899176088
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.014653098899176088
GRISCELLI SYNDROME, TYPE 1	0.000915751	0.014653098899176088
EPILEPSY, READING	0.000915751	0.014653098899176088
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000915751	0.014653098899176088
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000915751	0.014653098899176088
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000915751	0.014653098899176088
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000915751	0.014653098899176088
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000915751	0.014653098899176088
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000915751	0.014653098899176088
KEUTEL SYNDROME; KTLS	0.000915751	0.014653098899176088
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000915751	0.014653098899176088
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000915751	0.014653098899176088
MACDERMOT-WINTER SYNDROME	0.000915751	0.014653098899176088
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.014653098899176088
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000915751	0.014653098899176088
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000915751	0.014653098899176088
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000915751	0.014653098899176088
Wolf-Hirschhorn Syndrome	0.000915751	0.014653098899176088
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000915751	0.014653098899176088
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.014653098899176088
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000915751	0.014653098899176088
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.014653098899176088
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.014653098899176088
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000915751	0.014653098899176088
PARIETAL FORAMINA	0.000915751	0.014653098899176088
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.014653098899176088
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.014653098899176088
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.014653098899176088
MENTAL RETARDATION, X-LINKED 103	0.000915751	0.014653098899176088
MENTAL RETARDATION, X-LINKED 88	0.000915751	0.014653098899176088
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.014653098899176088
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.014653098899176088
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.000915751	0.014653098899176088
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.000915751	0.014653098899176088
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.014653098899176088
LISSENCEPHALY 3; LIS3	0.000915751	0.014653098899176088
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000915751	0.014653098899176088
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000915751	0.014653098899176088
15q13.3 microdeletion syndrome	0.000915751	0.014653098899176088
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.014653098899176088
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.014653098899176088
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.014653098899176088
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000915751	0.014653098899176088
Angelman syndrome (Type 1)	0.000915751	0.014653098899176088
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.014653098899176088
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.014653098899176088
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.014653098899176088
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.014653098899176088
PERRAULT SYNDROME 3	0.000915751	0.014653098899176088
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.014653098899176088
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000915751	0.014653098899176088
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000915751	0.014653098899176088
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.014653098899176088
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.014653098899176088
MIRAGE SYNDROME; MIRAGE	0.000915751	0.014653098899176088
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000915751	0.014653098899176088
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.014653098899176088
BAND HETEROTOPIA; BH	0.000915751	0.014653098899176088
KIFAFA SEIZURE DISORDER	0.000915751	0.014653098899176088
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.014653098899176088
HHHH SYNDROME	0.000915751	0.014653098899176088
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.014653098899176088
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.014653098899176088
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.014653098899176088
MEGALENCEPHALY WITH DYSMYELINATION	0.000915751	0.014653098899176088
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000915751	0.014653098899176088
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.014653098899176088
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000915751	0.014653098899176088
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.014653098899176088
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.014653098899176088
GURRIERI SYNDROME	0.000915751	0.014653098899176088
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.014653098899176088
THREONINEMIA	0.000915751	0.014653098899176088
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.014653098899176088
TIMOTHY SYNDROME; TS	0.000915751	0.014653098899176088
